Background  ||| S:24 E:43 ||| NNP
Fibronectin  ||| S:43 E:55 ||| NNP
can  ||| S:55 E:59 ||| MD
control  ||| S:59 E:67 ||| VB
many  ||| S:67 E:72 ||| JJ
aspects  ||| S:72 E:80 ||| NNS
of  ||| S:80 E:83 ||| IN
cell  ||| S:83 E:88 ||| NN
behavior ||| S:88 E:96 ||| NN
,  ||| S:96 E:106 ||| ,
including  ||| S:106 E:116 ||| VBG
cell  ||| S:116 E:121 ||| NN
growth ||| S:121 E:127 ||| NN
,  ||| S:127 E:129 ||| ,
migration  ||| S:129 E:139 ||| NN
and  ||| S:139 E:143 ||| CC
differentiation  ||| S:143 E:159 ||| NNS
[  ||| S:159 E:161 ||| -LRB-
1  ||| S:161 E:163 ||| LS
]  ||| S:163 E:173 ||| -RRB-
.  ||| S:173 E:175 ||| .
Fibronectin  ||| S:175 E:187 ||| NNP
exists  ||| S:187 E:194 ||| VBZ
in  ||| S:194 E:197 ||| IN
the  ||| S:197 E:201 ||| DT
blood  ||| S:201 E:207 ||| NN
as  ||| S:207 E:210 ||| IN
a  ||| S:210 E:212 ||| DT
dimer ||| S:212 E:217 ||| NN
,  ||| S:217 E:219 ||| ,
but  ||| S:219 E:223 ||| CC
in  ||| S:223 E:234 ||| IN
tissues  ||| S:234 E:242 ||| NNS
it  ||| S:242 E:245 ||| PRP
is  ||| S:245 E:248 ||| VBZ
in  ||| S:248 E:251 ||| IN
the  ||| S:251 E:255 ||| DT
form  ||| S:255 E:260 ||| NN
of  ||| S:260 E:263 ||| IN
an  ||| S:263 E:266 ||| DT
insoluble  ||| S:266 E:276 ||| JJ
fibrillar  ||| S:276 E:286 ||| JJ
matrix ||| S:286 E:292 ||| NN
.  ||| S:292 E:302 ||| .
The  ||| S:302 E:306 ||| DT
fibrillar  ||| S:306 E:316 ||| JJ
form  ||| S:316 E:321 ||| NN
of  ||| S:321 E:324 ||| IN
fibronectin  ||| S:324 E:336 ||| NN
is  ||| S:336 E:339 ||| VBZ
thought  ||| S:339 E:347 ||| VBN
to  ||| S:347 E:350 ||| TO
be  ||| S:350 E:353 ||| VB
the  ||| S:353 E:357 ||| DT
most  ||| S:357 E:370 ||| RBS
relevant  ||| S:370 E:379 ||| JJ
form  ||| S:379 E:384 ||| NN
in  ||| S:384 E:387 ||| IN
vivo  ||| S:387 E:392 ||| NN
because  ||| S:392 E:400 ||| IN
this  ||| S:400 E:405 ||| DT
is  ||| S:405 E:408 ||| VBZ
the  ||| S:408 E:412 ||| DT
form  ||| S:412 E:417 ||| NN
with  ||| S:417 E:422 ||| IN
which  ||| S:422 E:436 ||| WDT
most  ||| S:436 E:441 ||| JJS
cells  ||| S:441 E:447 ||| NNS
interact  ||| S:447 E:456 ||| VBP
[  ||| S:456 E:458 ||| -LRB-
1  ||| S:458 E:460 ||| LS
]  ||| S:460 E:462 ||| -RRB-
.  ||| S:462 E:464 ||| .
Various  ||| S:464 E:472 ||| JJ
lines  ||| S:472 E:478 ||| NNS
of  ||| S:478 E:481 ||| IN
evidence  ||| S:481 E:498 ||| NN
suggest  ||| S:498 E:506 ||| VBP
that  ||| S:506 E:511 ||| IN
the  ||| S:511 E:515 ||| DT
fibrillar  ||| S:515 E:525 ||| JJ
matrix  ||| S:525 E:532 ||| JJ
form  ||| S:532 E:537 ||| NN
of  ||| S:537 E:540 ||| IN
fibronectin  ||| S:540 E:560 ||| JJ
exerts  ||| S:560 E:567 ||| JJ
effects  ||| S:567 E:575 ||| NNS
on  ||| S:575 E:578 ||| IN
cells  ||| S:578 E:584 ||| NNS
that  ||| S:584 E:589 ||| WDT
are  ||| S:589 E:593 ||| VBP
not  ||| S:593 E:597 ||| RB
duplicated  ||| S:597 E:608 ||| VBN
by  ||| S:608 E:611 ||| IN
the  ||| S:611 E:623 ||| DT
dimeric  ||| S:623 E:631 ||| JJ
form  ||| S:631 E:636 ||| NN
of  ||| S:636 E:639 ||| IN
fibronectin ||| S:639 E:650 ||| NN
.  ||| S:650 E:652 ||| .
For  ||| S:652 E:656 ||| IN
example ||| S:656 E:663 ||| NN
,  ||| S:663 E:665 ||| ,
high  ||| S:665 E:678 ||| JJ
concentrations  ||| S:678 E:693 ||| NNS
of  ||| S:693 E:696 ||| IN
dimeric  ||| S:696 E:704 ||| FW
fibronectin  ||| S:704 E:716 ||| FW
enhance  ||| S:716 E:724 ||| FW
cell  ||| S:724 E:737 ||| FW
migration  ||| S:737 E:747 ||| FW
whereas  ||| S:747 E:755 ||| FW
high  ||| S:755 E:760 ||| JJ
concentrations  ||| S:760 E:775 ||| NNS
of  ||| S:775 E:778 ||| IN
fibrillar  ||| S:778 E:796 ||| FW
fibronectin  ||| S:796 E:808 ||| FW
reduce  ||| S:808 E:815 ||| FW
cell  ||| S:815 E:820 ||| FW
migration  ||| S:820 E:830 ||| FW
[  ||| S:830 E:832 ||| -LRB-
2  ||| S:832 E:834 ||| LS
]  ||| S:834 E:836 ||| -RRB-
.  ||| S:836 E:838 ||| .
Also ||| S:838 E:842 ||| RB
,  ||| S:842 E:844 ||| ,
inhibition  ||| S:844 E:863 ||| VBG
of  ||| S:863 E:866 ||| IN
fibronectin  ||| S:866 E:878 ||| JJ
matrix  ||| S:878 E:885 ||| JJ
assembly  ||| S:885 E:894 ||| NN
has  ||| S:894 E:898 ||| VBZ
been  ||| S:898 E:903 ||| VBN
shown  ||| S:903 E:909 ||| VBN
to  ||| S:909 E:912 ||| TO
inhibit  ||| S:912 E:928 ||| VB
cell  ||| S:928 E:933 ||| NN
growth  ||| S:933 E:940 ||| NN
in  ||| S:940 E:943 ||| IN
various  ||| S:943 E:951 ||| JJ
systems  ||| S:951 E:959 ||| NNS
[  ||| S:959 E:961 ||| -LRB-
3  ||| S:961 E:963 ||| CD
4  ||| S:963 E:965 ||| CD
5  ||| S:965 E:967 ||| CD
]  ||| S:967 E:969 ||| -RRB-
.  ||| S:969 E:971 ||| .
These  ||| S:971 E:977 ||| DT
findings  ||| S:977 E:994 ||| NNS
suggest  ||| S:994 E:1002 ||| VBP
that  ||| S:1002 E:1007 ||| IN
fibrillar  ||| S:1007 E:1017 ||| JJ
fibronectin  ||| S:1017 E:1029 ||| NN
may  ||| S:1029 E:1033 ||| MD
stimulate  ||| S:1033 E:1043 ||| VB
signal  ||| S:1043 E:1058 ||| VB
transduction  ||| S:1058 E:1071 ||| JJ
pathways  ||| S:1071 E:1080 ||| NN
in  ||| S:1080 E:1083 ||| IN
cells  ||| S:1083 E:1089 ||| NNS
that  ||| S:1089 E:1094 ||| WDT
are  ||| S:1094 E:1098 ||| VBP
either  ||| S:1098 E:1105 ||| RB
not  ||| S:1105 E:1117 ||| RB
stimulated ||| S:1117 E:1127 ||| VBN
,  ||| S:1127 E:1129 ||| ,
or  ||| S:1129 E:1132 ||| CC
only  ||| S:1132 E:1137 ||| RB
marginally  ||| S:1137 E:1148 ||| RB
stimulated ||| S:1148 E:1158 ||| VBN
,  ||| S:1158 E:1160 ||| ,
by  ||| S:1160 E:1163 ||| IN
dimeric  ||| S:1163 E:1179 ||| JJ
fibronectin ||| S:1179 E:1190 ||| NN
.  ||| S:1190 E:1200 ||| .
Fibronectin  ||| S:1200 E:1212 ||| JJ
matrix  ||| S:1212 E:1219 ||| JJ
assembly  ||| S:1219 E:1228 ||| NN
is  ||| S:1228 E:1231 ||| VBZ
a  ||| S:1231 E:1233 ||| DT
cell-mediated  ||| S:1233 E:1247 ||| JJ
process  ||| S:1247 E:1263 ||| NN
that  ||| S:1263 E:1268 ||| WDT
requires  ||| S:1268 E:1277 ||| VBZ
the  ||| S:1277 E:1281 ||| DT
activity  ||| S:1281 E:1290 ||| NN
of  ||| S:1290 E:1293 ||| IN
integrins  ||| S:1293 E:1303 ||| NNS
[  ||| S:1303 E:1305 ||| -LRB-
1  ||| S:1305 E:1307 ||| CD
6  ||| S:1307 E:1309 ||| CD
7  ||| S:1309 E:1311 ||| CD
8  ||| S:1311 E:1313 ||| CD
]  ||| S:1313 E:1315 ||| -RRB-
.  ||| S:1315 E:1317 ||| .
The  ||| S:1317 E:1329 ||| DT
integrin  ||| S:1329 E:1338 ||| NN
that  ||| S:1338 E:1343 ||| WDT
is  ||| S:1343 E:1346 ||| VBZ
primarily  ||| S:1346 E:1356 ||| RB
responsible  ||| S:1356 E:1368 ||| JJ
for  ||| S:1368 E:1372 ||| IN
assembling  ||| S:1372 E:1391 ||| VBG
fibronectin  ||| S:1391 E:1403 ||| NN
into  ||| S:1403 E:1408 ||| IN
the  ||| S:1408 E:1412 ||| DT
matrix  ||| S:1412 E:1419 ||| NN
is  ||| S:1419 E:1422 ||| VBZ
α5β1 ||| S:1422 E:1426 ||| NNP
,  ||| S:1426 E:1428 ||| ,
although  ||| S:1428 E:1437 ||| IN
αvβ3 ||| S:1437 E:1441 ||| NNP
,  ||| S:1441 E:1443 ||| ,
αllbβ3  ||| S:1443 E:1458 ||| NNP
and  ||| S:1458 E:1462 ||| CC
α4β1  ||| S:1462 E:1467 ||| NNP
can  ||| S:1467 E:1471 ||| MD
also  ||| S:1471 E:1476 ||| RB
function  ||| S:1476 E:1485 ||| VBP
in  ||| S:1485 E:1488 ||| IN
this  ||| S:1488 E:1493 ||| DT
capacity  ||| S:1493 E:1502 ||| NN
[  ||| S:1502 E:1504 ||| -LRB-
9  ||| S:1504 E:1506 ||| CD
10  ||| S:1506 E:1509 ||| CD
11  ||| S:1509 E:1512 ||| CD
12  ||| S:1512 E:1515 ||| CD
13  ||| S:1515 E:1526 ||| CD
14  ||| S:1526 E:1529 ||| CD
]  ||| S:1529 E:1531 ||| -RRB-
.  ||| S:1531 E:1533 ||| .
In  ||| S:1533 E:1536 ||| IN
addition  ||| S:1536 E:1545 ||| NN
to  ||| S:1545 E:1548 ||| TO
integrins ||| S:1548 E:1557 ||| VB
,  ||| S:1557 E:1559 ||| ,
fibronectin  ||| S:1559 E:1571 ||| JJ
matrix  ||| S:1571 E:1586 ||| JJ
assembly  ||| S:1586 E:1595 ||| NN
also  ||| S:1595 E:1600 ||| RB
depends  ||| S:1600 E:1608 ||| VBZ
on  ||| S:1608 E:1611 ||| IN
self-association  ||| S:1611 E:1628 ||| JJ
sites  ||| S:1628 E:1634 ||| NNS
within  ||| S:1634 E:1649 ||| IN
fibronectin ||| S:1649 E:1660 ||| NN
.  ||| S:1660 E:1662 ||| .
For  ||| S:1662 E:1666 ||| IN
example ||| S:1666 E:1673 ||| NN
,  ||| S:1673 E:1675 ||| ,
the  ||| S:1675 E:1679 ||| DT
N-terminal  ||| S:1679 E:1690 ||| JJ
70  ||| S:1690 E:1693 ||| CD
kDa  ||| S:1693 E:1697 ||| JJ
region ||| S:1697 E:1703 ||| NN
,  ||| S:1703 E:1705 ||| ,
the  ||| S:1705 E:1717 ||| DT
1  ||| S:1717 E:1719 ||| CD
sttype  ||| S:1719 E:1726 ||| JJ
III  ||| S:1726 E:1730 ||| NNP
repeat  ||| S:1730 E:1737 ||| NN
and  ||| S:1737 E:1741 ||| CC
the  ||| S:1741 E:1745 ||| DT
10  ||| S:1745 E:1748 ||| CD
thtype  ||| S:1748 E:1755 ||| JJ
III  ||| S:1755 E:1759 ||| NNP
repeat  ||| S:1759 E:1766 ||| NNS
are  ||| S:1766 E:1778 ||| VBP
thought  ||| S:1778 E:1786 ||| VBN
to  ||| S:1786 E:1789 ||| TO
be  ||| S:1789 E:1792 ||| VB
important  ||| S:1792 E:1802 ||| JJ
for  ||| S:1802 E:1806 ||| IN
the  ||| S:1806 E:1810 ||| DT
proper  ||| S:1810 E:1817 ||| JJ
alignment  ||| S:1817 E:1827 ||| NN
of  ||| S:1827 E:1838 ||| IN
fibronectin  ||| S:1838 E:1850 ||| JJ
molecules  ||| S:1850 E:1860 ||| NNS
during  ||| S:1860 E:1867 ||| IN
matrix  ||| S:1867 E:1874 ||| JJ
assembly  ||| S:1874 E:1883 ||| NN
[  ||| S:1883 E:1885 ||| -LRB-
15  ||| S:1885 E:1888 ||| CD
16  ||| S:1888 E:1891 ||| CD
17  ||| S:1891 E:1894 ||| CD
18  ||| S:1894 E:1905 ||| CD
19  ||| S:1905 E:1908 ||| CD
20  ||| S:1908 E:1911 ||| CD
21  ||| S:1911 E:1914 ||| CD
22  ||| S:1914 E:1917 ||| CD
]  ||| S:1917 E:1919 ||| -RRB-
.  ||| S:1919 E:1921 ||| .
We  ||| S:1921 E:1924 ||| PRP
and  ||| S:1924 E:1928 ||| CC
others  ||| S:1928 E:1935 ||| NNS
have  ||| S:1935 E:1940 ||| VBP
shown  ||| S:1940 E:1946 ||| VBN
that  ||| S:1946 E:1951 ||| IN
a  ||| S:1951 E:1953 ||| DT
recombinant  ||| S:1953 E:1973 ||| JJ
protein  ||| S:1973 E:1981 ||| NN
representing  ||| S:1981 E:1994 ||| VBG
a  ||| S:1994 E:1996 ||| DT
portion  ||| S:1996 E:2004 ||| NN
of  ||| S:2004 E:2007 ||| IN
the  ||| S:2007 E:2011 ||| DT
first  ||| S:2011 E:2017 ||| JJ
type  ||| S:2017 E:2022 ||| NN
III  ||| S:2022 E:2026 ||| NNP
repeat  ||| S:2026 E:2041 ||| NN
( ||| S:2041 E:2042 ||| -LRB-
protein  ||| S:2042 E:2050 ||| FW
III1-C ||| S:2050 E:2056 ||| FW
)  ||| S:2056 E:2058 ||| -RRB-
can  ||| S:2058 E:2062 ||| MD
affect  ||| S:2062 E:2069 ||| VB
fibronectin  ||| S:2069 E:2081 ||| JJ
matrix  ||| S:2081 E:2088 ||| JJ
assembly  ||| S:2088 E:2097 ||| NN
and  ||| S:2097 E:2109 ||| CC
cell  ||| S:2109 E:2114 ||| NN
growth  ||| S:2114 E:2121 ||| NN
[  ||| S:2121 E:2123 ||| -LRB-
2  ||| S:2123 E:2125 ||| CD
3  ||| S:2125 E:2127 ||| CD
4  ||| S:2127 E:2129 ||| CD
16  ||| S:2129 E:2132 ||| CD
]  ||| S:2132 E:2134 ||| -RRB-
.  ||| S:2134 E:2136 ||| .
Moreover ||| S:2136 E:2144 ||| RB
,  ||| S:2144 E:2146 ||| ,
a  ||| S:2146 E:2148 ||| DT
mutant  ||| S:2148 E:2155 ||| JJ
recombinant  ||| S:2155 E:2175 ||| JJ
fibronectin  ||| S:2175 E:2187 ||| JJ
molecule  ||| S:2187 E:2196 ||| NN
that  ||| S:2196 E:2201 ||| WDT
is  ||| S:2201 E:2204 ||| VBZ
lacking  ||| S:2204 E:2212 ||| VBG
the  ||| S:2212 E:2216 ||| DT
first  ||| S:2216 E:2222 ||| JJ
seven  ||| S:2222 E:2228 ||| CD
type  ||| S:2228 E:2241 ||| NN
III  ||| S:2241 E:2245 ||| NNP
repeats  ||| S:2245 E:2253 ||| NN
has  ||| S:2253 E:2257 ||| VBZ
been  ||| S:2257 E:2262 ||| VBN
shown  ||| S:2262 E:2268 ||| VBN
to  ||| S:2268 E:2271 ||| TO
lead  ||| S:2271 E:2276 ||| VB
to  ||| S:2276 E:2279 ||| TO
defective  ||| S:2279 E:2289 ||| JJ
fibronectin  ||| S:2289 E:2309 ||| JJ
matrix  ||| S:2309 E:2316 ||| JJ
assembly  ||| S:2316 E:2325 ||| NN
in  ||| S:2325 E:2328 ||| IN
cell  ||| S:2328 E:2333 ||| NN
culture  ||| S:2333 E:2341 ||| NN
and  ||| S:2341 E:2345 ||| CC
in  ||| S:2345 E:2348 ||| IN
vivo ||| S:2348 E:2352 ||| NN
,  ||| S:2352 E:2354 ||| ,
and  ||| S:2354 E:2358 ||| CC
to  ||| S:2358 E:2369 ||| TO
inhibition  ||| S:2369 E:2380 ||| VB
of  ||| S:2380 E:2383 ||| IN
cell  ||| S:2383 E:2388 ||| NN
proliferation  ||| S:2388 E:2402 ||| NN
[  ||| S:2402 E:2404 ||| -LRB-
23  ||| S:2404 E:2407 ||| CD
24  ||| S:2407 E:2410 ||| CD
]  ||| S:2410 E:2412 ||| -RRB-
.  ||| S:2412 E:2414 ||| .
Although  ||| S:2414 E:2423 ||| IN
the  ||| S:2423 E:2435 ||| DT
matrix  ||| S:2435 E:2442 ||| NN
produced  ||| S:2442 E:2451 ||| VBN
with  ||| S:2451 E:2456 ||| IN
fibronectin  ||| S:2456 E:2468 ||| NNS
lacking  ||| S:2468 E:2476 ||| VBG
the  ||| S:2476 E:2480 ||| DT
first  ||| S:2480 E:2486 ||| JJ
seven  ||| S:2486 E:2500 ||| CD
type  ||| S:2500 E:2505 ||| NN
III  ||| S:2505 E:2509 ||| NNP
repeats  ||| S:2509 E:2517 ||| NNS
was  ||| S:2517 E:2521 ||| VBD
somewhat  ||| S:2521 E:2530 ||| RB
aberrant ||| S:2530 E:2538 ||| JJ
,  ||| S:2538 E:2540 ||| ,
this  ||| S:2540 E:2545 ||| DT
study  ||| S:2545 E:2551 ||| NN
does  ||| S:2551 E:2564 ||| VBZ
show  ||| S:2564 E:2569 ||| NN
that  ||| S:2569 E:2574 ||| IN
some  ||| S:2574 E:2579 ||| DT
matrix  ||| S:2579 E:2586 ||| JJ
assembly  ||| S:2586 E:2595 ||| NN
can  ||| S:2595 E:2599 ||| MD
occur  ||| S:2599 E:2605 ||| VB
without  ||| S:2605 E:2613 ||| IN
the  ||| S:2613 E:2617 ||| DT
first  ||| S:2617 E:2631 ||| JJ
type  ||| S:2631 E:2636 ||| NN
III  ||| S:2636 E:2640 ||| NNP
repeat ||| S:2640 E:2646 ||| NN
.  ||| S:2646 E:2648 ||| .
Therefore ||| S:2648 E:2657 ||| RB
,  ||| S:2657 E:2659 ||| ,
several  ||| S:2659 E:2667 ||| JJ
approaches  ||| S:2667 E:2678 ||| NNS
reveal  ||| S:2678 E:2685 ||| VBP
that  ||| S:2685 E:2698 ||| IN
the  ||| S:2698 E:2702 ||| DT
fibronectin  ||| S:2702 E:2714 ||| JJ
type  ||| S:2714 E:2719 ||| NN
III  ||| S:2719 E:2723 ||| NNP
repeats ||| S:2723 E:2730 ||| NNS
,  ||| S:2730 E:2732 ||| ,
and  ||| S:2732 E:2736 ||| CC
especially  ||| S:2736 E:2747 ||| RB
the  ||| S:2747 E:2751 ||| DT
first  ||| S:2751 E:2765 ||| JJ
type  ||| S:2765 E:2770 ||| NN
III  ||| S:2770 E:2774 ||| NNP
repeat ||| S:2774 E:2780 ||| NN
,  ||| S:2780 E:2782 ||| ,
play  ||| S:2782 E:2787 ||| VB
important  ||| S:2787 E:2797 ||| JJ
roles  ||| S:2797 E:2803 ||| NNS
in  ||| S:2803 E:2806 ||| IN
the  ||| S:2806 E:2810 ||| DT
regulation  ||| S:2810 E:2821 ||| NN
of  ||| S:2821 E:2832 ||| IN
fibronectin  ||| S:2832 E:2844 ||| JJ
matrix  ||| S:2844 E:2851 ||| JJ
assembly  ||| S:2851 E:2860 ||| NN
and  ||| S:2860 E:2864 ||| CC
cell  ||| S:2864 E:2869 ||| NN
growth ||| S:2869 E:2875 ||| NN
.  ||| S:2875 E:2885 ||| .
III1-C  ||| S:2885 E:2892 ||| NNP
is  ||| S:2892 E:2895 ||| VBZ
known  ||| S:2895 E:2901 ||| VBN
to  ||| S:2901 E:2904 ||| TO
inhibit  ||| S:2904 E:2912 ||| VB
cell  ||| S:2912 E:2917 ||| NN
proliferation  ||| S:2917 E:2931 ||| NN
[  ||| S:2931 E:2933 ||| -LRB-
3  ||| S:2933 E:2935 ||| CD
4  ||| S:2935 E:2937 ||| CD
]  ||| S:2937 E:2939 ||| -RRB-
.  ||| S:2939 E:2949 ||| .
Recently ||| S:2949 E:2957 ||| RB
,  ||| S:2957 E:2959 ||| ,
III1-C  ||| S:2959 E:2966 ||| NNP
( ||| S:2966 E:2967 ||| -LRB-
also  ||| S:2967 E:2972 ||| RB
known  ||| S:2972 E:2978 ||| VBN
as  ||| S:2978 E:2981 ||| IN
anastellin ||| S:2981 E:2991 ||| CD
)  ||| S:2991 E:2993 ||| -RRB-
has  ||| S:2993 E:2997 ||| VBZ
been  ||| S:2997 E:3002 ||| VBN
shown  ||| S:3002 E:3016 ||| VBN
to  ||| S:3016 E:3019 ||| TO
inhibit  ||| S:3019 E:3027 ||| VB
angiogenesis ||| S:3027 E:3039 ||| NNS
,  ||| S:3039 E:3041 ||| ,
and  ||| S:3041 E:3045 ||| CC
tumor  ||| S:3045 E:3051 ||| NN
growth  ||| S:3051 E:3058 ||| NN
and  ||| S:3058 E:3062 ||| CC
metastasis  ||| S:3062 E:3073 ||| NNS
[  ||| S:3073 E:3083 ||| -LRB-
25  ||| S:3083 E:3086 ||| CD
]  ||| S:3086 E:3088 ||| -RRB-
.  ||| S:3088 E:3090 ||| .
In  ||| S:3090 E:3093 ||| IN
the  ||| S:3093 E:3097 ||| DT
present  ||| S:3097 E:3105 ||| JJ
study  ||| S:3105 E:3111 ||| NN
we  ||| S:3111 E:3114 ||| PRP
examine  ||| S:3114 E:3122 ||| VBP
how  ||| S:3122 E:3126 ||| WRB
cells  ||| S:3126 E:3132 ||| NNS
interact  ||| S:3132 E:3149 ||| VBN
with  ||| S:3149 E:3154 ||| IN
and  ||| S:3154 E:3158 ||| CC
respond  ||| S:3158 E:3166 ||| VB
to  ||| S:3166 E:3169 ||| TO
III1-C ||| S:3169 E:3175 ||| CD
,  ||| S:3175 E:3177 ||| ,
with  ||| S:3177 E:3182 ||| IN
a  ||| S:3182 E:3184 ||| DT
particular  ||| S:3184 E:3195 ||| JJ
focus  ||| S:3195 E:3201 ||| NN
on  ||| S:3201 E:3212 ||| IN
signaling  ||| S:3212 E:3222 ||| VBG
through  ||| S:3222 E:3230 ||| IN
the  ||| S:3230 E:3234 ||| DT
Ras ||| S:3234 E:3237 ||| NNP
/ ||| S:3237 E:3238 ||| NNP
ERK  ||| S:3238 E:3242 ||| NNP
pathway ||| S:3242 E:3249 ||| NN
.  ||| S:3249 E:3251 ||| .
We  ||| S:3251 E:3254 ||| PRP
find  ||| S:3254 E:3259 ||| VBP
that  ||| S:3259 E:3264 ||| IN
cells  ||| S:3264 E:3278 ||| NNS
can  ||| S:3278 E:3282 ||| MD
adhere  ||| S:3282 E:3289 ||| VB
and  ||| S:3289 E:3293 ||| CC
spread  ||| S:3293 E:3300 ||| NN
on  ||| S:3300 E:3303 ||| IN
III1-C  ||| S:3303 E:3310 ||| NNP
and  ||| S:3310 E:3314 ||| CC
that  ||| S:3314 E:3319 ||| IN
two  ||| S:3319 E:3323 ||| CD
classes  ||| S:3323 E:3331 ||| NNS
of  ||| S:3331 E:3342 ||| IN
receptors  ||| S:3342 E:3352 ||| JJ
function  ||| S:3352 E:3361 ||| NN
in  ||| S:3361 E:3364 ||| IN
cell  ||| S:3364 E:3369 ||| NN
adhesion  ||| S:3369 E:3378 ||| NN
to  ||| S:3378 E:3381 ||| TO
III1-C ||| S:3381 E:3387 ||| CD
;  ||| S:3387 E:3389 ||| :
integrins  ||| S:3389 E:3407 ||| NNS
and  ||| S:3407 E:3411 ||| CC
cell-surface  ||| S:3411 E:3424 ||| JJ
proteoglycans ||| S:3424 E:3437 ||| NN
.  ||| S:3437 E:3461 ||| .
Results  ||| S:3461 E:3488 ||| NNS
Cell  ||| S:3488 E:3493 ||| JJ
attachment  ||| S:3493 E:3504 ||| NN
and  ||| S:3504 E:3508 ||| CC
spreading  ||| S:3508 E:3518 ||| VBG
on  ||| S:3518 E:3521 ||| IN
the  ||| S:3521 E:3525 ||| DT
first  ||| S:3525 E:3531 ||| JJ
type  ||| S:3531 E:3536 ||| NN
III  ||| S:3536 E:3550 ||| NNP
repeat  ||| S:3550 E:3557 ||| NN
of  ||| S:3557 E:3560 ||| IN
fibronectin  ||| S:3560 E:3582 ||| JJ
III1-C  ||| S:3582 E:3589 ||| NN
is  ||| S:3589 E:3592 ||| VBZ
a  ||| S:3592 E:3594 ||| DT
recombinant  ||| S:3594 E:3606 ||| JJ
fibronectin  ||| S:3606 E:3618 ||| JJ
fragment  ||| S:3618 E:3627 ||| NN
that  ||| S:3627 E:3642 ||| WDT
encompasses  ||| S:3642 E:3654 ||| VBZ
most  ||| S:3654 E:3659 ||| RBS
of  ||| S:3659 E:3662 ||| IN
the  ||| S:3662 E:3666 ||| DT
first  ||| S:3666 E:3672 ||| JJ
type  ||| S:3672 E:3677 ||| NN
III  ||| S:3677 E:3681 ||| NNP
repeat ||| S:3681 E:3687 ||| NN
,  ||| S:3687 E:3689 ||| ,
but  ||| S:3689 E:3693 ||| CC
is  ||| S:3693 E:3706 ||| VBZ
missing  ||| S:3706 E:3714 ||| VBG
the  ||| S:3714 E:3718 ||| DT
A  ||| S:3718 E:3720 ||| NNP
and  ||| S:3720 E:3724 ||| CC
B  ||| S:3724 E:3726 ||| NNP
β-strands  ||| S:3726 E:3736 ||| NNP
of  ||| S:3736 E:3739 ||| IN
the  ||| S:3739 E:3743 ||| DT
repeat  ||| S:3743 E:3750 ||| NN
[  ||| S:3750 E:3752 ||| -LRB-
2  ||| S:3752 E:3754 ||| LS
]  ||| S:3754 E:3756 ||| -RRB-
.  ||| S:3756 E:3758 ||| .
We  ||| S:3758 E:3771 ||| PRP
had  ||| S:3771 E:3775 ||| VBD
previously  ||| S:3775 E:3786 ||| RB
found  ||| S:3786 E:3792 ||| VBN
that  ||| S:3792 E:3797 ||| IN
III1-C  ||| S:3797 E:3804 ||| NNP
inhibited  ||| S:3804 E:3814 ||| VBD
the  ||| S:3814 E:3818 ||| DT
growth  ||| S:3818 E:3825 ||| NN
of  ||| S:3825 E:3838 ||| IN
normal  ||| S:3838 E:3845 ||| JJ
diploid  ||| S:3845 E:3853 ||| JJ
smooth  ||| S:3853 E:3860 ||| JJ
muscle  ||| S:3860 E:3867 ||| NN
cells  ||| S:3867 E:3873 ||| NNS
( ||| S:3873 E:3874 ||| -LRB-
SMCs ||| S:3874 E:3878 ||| NNP
)  ||| S:3878 E:3880 ||| -RRB-
in  ||| S:3880 E:3883 ||| IN
culture  ||| S:3883 E:3891 ||| NN
[  ||| S:3891 E:3893 ||| -LRB-
4  ||| S:3893 E:3905 ||| LS
]  ||| S:3905 E:3907 ||| -RRB-
.  ||| S:3907 E:3909 ||| .
During  ||| S:3909 E:3916 ||| IN
these  ||| S:3916 E:3922 ||| DT
experiments  ||| S:3922 E:3934 ||| NNS
we  ||| S:3934 E:3937 ||| PRP
noticed  ||| S:3937 E:3945 ||| VBD
that  ||| S:3945 E:3950 ||| IN
the  ||| S:3950 E:3954 ||| DT
presence  ||| S:3954 E:3973 ||| NN
of  ||| S:3973 E:3976 ||| IN
III1-C  ||| S:3976 E:3983 ||| CD
in  ||| S:3983 E:3986 ||| IN
the  ||| S:3986 E:3990 ||| DT
culture  ||| S:3990 E:3998 ||| NN
medium  ||| S:3998 E:4005 ||| NN
affected  ||| S:4005 E:4014 ||| VBD
the  ||| S:4014 E:4018 ||| DT
morphology  ||| S:4018 E:4039 ||| NN
of  ||| S:4039 E:4042 ||| IN
cells  ||| S:4042 E:4048 ||| NNS
at  ||| S:4048 E:4051 ||| IN
early  ||| S:4051 E:4057 ||| JJ
times  ||| S:4057 E:4063 ||| NNS
after  ||| S:4063 E:4069 ||| IN
plating ||| S:4069 E:4076 ||| NN
.  ||| S:4076 E:4078 ||| .
As  ||| S:4078 E:4081 ||| RB
shown  ||| S:4081 E:4087 ||| VBN
in  ||| S:4087 E:4090 ||| IN
Figure  ||| S:4090 E:4107 ||| NNP
1 ||| S:4107 E:4108 ||| CD
,  ||| S:4108 E:4110 ||| ,
cells  ||| S:4110 E:4116 ||| NNS
plated  ||| S:4116 E:4123 ||| VBN
onto  ||| S:4123 E:4128 ||| IN
fibronectin  ||| S:4128 E:4140 ||| JJ
coated  ||| S:4140 E:4147 ||| JJ
dishes  ||| S:4147 E:4154 ||| NNS
attached  ||| S:4154 E:4173 ||| VBN
and  ||| S:4173 E:4177 ||| CC
spread  ||| S:4177 E:4184 ||| VBD
well ||| S:4184 E:4188 ||| RB
,  ||| S:4188 E:4190 ||| ,
typically  ||| S:4190 E:4200 ||| RB
containing  ||| S:4200 E:4211 ||| VBG
numerous  ||| S:4211 E:4230 ||| JJ
lamellipodia  ||| S:4230 E:4243 ||| NN
per  ||| S:4243 E:4247 ||| IN
cell  ||| S:4247 E:4252 ||| NN
( ||| S:4252 E:4253 ||| -LRB-
Fig.  ||| S:4253 E:4258 ||| NNP
1A ||| S:4258 E:4260 ||| NNP
,  ||| S:4260 E:4262 ||| ,
panel  ||| S:4262 E:4268 ||| NN
FN ||| S:4268 E:4270 ||| NNP
) ||| S:4270 E:4271 ||| -RRB-
.  ||| S:4271 E:4273 ||| .
Cells  ||| S:4273 E:4279 ||| NNS
seeded  ||| S:4279 E:4296 ||| VBN
onto  ||| S:4296 E:4301 ||| IN
fibronectin  ||| S:4301 E:4313 ||| JJ
coated  ||| S:4313 E:4320 ||| JJ
dishes  ||| S:4320 E:4327 ||| NNS
with  ||| S:4327 E:4332 ||| IN
III1-C  ||| S:4332 E:4339 ||| CD
in  ||| S:4339 E:4342 ||| IN
the  ||| S:4342 E:4346 ||| DT
culture  ||| S:4346 E:4364 ||| NN
medium  ||| S:4364 E:4371 ||| NN
spread  ||| S:4371 E:4378 ||| NN
more  ||| S:4378 E:4383 ||| RBR
extensively  ||| S:4383 E:4395 ||| JJ
and  ||| S:4395 E:4399 ||| CC
in  ||| S:4399 E:4402 ||| IN
a  ||| S:4402 E:4404 ||| DT
more  ||| S:4404 E:4409 ||| RBR
circular  ||| S:4409 E:4428 ||| JJ
pattern  ||| S:4428 E:4436 ||| NN
at  ||| S:4436 E:4439 ||| IN
early  ||| S:4439 E:4445 ||| JJ
times  ||| S:4445 E:4451 ||| NNS
after  ||| S:4451 E:4457 ||| IN
plating  ||| S:4457 E:4465 ||| NN
than  ||| S:4465 E:4470 ||| IN
cells  ||| S:4470 E:4476 ||| NNS
plated  ||| S:4476 E:4483 ||| VBN
on  ||| S:4483 E:4496 ||| IN
fibronectin  ||| S:4496 E:4508 ||| NN
in  ||| S:4508 E:4511 ||| IN
the  ||| S:4511 E:4515 ||| DT
absence  ||| S:4515 E:4523 ||| NN
of  ||| S:4523 E:4526 ||| IN
III1-C  ||| S:4526 E:4533 ||| NNP
( ||| S:4533 E:4534 ||| -LRB-
Fig.  ||| S:4534 E:4539 ||| NNP
1A ||| S:4539 E:4541 ||| NNP
,  ||| S:4541 E:4543 ||| ,
panels  ||| S:4543 E:4550 ||| VBG
FN  ||| S:4550 E:4563 ||| NNP
and  ||| S:4563 E:4567 ||| CC
FN+C ||| S:4567 E:4571 ||| NNP
,  ||| S:4571 E:4573 ||| ,
and  ||| S:4573 E:4577 ||| CC
Fig.  ||| S:4577 E:4582 ||| CD
1B ||| S:4582 E:4584 ||| CD
) ||| S:4584 E:4585 ||| -RRB-
.  ||| S:4585 E:4587 ||| .
Cells  ||| S:4587 E:4593 ||| NNS
cultured  ||| S:4593 E:4602 ||| VBN
on  ||| S:4602 E:4605 ||| IN
fibronectin  ||| S:4605 E:4617 ||| NN
for  ||| S:4617 E:4631 ||| IN
4  ||| S:4631 E:4633 ||| CD
hours  ||| S:4633 E:4639 ||| NNS
show  ||| S:4639 E:4644 ||| VBP
approximately  ||| S:4644 E:4658 ||| RB
the  ||| S:4658 E:4662 ||| DT
same  ||| S:4662 E:4667 ||| JJ
extent  ||| S:4667 E:4674 ||| NN
of  ||| S:4674 E:4677 ||| IN
spreading  ||| S:4677 E:4697 ||| VBG
as  ||| S:4697 E:4700 ||| IN
cells  ||| S:4700 E:4706 ||| NNS
on  ||| S:4706 E:4709 ||| IN
fibronectin  ||| S:4709 E:4721 ||| NN
plus  ||| S:4721 E:4726 ||| CC
III1-C  ||| S:4726 E:4733 ||| NNP
( ||| S:4733 E:4734 ||| -LRB-
Fig.  ||| S:4734 E:4739 ||| NNP
1B ||| S:4739 E:4741 ||| NNP
) ||| S:4741 E:4742 ||| -RRB-
,  ||| S:4742 E:4744 ||| ,
indicating  ||| S:4744 E:4765 ||| VBG
that  ||| S:4765 E:4770 ||| IN
III1-C  ||| S:4770 E:4777 ||| NNP
accelerated  ||| S:4777 E:4789 ||| VBD
the  ||| S:4789 E:4793 ||| DT
rate  ||| S:4793 E:4798 ||| NN
of  ||| S:4798 E:4801 ||| IN
spreading  ||| S:4801 E:4811 ||| VBG
of  ||| S:4811 E:4814 ||| IN
the  ||| S:4814 E:4828 ||| DT
cells  ||| S:4828 E:4834 ||| NNS
but  ||| S:4834 E:4838 ||| CC
did  ||| S:4838 E:4842 ||| VBD
not  ||| S:4842 E:4846 ||| RB
affect  ||| S:4846 E:4853 ||| VB
the  ||| S:4853 E:4857 ||| DT
eventual  ||| S:4857 E:4866 ||| JJ
extent  ||| S:4866 E:4873 ||| NN
of  ||| S:4873 E:4886 ||| IN
spreading ||| S:4886 E:4895 ||| VBG
.  ||| S:4895 E:4897 ||| .
The  ||| S:4897 E:4901 ||| DT
effect  ||| S:4901 E:4908 ||| NN
on  ||| S:4908 E:4911 ||| IN
cell  ||| S:4911 E:4916 ||| NN
morphology  ||| S:4916 E:4927 ||| NNS
was  ||| S:4927 E:4931 ||| VBD
specific  ||| S:4931 E:4940 ||| JJ
for  ||| S:4940 E:4954 ||| IN
III1-C  ||| S:4954 E:4961 ||| CD
because  ||| S:4961 E:4969 ||| IN
the  ||| S:4969 E:4973 ||| DT
negative  ||| S:4973 E:4982 ||| JJ
control  ||| S:4982 E:4990 ||| NN
protein  ||| S:4990 E:4998 ||| NN
III  ||| S:4998 E:5002 ||| NNP
11-C  ||| S:5002 E:5007 ||| NNP
( ||| S:5007 E:5008 ||| -LRB-
a  ||| S:5008 E:5020 ||| DT
recombinant  ||| S:5020 E:5032 ||| JJ
protein  ||| S:5032 E:5040 ||| NN
derived  ||| S:5040 E:5048 ||| VBN
from  ||| S:5048 E:5053 ||| IN
the  ||| S:5053 E:5057 ||| DT
11  ||| S:5057 E:5060 ||| CD
thtype  ||| S:5060 E:5067 ||| JJ
III  ||| S:5067 E:5071 ||| NNP
repeat  ||| S:5071 E:5088 ||| NN
in  ||| S:5088 E:5091 ||| IN
fibronectin ||| S:5091 E:5102 ||| NN
,  ||| S:5102 E:5104 ||| ,
which ||| S:5104 E:5109 ||| WDT
,  ||| S:5109 E:5111 ||| ,
similar  ||| S:5111 E:5119 ||| JJ
to  ||| S:5119 E:5122 ||| TO
III1-C ||| S:5122 E:5128 ||| CD
,  ||| S:5128 E:5130 ||| ,
is  ||| S:5130 E:5133 ||| VBZ
missing  ||| S:5133 E:5141 ||| VBG
the  ||| S:5141 E:5155 ||| DT
A  ||| S:5155 E:5157 ||| NNP
and  ||| S:5157 E:5161 ||| CC
B  ||| S:5161 E:5163 ||| NNP
β-strands  ||| S:5163 E:5173 ||| NNP
of  ||| S:5173 E:5176 ||| IN
this  ||| S:5176 E:5181 ||| DT
repeat ||| S:5181 E:5187 ||| NN
)  ||| S:5187 E:5189 ||| -RRB-
had  ||| S:5189 E:5193 ||| VBD
no  ||| S:5193 E:5196 ||| DT
effect  ||| S:5196 E:5203 ||| NN
on  ||| S:5203 E:5206 ||| IN
the  ||| S:5206 E:5220 ||| DT
morphology  ||| S:5220 E:5231 ||| NN
of  ||| S:5231 E:5234 ||| IN
the  ||| S:5234 E:5238 ||| DT
cells  ||| S:5238 E:5244 ||| NNS
( ||| S:5244 E:5245 ||| -LRB-
Fig.  ||| S:5245 E:5250 ||| NNP
1A ||| S:5250 E:5252 ||| NNP
,  ||| S:5252 E:5254 ||| ,
panel  ||| S:5254 E:5260 ||| NN
FN+11C ||| S:5260 E:5266 ||| NN
,  ||| S:5266 E:5268 ||| ,
and  ||| S:5268 E:5272 ||| CC
Fig.  ||| S:5272 E:5287 ||| CD
1B ||| S:5287 E:5289 ||| CD
) ||| S:5289 E:5290 ||| -RRB-
.  ||| S:5290 E:5292 ||| .
Interestingly ||| S:5292 E:5305 ||| RB
,  ||| S:5305 E:5307 ||| ,
the  ||| S:5307 E:5311 ||| DT
effect  ||| S:5311 E:5318 ||| NN
of  ||| S:5318 E:5321 ||| IN
III1-C  ||| S:5321 E:5328 ||| CD
on  ||| S:5328 E:5331 ||| IN
cell  ||| S:5331 E:5346 ||| NN
morphology  ||| S:5346 E:5357 ||| NNS
was  ||| S:5357 E:5361 ||| VBD
seen  ||| S:5361 E:5366 ||| VBN
even  ||| S:5366 E:5371 ||| RB
when  ||| S:5371 E:5376 ||| WRB
the  ||| S:5376 E:5380 ||| DT
plates  ||| S:5380 E:5387 ||| NN
had  ||| S:5387 E:5402 ||| VBD
not  ||| S:5402 E:5406 ||| RB
been  ||| S:5406 E:5411 ||| VBN
coated  ||| S:5411 E:5418 ||| VBN
with  ||| S:5418 E:5423 ||| IN
fibronectin  ||| S:5423 E:5445 ||| NNS
( ||| S:5445 E:5446 ||| -LRB-
Fig.  ||| S:5446 E:5451 ||| NNP
1A ||| S:5451 E:5453 ||| NNP
,  ||| S:5453 E:5455 ||| ,
panel  ||| S:5455 E:5461 ||| NN
C ||| S:5461 E:5462 ||| NNP
,  ||| S:5462 E:5464 ||| ,
and  ||| S:5464 E:5468 ||| CC
Fig.  ||| S:5468 E:5473 ||| CD
1B ||| S:5473 E:5475 ||| CD
) ||| S:5475 E:5476 ||| -RRB-
,  ||| S:5476 E:5478 ||| ,
indicating  ||| S:5478 E:5489 ||| VBG
that  ||| S:5489 E:5494 ||| IN
intact  ||| S:5494 E:5511 ||| JJ
fibronectin  ||| S:5511 E:5523 ||| NN
was  ||| S:5523 E:5527 ||| VBD
not  ||| S:5527 E:5531 ||| RB
required  ||| S:5531 E:5540 ||| VBN
for  ||| S:5540 E:5544 ||| IN
cell  ||| S:5544 E:5549 ||| NN
attachment  ||| S:5549 E:5560 ||| NN
and  ||| S:5560 E:5574 ||| CC
spreading  ||| S:5574 E:5584 ||| VBG
when  ||| S:5584 E:5589 ||| WRB
III1-C  ||| S:5589 E:5596 ||| NNP
was  ||| S:5596 E:5600 ||| VBD
in  ||| S:5600 E:5603 ||| IN
the  ||| S:5603 E:5607 ||| DT
culture  ||| S:5607 E:5615 ||| NN
medium ||| S:5615 E:5621 ||| NN
.  ||| S:5621 E:5623 ||| .
Again ||| S:5623 E:5628 ||| RB
,  ||| S:5628 E:5640 ||| ,
the  ||| S:5640 E:5644 ||| DT
negative  ||| S:5644 E:5653 ||| JJ
control  ||| S:5653 E:5661 ||| NN
protein  ||| S:5661 E:5669 ||| NN
III  ||| S:5669 E:5673 ||| NNP
11-C  ||| S:5673 E:5678 ||| NNP
had  ||| S:5678 E:5682 ||| VBD
no  ||| S:5682 E:5685 ||| DT
effect  ||| S:5685 E:5692 ||| NN
on  ||| S:5692 E:5705 ||| IN
cell  ||| S:5705 E:5710 ||| NN
morphology ||| S:5710 E:5720 ||| NNS
;  ||| S:5720 E:5722 ||| :
cells  ||| S:5722 E:5728 ||| NNS
seeded  ||| S:5728 E:5735 ||| VBN
onto  ||| S:5735 E:5740 ||| IN
uncoated  ||| S:5740 E:5749 ||| JJ
plates  ||| S:5749 E:5756 ||| NN
with  ||| S:5756 E:5771 ||| IN
III  ||| S:5771 E:5775 ||| NNP
11-C  ||| S:5775 E:5780 ||| NNP
in  ||| S:5780 E:5783 ||| IN
the  ||| S:5783 E:5787 ||| DT
culture  ||| S:5787 E:5795 ||| NN
medium  ||| S:5795 E:5802 ||| NN
remained  ||| S:5802 E:5811 ||| VBD
rounded  ||| S:5811 E:5819 ||| VBN
and  ||| S:5819 E:5823 ||| CC
did  ||| S:5823 E:5837 ||| VBD
not  ||| S:5837 E:5841 ||| RB
appreciably  ||| S:5841 E:5853 ||| RB
spread  ||| S:5853 E:5860 ||| VBN
over  ||| S:5860 E:5865 ||| IN
several  ||| S:5865 E:5873 ||| JJ
hours  ||| S:5873 E:5879 ||| NNS
( ||| S:5879 E:5880 ||| -LRB-
Fig.  ||| S:5880 E:5885 ||| NNP
1A ||| S:5885 E:5887 ||| NNP
,  ||| S:5887 E:5889 ||| ,
panel  ||| S:5889 E:5905 ||| NN
11C ||| S:5905 E:5908 ||| NN
,  ||| S:5908 E:5910 ||| ,
and  ||| S:5910 E:5914 ||| CC
Fig.  ||| S:5914 E:5919 ||| CD
1B ||| S:5919 E:5921 ||| CD
) ||| S:5921 E:5922 ||| -RRB-
.  ||| S:5922 E:5924 ||| .
These  ||| S:5924 E:5930 ||| DT
results  ||| S:5930 E:5938 ||| NNS
indicated  ||| S:5938 E:5948 ||| VBD
that  ||| S:5948 E:5953 ||| IN
III1-C  ||| S:5953 E:5970 ||| NNP
had  ||| S:5970 E:5974 ||| VBD
an  ||| S:5974 E:5977 ||| DT
effect  ||| S:5977 E:5984 ||| NN
on  ||| S:5984 E:5987 ||| IN
the  ||| S:5987 E:5991 ||| DT
morphology  ||| S:5991 E:6002 ||| NN
of  ||| S:6002 E:6005 ||| IN
freshly  ||| S:6005 E:6013 ||| JJ
plated  ||| S:6013 E:6020 ||| JJ
cells ||| S:6020 E:6025 ||| NNS
.  ||| S:6025 E:6037 ||| .
Moreover ||| S:6037 E:6045 ||| RB
,  ||| S:6045 E:6047 ||| ,
the  ||| S:6047 E:6051 ||| DT
plates  ||| S:6051 E:6058 ||| NN
did  ||| S:6058 E:6062 ||| VBD
not  ||| S:6062 E:6066 ||| RB
need  ||| S:6066 E:6071 ||| VBP
to  ||| S:6071 E:6074 ||| TO
be  ||| S:6074 E:6077 ||| VB
coated  ||| S:6077 E:6084 ||| VBN
with  ||| S:6084 E:6089 ||| IN
any  ||| S:6089 E:6103 ||| DT
adhesive  ||| S:6103 E:6112 ||| JJ
protein  ||| S:6112 E:6120 ||| NN
prior  ||| S:6120 E:6126 ||| RB
to  ||| S:6126 E:6129 ||| TO
seeding  ||| S:6129 E:6137 ||| VB
the  ||| S:6137 E:6141 ||| DT
cells  ||| S:6141 E:6147 ||| NNS
with  ||| S:6147 E:6152 ||| IN
III1-C  ||| S:6152 E:6169 ||| CD
in  ||| S:6169 E:6172 ||| IN
the  ||| S:6172 E:6176 ||| DT
culture  ||| S:6176 E:6184 ||| NN
medium ||| S:6184 E:6190 ||| NN
,  ||| S:6190 E:6192 ||| ,
indicating  ||| S:6192 E:6203 ||| VBG
that  ||| S:6203 E:6208 ||| IN
III1-C  ||| S:6208 E:6215 ||| NNP
may  ||| S:6215 E:6219 ||| MD
have  ||| S:6219 E:6234 ||| VB
adsorbed  ||| S:6234 E:6243 ||| VBN
onto  ||| S:6243 E:6248 ||| IN
the  ||| S:6248 E:6252 ||| DT
tissue  ||| S:6252 E:6259 ||| NN
culture  ||| S:6259 E:6267 ||| NN
plastic  ||| S:6267 E:6275 ||| NN
and  ||| S:6275 E:6279 ||| CC
that  ||| S:6279 E:6284 ||| IN
cells  ||| S:6284 E:6300 ||| NNS
then  ||| S:6300 E:6305 ||| RB
attached  ||| S:6305 E:6314 ||| VBN
and  ||| S:6314 E:6318 ||| CC
spread  ||| S:6318 E:6325 ||| NN
on  ||| S:6325 E:6328 ||| IN
the  ||| S:6328 E:6332 ||| DT
adsorbed  ||| S:6332 E:6341 ||| JJ
III1-C ||| S:6341 E:6347 ||| NN
.  ||| S:6347 E:6359 ||| .
To  ||| S:6359 E:6362 ||| TO
directly  ||| S:6362 E:6371 ||| RB
test  ||| S:6371 E:6376 ||| VB
whether  ||| S:6376 E:6384 ||| IN
cells  ||| S:6384 E:6390 ||| NNS
were  ||| S:6390 E:6395 ||| VBD
able  ||| S:6395 E:6400 ||| JJ
to  ||| S:6400 E:6403 ||| TO
bind  ||| S:6403 E:6408 ||| VB
to  ||| S:6408 E:6421 ||| TO
III1-C  ||| S:6421 E:6428 ||| CD
coated  ||| S:6428 E:6435 ||| NN
on  ||| S:6435 E:6438 ||| IN
a  ||| S:6438 E:6440 ||| DT
dish ||| S:6440 E:6444 ||| NN
,  ||| S:6444 E:6446 ||| ,
various  ||| S:6446 E:6454 ||| JJ
concentrations  ||| S:6454 E:6469 ||| NNS
of  ||| S:6469 E:6472 ||| IN
either  ||| S:6472 E:6489 ||| DT
fibronectin ||| S:6489 E:6500 ||| NN
,  ||| S:6500 E:6502 ||| ,
III1-C  ||| S:6502 E:6509 ||| NNP
or  ||| S:6509 E:6512 ||| CC
III  ||| S:6512 E:6516 ||| NNP
11-C  ||| S:6516 E:6521 ||| NNP
were  ||| S:6521 E:6526 ||| VBD
coated  ||| S:6526 E:6533 ||| VBN
onto  ||| S:6533 E:6538 ||| IN
dishes  ||| S:6538 E:6555 ||| NNS
and  ||| S:6555 E:6559 ||| CC
cell  ||| S:6559 E:6564 ||| NN
attachment  ||| S:6564 E:6575 ||| NN
to  ||| S:6575 E:6578 ||| TO
these  ||| S:6578 E:6584 ||| DT
substrates  ||| S:6584 E:6595 ||| NN
was  ||| S:6595 E:6599 ||| VBD
measured ||| S:6599 E:6607 ||| VBN
.  ||| S:6607 E:6609 ||| .
As  ||| S:6609 E:6622 ||| RB
shown  ||| S:6622 E:6628 ||| VBN
in  ||| S:6628 E:6631 ||| IN
Figure  ||| S:6631 E:6638 ||| NNP
2 ||| S:6638 E:6639 ||| CD
,  ||| S:6639 E:6641 ||| ,
cells  ||| S:6641 E:6647 ||| NNS
attach  ||| S:6647 E:6654 ||| VBP
well  ||| S:6654 E:6659 ||| RB
to  ||| S:6659 E:6662 ||| TO
fibronectin  ||| S:6662 E:6674 ||| VB
and  ||| S:6674 E:6688 ||| CC
to  ||| S:6688 E:6691 ||| TO
III1-C ||| S:6691 E:6697 ||| CD
,  ||| S:6697 E:6699 ||| ,
but  ||| S:6699 E:6703 ||| CC
not  ||| S:6703 E:6707 ||| RB
to  ||| S:6707 E:6710 ||| TO
III  ||| S:6710 E:6714 ||| NNP
11-C  ||| S:6714 E:6719 ||| NNP
coated  ||| S:6719 E:6726 ||| NN
on  ||| S:6726 E:6729 ||| IN
a  ||| S:6729 E:6731 ||| DT
dish ||| S:6731 E:6735 ||| NN
.  ||| S:6735 E:6737 ||| .
On  ||| S:6737 E:6740 ||| IN
a  ||| S:6740 E:6752 ||| DT
molar  ||| S:6752 E:6758 ||| JJ
basis ||| S:6758 E:6763 ||| NN
,  ||| S:6763 E:6765 ||| ,
III1-C  ||| S:6765 E:6772 ||| NNP
was  ||| S:6772 E:6776 ||| VBD
less  ||| S:6776 E:6781 ||| RBR
effective  ||| S:6781 E:6791 ||| JJ
at  ||| S:6791 E:6794 ||| IN
supporting  ||| S:6794 E:6805 ||| VBG
cell  ||| S:6805 E:6820 ||| NN
attachment  ||| S:6820 E:6831 ||| NN
than  ||| S:6831 E:6836 ||| IN
fibronectin ||| S:6836 E:6847 ||| NN
,  ||| S:6847 E:6849 ||| ,
however ||| S:6849 E:6856 ||| RB
,  ||| S:6856 E:6858 ||| ,
it  ||| S:6858 E:6861 ||| PRP
was  ||| S:6861 E:6865 ||| VBD
clear  ||| S:6865 E:6871 ||| JJ
that  ||| S:6871 E:6886 ||| IN
RASMCs  ||| S:6886 E:6893 ||| NNS
do  ||| S:6893 E:6896 ||| VBP
attach  ||| S:6896 E:6903 ||| VBN
and  ||| S:6903 E:6907 ||| CC
spread  ||| S:6907 E:6914 ||| VBD
well  ||| S:6914 E:6919 ||| RB
on  ||| S:6919 E:6922 ||| IN
III1-C  ||| S:6922 E:6929 ||| CD
coated  ||| S:6929 E:6936 ||| NN
on  ||| S:6936 E:6939 ||| IN
a  ||| S:6939 E:6951 ||| DT
dish ||| S:6951 E:6955 ||| NN
.  ||| S:6955 E:6957 ||| .
The  ||| S:6957 E:6961 ||| DT
morphology  ||| S:6961 E:6972 ||| NN
of  ||| S:6972 E:6975 ||| IN
the  ||| S:6975 E:6979 ||| DT
cells  ||| S:6979 E:6985 ||| NNS
seeded  ||| S:6985 E:6992 ||| VBN
onto  ||| S:6992 E:6997 ||| IN
the  ||| S:6997 E:7011 ||| DT
III1-C-coated  ||| S:7011 E:7025 ||| CD
wells  ||| S:7025 E:7031 ||| NNS
was  ||| S:7031 E:7035 ||| VBD
indistinguishable  ||| S:7035 E:7053 ||| VBN
from  ||| S:7053 E:7058 ||| IN
the  ||| S:7058 E:7072 ||| DT
morphology  ||| S:7072 E:7083 ||| NN
shown  ||| S:7083 E:7089 ||| VBN
in  ||| S:7089 E:7092 ||| IN
Fig.  ||| S:7092 E:7097 ||| CD
1A ||| S:7097 E:7099 ||| CD
,  ||| S:7099 E:7101 ||| ,
panel  ||| S:7101 E:7107 ||| NN
C.  ||| S:7107 E:7138 ||| NNP
Role  ||| S:7138 E:7143 ||| NNP
of  ||| S:7143 E:7146 ||| IN
integrins  ||| S:7146 E:7156 ||| NN
in  ||| S:7156 E:7159 ||| IN
cell  ||| S:7159 E:7164 ||| NN
attachment  ||| S:7164 E:7175 ||| NN
to  ||| S:7175 E:7188 ||| TO
III1-C  ||| S:7188 E:7205 ||| CD
The  ||| S:7205 E:7209 ||| DT
attachment  ||| S:7209 E:7220 ||| NN
of  ||| S:7220 E:7223 ||| IN
RASMCs  ||| S:7223 E:7230 ||| JJ
to  ||| S:7230 E:7233 ||| TO
III1-C  ||| S:7233 E:7240 ||| NNP
was  ||| S:7240 E:7244 ||| VBD
analyzed  ||| S:7244 E:7263 ||| VBN
further  ||| S:7263 E:7271 ||| JJ
to  ||| S:7271 E:7274 ||| TO
determine  ||| S:7274 E:7284 ||| VB
the  ||| S:7284 E:7288 ||| DT
role  ||| S:7288 E:7293 ||| NN
played  ||| S:7293 E:7300 ||| VBD
by  ||| S:7300 E:7303 ||| IN
integrins  ||| S:7303 E:7313 ||| NN
as  ||| S:7313 E:7326 ||| IN
potential  ||| S:7326 E:7336 ||| JJ
adhesive  ||| S:7336 E:7345 ||| NN
receptors  ||| S:7345 E:7355 ||| NNS
for  ||| S:7355 E:7359 ||| IN
III1-C ||| S:7359 E:7365 ||| CD
.  ||| S:7365 E:7367 ||| .
Various  ||| S:7367 E:7385 ||| JJ
integrin-blocking  ||| S:7385 E:7403 ||| JJ
reagents  ||| S:7403 E:7412 ||| NN
were  ||| S:7412 E:7417 ||| VBD
tested  ||| S:7417 E:7424 ||| VBN
for  ||| S:7424 E:7428 ||| IN
their  ||| S:7428 E:7434 ||| PRP$
ability  ||| S:7434 E:7452 ||| NN
to  ||| S:7452 E:7455 ||| TO
block  ||| S:7455 E:7461 ||| VB
RASMC  ||| S:7461 E:7467 ||| JJ
attachment  ||| S:7467 E:7478 ||| NN
to  ||| S:7478 E:7481 ||| TO
III1-C  ||| S:7481 E:7488 ||| CD
and  ||| S:7488 E:7492 ||| CC
to  ||| S:7492 E:7495 ||| TO
fibronectin ||| S:7495 E:7506 ||| VB
.  ||| S:7506 E:7518 ||| .
The  ||| S:7518 E:7522 ||| DT
adhesion  ||| S:7522 E:7531 ||| NN
of  ||| S:7531 E:7534 ||| IN
SMCs  ||| S:7534 E:7539 ||| JJ
to  ||| S:7539 E:7542 ||| TO
fibronectin  ||| S:7542 E:7554 ||| NN
is  ||| S:7554 E:7557 ||| VBZ
mediated  ||| S:7557 E:7566 ||| VBN
through  ||| S:7566 E:7584 ||| IN
β1  ||| S:7584 E:7587 ||| CD
integrins  ||| S:7587 E:7597 ||| NNS
[  ||| S:7597 E:7599 ||| -LRB-
1  ||| S:7599 E:7601 ||| CD
26  ||| S:7601 E:7604 ||| CD
]  ||| S:7604 E:7606 ||| -RRB-
.  ||| S:7606 E:7608 ||| .
We  ||| S:7608 E:7611 ||| PRP
confirmed  ||| S:7611 E:7621 ||| VBD
these  ||| S:7621 E:7627 ||| DT
previous  ||| S:7627 E:7646 ||| JJ
findings  ||| S:7646 E:7655 ||| NNS
for  ||| S:7655 E:7659 ||| IN
our  ||| S:7659 E:7663 ||| PRP$
RASMCs ||| S:7663 E:7669 ||| JJ
,  ||| S:7669 E:7671 ||| ,
by  ||| S:7671 E:7674 ||| IN
showing  ||| S:7674 E:7682 ||| VBG
a  ||| S:7682 E:7684 ||| DT
complete  ||| S:7684 E:7693 ||| JJ
block  ||| S:7693 E:7699 ||| NN
of  ||| S:7699 E:7712 ||| IN
cell  ||| S:7712 E:7717 ||| NN
attachment  ||| S:7717 E:7728 ||| NN
to  ||| S:7728 E:7731 ||| TO
fibronectin  ||| S:7731 E:7743 ||| VB
by  ||| S:7743 E:7746 ||| IN
EDTA  ||| S:7746 E:7751 ||| NNP
( ||| S:7751 E:7752 ||| -LRB-
an  ||| S:7752 E:7755 ||| DT
agent  ||| S:7755 E:7761 ||| NN
that  ||| S:7761 E:7776 ||| WDT
blocks  ||| S:7776 E:7783 ||| VBZ
all  ||| S:7783 E:7787 ||| DT
integrins ||| S:7787 E:7796 ||| NN
) ||| S:7796 E:7797 ||| -RRB-
,  ||| S:7797 E:7799 ||| ,
anti-β1  ||| S:7799 E:7807 ||| RB
blocking  ||| S:7807 E:7816 ||| VBG
mAb ||| S:7816 E:7819 ||| JJ
,  ||| S:7819 E:7821 ||| ,
and  ||| S:7821 E:7825 ||| CC
RGD  ||| S:7825 E:7839 ||| NNP
peptide ||| S:7839 E:7846 ||| NN
,  ||| S:7846 E:7848 ||| ,
but  ||| S:7848 E:7852 ||| CC
not  ||| S:7852 E:7856 ||| RB
by  ||| S:7856 E:7859 ||| IN
the  ||| S:7859 E:7863 ||| DT
negative  ||| S:7863 E:7872 ||| JJ
control  ||| S:7872 E:7880 ||| NN
RAD  ||| S:7880 E:7884 ||| FW
peptide  ||| S:7884 E:7902 ||| FW
( ||| S:7902 E:7903 ||| -LRB-
Fig.  ||| S:7903 E:7908 ||| NNP
3A ||| S:7908 E:7910 ||| NNP
) ||| S:7910 E:7911 ||| -RRB-
.  ||| S:7911 E:7913 ||| .
Anti-fibronectin  ||| S:7913 E:7930 ||| JJ
antibodies  ||| S:7930 E:7941 ||| NNS
also  ||| S:7941 E:7946 ||| RB
effectively  ||| S:7946 E:7968 ||| RB
blocked  ||| S:7968 E:7976 ||| VBN
RASMC  ||| S:7976 E:7982 ||| NNP
attachment  ||| S:7982 E:7993 ||| VBD
to  ||| S:7993 E:7996 ||| TO
fibronectin  ||| S:7996 E:8008 ||| VB
( ||| S:8008 E:8009 ||| -LRB-
Fig.  ||| S:8009 E:8014 ||| NNP
3A ||| S:8014 E:8016 ||| NNP
) ||| S:8016 E:8017 ||| -RRB-
.  ||| S:8017 E:8029 ||| .
Heparin  ||| S:8029 E:8037 ||| NNP
did  ||| S:8037 E:8041 ||| VBD
not  ||| S:8041 E:8045 ||| RB
inhibit  ||| S:8045 E:8053 ||| VB
cell  ||| S:8053 E:8058 ||| NN
attachment  ||| S:8058 E:8069 ||| NN
to  ||| S:8069 E:8072 ||| TO
fibronectin  ||| S:8072 E:8094 ||| VB
( ||| S:8094 E:8095 ||| -LRB-
Fig.  ||| S:8095 E:8100 ||| NNP
3A ||| S:8100 E:8102 ||| NNP
) ||| S:8102 E:8103 ||| -RRB-
,  ||| S:8103 E:8105 ||| ,
however ||| S:8105 E:8112 ||| RB
,  ||| S:8112 E:8114 ||| ,
it  ||| S:8114 E:8117 ||| PRP
did  ||| S:8117 E:8121 ||| VBD
modestly  ||| S:8121 E:8130 ||| RB
reduce  ||| S:8130 E:8137 ||| VB
cell  ||| S:8137 E:8142 ||| NN
spreading  ||| S:8142 E:8162 ||| VBG
on  ||| S:8162 E:8165 ||| IN
fibronectin  ||| S:8165 E:8177 ||| NNS
( ||| S:8177 E:8178 ||| -LRB-
15 ||| S:8178 E:8180 ||| CD
%  ||| S:8180 E:8182 ||| NN
inhibition  ||| S:8182 E:8193 ||| NN
of  ||| S:8193 E:8196 ||| IN
cell  ||| S:8196 E:8201 ||| NN
spreading ||| S:8201 E:8210 ||| NN
,  ||| S:8210 E:8212 ||| ,
data  ||| S:8212 E:8227 ||| NNS
not  ||| S:8227 E:8231 ||| RB
shown ||| S:8231 E:8236 ||| VBN
) ||| S:8236 E:8237 ||| -RRB-
.  ||| S:8237 E:8239 ||| .
These  ||| S:8239 E:8245 ||| DT
results  ||| S:8245 E:8253 ||| NNS
indicate  ||| S:8253 E:8262 ||| VBP
that  ||| S:8262 E:8267 ||| IN
RASMC  ||| S:8267 E:8273 ||| NNP
adhesion  ||| S:8273 E:8282 ||| VBD
to  ||| S:8282 E:8295 ||| TO
fibronectin  ||| S:8295 E:8307 ||| NN
is  ||| S:8307 E:8310 ||| VBZ
mediated  ||| S:8310 E:8319 ||| VBN
by  ||| S:8319 E:8322 ||| IN
β1  ||| S:8322 E:8325 ||| CD
integrins ||| S:8325 E:8334 ||| NNS
.  ||| S:8334 E:8346 ||| .
Blocking  ||| S:8346 E:8355 ||| VBG
studies  ||| S:8355 E:8363 ||| NNS
indicated  ||| S:8363 E:8373 ||| VBD
that  ||| S:8373 E:8378 ||| DT
cell  ||| S:8378 E:8383 ||| NN
attachment  ||| S:8383 E:8394 ||| NN
to  ||| S:8394 E:8407 ||| TO
III1-C  ||| S:8407 E:8414 ||| NNP
was  ||| S:8414 E:8418 ||| VBD
partially  ||| S:8418 E:8428 ||| RB
mediated  ||| S:8428 E:8437 ||| VBN
by  ||| S:8437 E:8440 ||| IN
β1  ||| S:8440 E:8443 ||| CD
integrins ||| S:8443 E:8452 ||| NNS
.  ||| S:8452 E:8454 ||| .
For  ||| S:8454 E:8468 ||| IN
example ||| S:8468 E:8475 ||| NN
,  ||| S:8475 E:8477 ||| ,
RASMC  ||| S:8477 E:8483 ||| NNP
attachment  ||| S:8483 E:8494 ||| NN
was  ||| S:8494 E:8498 ||| VBD
partially  ||| S:8498 E:8508 ||| RB
blocked  ||| S:8508 E:8516 ||| VBN
by  ||| S:8516 E:8519 ||| IN
EDTA ||| S:8519 E:8523 ||| NNP
,  ||| S:8523 E:8535 ||| ,
anti-β1  ||| S:8535 E:8543 ||| NNP
mAb ||| S:8543 E:8546 ||| NNP
,  ||| S:8546 E:8548 ||| ,
and  ||| S:8548 E:8552 ||| CC
RGD  ||| S:8552 E:8556 ||| NNP
peptide  ||| S:8556 E:8564 ||| NNS
( ||| S:8564 E:8565 ||| -LRB-
Fig.  ||| S:8565 E:8570 ||| NNP
3B ||| S:8570 E:8572 ||| NNP
) ||| S:8572 E:8573 ||| -RRB-
,  ||| S:8573 E:8575 ||| ,
indicating  ||| S:8575 E:8586 ||| VBG
the  ||| S:8586 E:8600 ||| DT
involvement  ||| S:8600 E:8612 ||| NN
of  ||| S:8612 E:8615 ||| IN
integrins ||| S:8615 E:8624 ||| NN
.  ||| S:8624 E:8626 ||| .
However ||| S:8626 E:8633 ||| RB
,  ||| S:8633 E:8635 ||| ,
cell  ||| S:8635 E:8640 ||| NN
attachment  ||| S:8640 E:8651 ||| NN
was  ||| S:8651 E:8665 ||| VBD
also  ||| S:8665 E:8670 ||| RB
partially  ||| S:8670 E:8680 ||| RB
blocked  ||| S:8680 E:8688 ||| VBN
by  ||| S:8688 E:8691 ||| IN
heparin ||| S:8691 E:8698 ||| NN
,  ||| S:8698 E:8700 ||| ,
which  ||| S:8700 E:8706 ||| WDT
did  ||| S:8706 E:8710 ||| VBD
not  ||| S:8710 E:8714 ||| RB
inhibit  ||| S:8714 E:8732 ||| VB
cell  ||| S:8732 E:8737 ||| NN
attachment  ||| S:8737 E:8748 ||| NN
to  ||| S:8748 E:8751 ||| TO
fibronectin  ||| S:8751 E:8763 ||| VB
( ||| S:8763 E:8764 ||| -LRB-
Fig.  ||| S:8764 E:8769 ||| NNP
3Aand  ||| S:8769 E:8775 ||| NNP
3B ||| S:8775 E:8777 ||| NNP
,  ||| S:8777 E:8779 ||| ,
Hep  ||| S:8779 E:8793 ||| NNP
samples ||| S:8793 E:8800 ||| NNS
) ||| S:8800 E:8801 ||| -RRB-
,  ||| S:8801 E:8803 ||| ,
indicating  ||| S:8803 E:8814 ||| VBG
that  ||| S:8814 E:8819 ||| IN
a  ||| S:8819 E:8821 ||| DT
non-integrin  ||| S:8821 E:8834 ||| JJ
receptor  ||| S:8834 E:8843 ||| NN
also  ||| S:8843 E:8858 ||| RB
mediated  ||| S:8858 E:8867 ||| JJ
cell  ||| S:8867 E:8872 ||| NN
attachment  ||| S:8872 E:8883 ||| NN
to  ||| S:8883 E:8886 ||| TO
III1-C ||| S:8886 E:8892 ||| CD
.  ||| S:8892 E:8894 ||| .
A  ||| S:8894 E:8896 ||| DT
complete  ||| S:8896 E:8905 ||| JJ
block  ||| S:8905 E:8911 ||| NN
of  ||| S:8911 E:8924 ||| IN
cell  ||| S:8924 E:8929 ||| NN
attachment  ||| S:8929 E:8940 ||| NN
to  ||| S:8940 E:8943 ||| TO
III1-C  ||| S:8943 E:8950 ||| NNP
was  ||| S:8950 E:8954 ||| VBD
only  ||| S:8954 E:8959 ||| RB
observed  ||| S:8959 E:8968 ||| VBD
when  ||| S:8968 E:8973 ||| WRB
heparin  ||| S:8973 E:8991 ||| NNS
was  ||| S:8991 E:8995 ||| VBD
combined  ||| S:8995 E:9004 ||| VBN
with  ||| S:9004 E:9009 ||| IN
integrin  ||| S:9009 E:9018 ||| NNS
blocking  ||| S:9018 E:9027 ||| VBG
agents ||| S:9027 E:9033 ||| NNS
;  ||| S:9033 E:9035 ||| :
e.g. ||| S:9035 E:9039 ||| CD
,  ||| S:9039 E:9041 ||| ,
heparin  ||| S:9041 E:9059 ||| FW
+  ||| S:9059 E:9061 ||| FW
anti-β1  ||| S:9061 E:9069 ||| FW
mAb  ||| S:9069 E:9073 ||| FW
or  ||| S:9073 E:9076 ||| FW
heparin  ||| S:9076 E:9084 ||| FW
+  ||| S:9084 E:9086 ||| FW
RGD  ||| S:9086 E:9090 ||| FW
peptide  ||| S:9090 E:9098 ||| FW
( ||| S:9098 E:9099 ||| -LRB-
Fig.  ||| S:9099 E:9104 ||| NNP
3B ||| S:9104 E:9106 ||| NNP
) ||| S:9106 E:9107 ||| -RRB-
.  ||| S:9107 E:9119 ||| .
Anti-fibronectin  ||| S:9119 E:9136 ||| JJ
antibodies  ||| S:9136 E:9147 ||| NNS
modestly  ||| S:9147 E:9156 ||| RB
inhibited  ||| S:9156 E:9166 ||| JJ
cell  ||| S:9166 E:9181 ||| NN
attachment ||| S:9181 E:9191 ||| NN
,  ||| S:9191 E:9193 ||| ,
but  ||| S:9193 E:9197 ||| CC
anti-III  ||| S:9197 E:9206 ||| JJ
1-C  ||| S:9206 E:9210 ||| CD
antibodies  ||| S:9210 E:9221 ||| NNS
effectively  ||| S:9221 E:9243 ||| RB
blocked  ||| S:9243 E:9251 ||| VBN
cell  ||| S:9251 E:9256 ||| NN
attachment  ||| S:9256 E:9267 ||| NN
to  ||| S:9267 E:9270 ||| TO
III1-C  ||| S:9270 E:9277 ||| CD
( ||| S:9277 E:9278 ||| -LRB-
Fig.  ||| S:9278 E:9283 ||| NNP
3B ||| S:9283 E:9285 ||| NNP
) ||| S:9285 E:9286 ||| -RRB-
.  ||| S:9286 E:9288 ||| .
These  ||| S:9288 E:9304 ||| DT
results  ||| S:9304 E:9312 ||| NNS
demonstrate  ||| S:9312 E:9324 ||| VBP
that  ||| S:9324 E:9329 ||| DT
cell  ||| S:9329 E:9334 ||| NN
attachment  ||| S:9334 E:9345 ||| NN
to  ||| S:9345 E:9348 ||| TO
III1-C  ||| S:9348 E:9355 ||| NNP
was  ||| S:9355 E:9369 ||| VBD
mediated  ||| S:9369 E:9378 ||| VBN
through  ||| S:9378 E:9386 ||| IN
both  ||| S:9386 E:9391 ||| DT
β1  ||| S:9391 E:9394 ||| CD
integrins  ||| S:9394 E:9404 ||| NNS
and  ||| S:9404 E:9408 ||| CC
another  ||| S:9408 E:9416 ||| DT
class  ||| S:9416 E:9422 ||| NN
of  ||| S:9422 E:9435 ||| IN
receptors  ||| S:9435 E:9445 ||| NNS
on  ||| S:9445 E:9448 ||| IN
RASMCs ||| S:9448 E:9454 ||| JJ
.  ||| S:9454 E:9466 ||| .
One  ||| S:9466 E:9470 ||| CD
way  ||| S:9470 E:9474 ||| NN
in  ||| S:9474 E:9477 ||| IN
which  ||| S:9477 E:9483 ||| WDT
integrins  ||| S:9483 E:9493 ||| NNS
were  ||| S:9493 E:9498 ||| VBD
originally  ||| S:9498 E:9509 ||| RB
shown  ||| S:9509 E:9515 ||| VBN
to  ||| S:9515 E:9518 ||| TO
be  ||| S:9518 E:9531 ||| VB
fibronectin  ||| S:9531 E:9543 ||| JJ
receptors  ||| S:9543 E:9553 ||| NNS
was  ||| S:9553 E:9557 ||| VBD
by  ||| S:9557 E:9560 ||| IN
affinity  ||| S:9560 E:9569 ||| JJ
chromatography  ||| S:9569 E:9584 ||| NN
of  ||| S:9584 E:9597 ||| IN
radioiodinated  ||| S:9597 E:9612 ||| JJ
cell  ||| S:9612 E:9617 ||| NN
surface  ||| S:9617 E:9625 ||| NN
proteins  ||| S:9625 E:9634 ||| NNS
on  ||| S:9634 E:9637 ||| IN
a  ||| S:9637 E:9639 ||| DT
fibronectin  ||| S:9639 E:9661 ||| JJ
column  ||| S:9661 E:9668 ||| NN
[  ||| S:9668 E:9670 ||| -LRB-
27  ||| S:9670 E:9673 ||| CD
28  ||| S:9673 E:9676 ||| CD
]  ||| S:9676 E:9678 ||| -RRB-
.  ||| S:9678 E:9680 ||| .
Consistent  ||| S:9680 E:9691 ||| JJ
with  ||| S:9691 E:9696 ||| IN
these  ||| S:9696 E:9702 ||| DT
earlier  ||| S:9702 E:9710 ||| JJR
studies ||| S:9710 E:9717 ||| NNS
,  ||| S:9717 E:9729 ||| ,
cell  ||| S:9729 E:9734 ||| NN
surface  ||| S:9734 E:9742 ||| NN
radioiodination  ||| S:9742 E:9758 ||| NN
of  ||| S:9758 E:9761 ||| IN
RASMCs  ||| S:9761 E:9768 ||| NNP
followed  ||| S:9768 E:9777 ||| VBD
by  ||| S:9777 E:9790 ||| IN
affinity  ||| S:9790 E:9799 ||| JJ
chromatography  ||| S:9799 E:9814 ||| NN
on  ||| S:9814 E:9817 ||| IN
fibronectin  ||| S:9817 E:9829 ||| JJ
Sepharose  ||| S:9829 E:9839 ||| NNP
and  ||| S:9839 E:9853 ||| CC
elution  ||| S:9853 E:9861 ||| NN
with  ||| S:9861 E:9866 ||| IN
EDTA  ||| S:9866 E:9871 ||| NNP
revealed  ||| S:9871 E:9880 ||| VBD
the  ||| S:9880 E:9884 ||| DT
binding  ||| S:9884 E:9892 ||| NN
of  ||| S:9892 E:9895 ||| IN
two  ||| S:9895 E:9899 ||| CD
major  ||| S:9899 E:9905 ||| JJ
bands  ||| S:9905 E:9921 ||| NNS
at  ||| S:9921 E:9924 ||| IN
120  ||| S:9924 E:9928 ||| CD
kDa  ||| S:9928 E:9932 ||| JJ
and  ||| S:9932 E:9936 ||| CC
140  ||| S:9936 E:9940 ||| CD
kDa  ||| S:9940 E:9944 ||| NNS
( ||| S:9944 E:9945 ||| -LRB-
Fig.  ||| S:9945 E:9950 ||| CD
4 ||| S:9950 E:9951 ||| CD
, ||| S:9951 E:9952 ||| ,
Elane  ||| S:9952 E:9958 ||| NNP
under  ||| S:9958 E:9964 ||| IN
FN ||| S:9964 E:9966 ||| NNP
) ||| S:9966 E:9967 ||| -RRB-
.  ||| S:9967 E:9969 ||| .
These  ||| S:9969 E:9985 ||| DT
sizes  ||| S:9985 E:9991 ||| NNS
match  ||| S:9991 E:9997 ||| VBP
those  ||| S:9997 E:10003 ||| DT
of  ||| S:10003 E:10006 ||| IN
the  ||| S:10006 E:10010 ||| DT
β1  ||| S:10010 E:10013 ||| NNP
and  ||| S:10013 E:10017 ||| CC
α5  ||| S:10017 E:10020 ||| CD
integrin  ||| S:10020 E:10029 ||| JJ
submits ||| S:10029 E:10036 ||| NN
,  ||| S:10036 E:10048 ||| ,
respectively ||| S:10048 E:10060 ||| RB
,  ||| S:10060 E:10062 ||| ,
that  ||| S:10062 E:10067 ||| WDT
have  ||| S:10067 E:10072 ||| VBP
been  ||| S:10072 E:10077 ||| VBN
shown  ||| S:10077 E:10083 ||| VBN
by  ||| S:10083 E:10086 ||| IN
affinity  ||| S:10086 E:10105 ||| JJ
chromatography  ||| S:10105 E:10120 ||| NN
to  ||| S:10120 E:10123 ||| TO
bind  ||| S:10123 E:10128 ||| VB
to  ||| S:10128 E:10131 ||| TO
the  ||| S:10131 E:10135 ||| DT
cell  ||| S:10135 E:10140 ||| NN
binding  ||| S:10140 E:10148 ||| JJ
domain  ||| S:10148 E:10155 ||| NN
( ||| S:10155 E:10156 ||| -LRB-
i.e. ||| S:10156 E:10160 ||| FW
,  ||| S:10160 E:10172 ||| ,
10  ||| S:10172 E:10175 ||| CD
thtype  ||| S:10175 E:10182 ||| JJ
III  ||| S:10182 E:10186 ||| NNP
repeat ||| S:10186 E:10192 ||| NN
)  ||| S:10192 E:10194 ||| -RRB-
of  ||| S:10194 E:10197 ||| IN
fibronectin  ||| S:10197 E:10209 ||| NNS
[  ||| S:10209 E:10211 ||| -LRB-
27  ||| S:10211 E:10214 ||| CD
28  ||| S:10214 E:10217 ||| CD
29  ||| S:10217 E:10220 ||| CD
30  ||| S:10220 E:10223 ||| CD
31  ||| S:10223 E:10226 ||| CD
]  ||| S:10226 E:10228 ||| -RRB-
.  ||| S:10228 E:10240 ||| .
Affinity  ||| S:10240 E:10249 ||| JJ
chromatography  ||| S:10249 E:10264 ||| NN
on  ||| S:10264 E:10267 ||| IN
a  ||| S:10267 E:10269 ||| DT
III1-C  ||| S:10269 E:10276 ||| NNP
Sepharose  ||| S:10276 E:10286 ||| NNP
column  ||| S:10286 E:10303 ||| NN
revealed  ||| S:10303 E:10312 ||| VBD
the  ||| S:10312 E:10316 ||| DT
binding  ||| S:10316 E:10324 ||| NN
of  ||| S:10324 E:10327 ||| IN
three  ||| S:10327 E:10333 ||| CD
major  ||| S:10333 E:10339 ||| JJ
bands  ||| S:10339 E:10345 ||| NNS
of  ||| S:10345 E:10348 ||| IN
sizes  ||| S:10348 E:10354 ||| CD
120  ||| S:10354 E:10368 ||| CD
kDa ||| S:10368 E:10371 ||| NN
,  ||| S:10371 E:10373 ||| ,
140  ||| S:10373 E:10377 ||| CD
kDa  ||| S:10377 E:10381 ||| JJ
and  ||| S:10381 E:10385 ||| CC
150  ||| S:10385 E:10389 ||| CD
kDa  ||| S:10389 E:10393 ||| NNS
( ||| S:10393 E:10394 ||| -LRB-
Fig.  ||| S:10394 E:10399 ||| CD
4 ||| S:10399 E:10400 ||| CD
, ||| S:10400 E:10401 ||| ,
Elane  ||| S:10401 E:10407 ||| NNP
under  ||| S:10407 E:10413 ||| IN
C ||| S:10413 E:10414 ||| NNP
) ||| S:10414 E:10415 ||| -RRB-
.  ||| S:10415 E:10417 ||| .
The  ||| S:10417 E:10421 ||| DT
120  ||| S:10421 E:10435 ||| CD
kDa  ||| S:10435 E:10439 ||| JJ
and  ||| S:10439 E:10443 ||| CC
140  ||| S:10443 E:10447 ||| CD
kDa  ||| S:10447 E:10451 ||| JJ
bands  ||| S:10451 E:10457 ||| NNS
likely  ||| S:10457 E:10464 ||| RB
represent  ||| S:10464 E:10474 ||| VB
the  ||| S:10474 E:10478 ||| DT
β1  ||| S:10478 E:10481 ||| NNP
and  ||| S:10481 E:10485 ||| CC
α5  ||| S:10485 E:10498 ||| CD
subunits  ||| S:10498 E:10507 ||| NNS
( ||| S:10507 E:10508 ||| -LRB-
as  ||| S:10508 E:10511 ||| IN
above ||| S:10511 E:10516 ||| JJ
) ||| S:10516 E:10517 ||| -RRB-
,  ||| S:10517 E:10519 ||| ,
while  ||| S:10519 E:10525 ||| IN
the  ||| S:10525 E:10529 ||| DT
150  ||| S:10529 E:10533 ||| CD
kDa  ||| S:10533 E:10537 ||| JJ
band  ||| S:10537 E:10542 ||| NN
may  ||| S:10542 E:10546 ||| MD
represent  ||| S:10546 E:10566 ||| VB
either  ||| S:10566 E:10573 ||| RB
the  ||| S:10573 E:10577 ||| DT
α2  ||| S:10577 E:10580 ||| NNP
or  ||| S:10580 E:10583 ||| CC
α3  ||| S:10583 E:10586 ||| CD
integrin  ||| S:10586 E:10595 ||| JJ
subunits ||| S:10595 E:10603 ||| NN
,  ||| S:10603 E:10605 ||| ,
which  ||| S:10605 E:10611 ||| WDT
are  ||| S:10611 E:10615 ||| VBP
known  ||| S:10615 E:10621 ||| VBN
to  ||| S:10621 E:10634 ||| TO
be  ||| S:10634 E:10637 ||| VB
expressed  ||| S:10637 E:10647 ||| VBN
by  ||| S:10647 E:10650 ||| IN
VSMCs  ||| S:10650 E:10656 ||| NNP
[  ||| S:10656 E:10658 ||| -LRB-
26  ||| S:10658 E:10661 ||| CD
]  ||| S:10661 E:10663 ||| -RRB-
.  ||| S:10663 E:10665 ||| .
Affinity  ||| S:10665 E:10674 ||| JJ
chromatography  ||| S:10674 E:10689 ||| NN
on  ||| S:10689 E:10702 ||| IN
the  ||| S:10702 E:10706 ||| DT
control  ||| S:10706 E:10714 ||| NN
III  ||| S:10714 E:10718 ||| NNP
11-C  ||| S:10718 E:10723 ||| NNP
column  ||| S:10723 E:10730 ||| NN
yielded  ||| S:10730 E:10738 ||| VBD
no  ||| S:10738 E:10741 ||| DT
radioiodinated  ||| S:10741 E:10766 ||| JJ
proteins  ||| S:10766 E:10775 ||| NNS
that  ||| S:10775 E:10780 ||| WDT
were  ||| S:10780 E:10785 ||| VBD
eluted  ||| S:10785 E:10792 ||| VBN
from  ||| S:10792 E:10797 ||| IN
the  ||| S:10797 E:10801 ||| DT
column  ||| S:10801 E:10808 ||| NN
( ||| S:10808 E:10809 ||| -LRB-
Fig.  ||| S:10809 E:10814 ||| CD
4 ||| S:10814 E:10815 ||| CD
, ||| S:10815 E:10816 ||| ,
Elane  ||| S:10816 E:10832 ||| NNP
under  ||| S:10832 E:10838 ||| IN
11C ||| S:10838 E:10841 ||| CD
) ||| S:10841 E:10842 ||| -RRB-
.  ||| S:10842 E:10844 ||| .
These  ||| S:10844 E:10850 ||| DT
results  ||| S:10850 E:10858 ||| NNS
are  ||| S:10858 E:10862 ||| VBP
consistent  ||| S:10862 E:10873 ||| JJ
with  ||| S:10873 E:10878 ||| IN
the  ||| S:10878 E:10892 ||| DT
hypothesis  ||| S:10892 E:10903 ||| NN
that  ||| S:10903 E:10908 ||| IN
one  ||| S:10908 E:10912 ||| CD
or  ||| S:10912 E:10915 ||| CC
more  ||| S:10915 E:10920 ||| RBR
pi  ||| S:10920 E:10923 ||| JJ
integrins  ||| S:10923 E:10933 ||| JJ
act  ||| S:10933 E:10937 ||| NN
as  ||| S:10937 E:10940 ||| IN
receptors  ||| S:10940 E:10960 ||| NNS
for  ||| S:10960 E:10964 ||| IN
III1-C ||| S:10964 E:10970 ||| CD
.  ||| S:10970 E:10972 ||| .
Taken  ||| S:10972 E:10978 ||| VBN
together  ||| S:10978 E:10987 ||| RP
with  ||| S:10987 E:10992 ||| IN
the  ||| S:10992 E:10996 ||| DT
integrin-blocking  ||| S:10996 E:11024 ||| JJ
results  ||| S:11024 E:11032 ||| NNS
described  ||| S:11032 E:11042 ||| VBD
above ||| S:11042 E:11047 ||| RB
,  ||| S:11047 E:11049 ||| ,
it  ||| S:11049 E:11052 ||| PRP
is  ||| S:11052 E:11055 ||| VBZ
clear  ||| S:11055 E:11061 ||| JJ
that  ||| S:11061 E:11066 ||| IN
RASMC  ||| S:11066 E:11072 ||| NNP
adhesion  ||| S:11072 E:11091 ||| VBD
to  ||| S:11091 E:11094 ||| TO
III1-C  ||| S:11094 E:11101 ||| NNP
is  ||| S:11101 E:11104 ||| VBZ
partially  ||| S:11104 E:11114 ||| RB
mediated  ||| S:11114 E:11123 ||| VBN
through  ||| S:11123 E:11131 ||| IN
β1  ||| S:11131 E:11134 ||| CD
integrins ||| S:11134 E:11143 ||| NNS
.  ||| S:11143 E:11173 ||| .
Cell  ||| S:11173 E:11178 ||| NN
adhesion  ||| S:11178 E:11187 ||| NN
to  ||| S:11187 E:11190 ||| TO
III1-C  ||| S:11190 E:11197 ||| CD
activates  ||| S:11197 E:11207 ||| CD
ERK1 ||| S:11207 E:11211 ||| CD
/ ||| S:11211 E:11212 ||| CD
2  ||| S:11212 E:11224 ||| CD
Integrins  ||| S:11224 E:11234 ||| NNS
are  ||| S:11234 E:11238 ||| VBP
known  ||| S:11238 E:11244 ||| VBN
to  ||| S:11244 E:11247 ||| TO
activate  ||| S:11247 E:11256 ||| VB
signaling  ||| S:11256 E:11266 ||| VBG
pathways  ||| S:11266 E:11275 ||| NN
in  ||| S:11275 E:11288 ||| IN
cells  ||| S:11288 E:11294 ||| NNS
[  ||| S:11294 E:11296 ||| -LRB-
32  ||| S:11296 E:11299 ||| CD
33  ||| S:11299 E:11302 ||| CD
34  ||| S:11302 E:11305 ||| CD
35  ||| S:11305 E:11308 ||| CD
]  ||| S:11308 E:11310 ||| -RRB-
.  ||| S:11310 E:11312 ||| .
Among  ||| S:11312 E:11318 ||| IN
the  ||| S:11318 E:11322 ||| DT
most  ||| S:11322 E:11327 ||| RBS
well-studied  ||| S:11327 E:11350 ||| JJ
signaling  ||| S:11350 E:11360 ||| JJ
pathways  ||| S:11360 E:11369 ||| NN
is  ||| S:11369 E:11372 ||| VBZ
the  ||| S:11372 E:11376 ||| DT
Ras ||| S:11376 E:11379 ||| NNP
/ ||| S:11379 E:11380 ||| NNP
MAPK  ||| S:11380 E:11385 ||| NNP
pathway  ||| S:11385 E:11393 ||| VBZ
leading  ||| S:11393 E:11401 ||| VBG
to  ||| S:11401 E:11414 ||| TO
activation  ||| S:11414 E:11425 ||| VB
of  ||| S:11425 E:11428 ||| IN
ERK1  ||| S:11428 E:11433 ||| NNP
and  ||| S:11433 E:11437 ||| CC
ERK2  ||| S:11437 E:11442 ||| NNP
[  ||| S:11442 E:11444 ||| -LRB-
36  ||| S:11444 E:11447 ||| CD
]  ||| S:11447 E:11449 ||| -RRB-
.  ||| S:11449 E:11451 ||| .
We  ||| S:11451 E:11454 ||| PRP
therefore  ||| S:11454 E:11464 ||| RB
decided  ||| S:11464 E:11482 ||| VBN
to  ||| S:11482 E:11485 ||| TO
test  ||| S:11485 E:11490 ||| VB
the  ||| S:11490 E:11494 ||| DT
effect  ||| S:11494 E:11501 ||| NN
of  ||| S:11501 E:11504 ||| IN
cell  ||| S:11504 E:11509 ||| NN
adhesion  ||| S:11509 E:11518 ||| NN
to  ||| S:11518 E:11521 ||| TO
III1-C  ||| S:11521 E:11528 ||| CD
on  ||| S:11528 E:11531 ||| IN
ERK  ||| S:11531 E:11545 ||| NNP
activation ||| S:11545 E:11555 ||| NN
.  ||| S:11555 E:11557 ||| .
As  ||| S:11557 E:11560 ||| RB
expected ||| S:11560 E:11568 ||| VBN
,  ||| S:11568 E:11570 ||| ,
treatment  ||| S:11570 E:11580 ||| NN
of  ||| S:11580 E:11583 ||| IN
RASMCs  ||| S:11583 E:11590 ||| JJ
with  ||| S:11590 E:11595 ||| IN
PDGF  ||| S:11595 E:11610 ||| NNP
resulted  ||| S:11610 E:11619 ||| VBD
in  ||| S:11619 E:11622 ||| IN
activation  ||| S:11622 E:11633 ||| NN
of  ||| S:11633 E:11636 ||| IN
ERK1 ||| S:11636 E:11640 ||| CD
/ ||| S:11640 E:11641 ||| CD
2  ||| S:11641 E:11643 ||| CD
( ||| S:11643 E:11644 ||| -LRB-
Fig.  ||| S:11644 E:11649 ||| CD
5 ||| S:11649 E:11650 ||| CD
,  ||| S:11650 E:11652 ||| ,
PDGF  ||| S:11652 E:11657 ||| NNP
lanes ||| S:11657 E:11662 ||| NNS
) ||| S:11662 E:11663 ||| -RRB-
.  ||| S:11663 E:11675 ||| .
Plating  ||| S:11675 E:11683 ||| JJ
RASMCs  ||| S:11683 E:11690 ||| NN
onto  ||| S:11690 E:11695 ||| IN
a  ||| S:11695 E:11697 ||| DT
fibronectin  ||| S:11697 E:11709 ||| JJ
coated  ||| S:11709 E:11716 ||| JJ
dish  ||| S:11716 E:11721 ||| NN
in  ||| S:11721 E:11724 ||| IN
the  ||| S:11724 E:11738 ||| DT
absence  ||| S:11738 E:11746 ||| NN
of  ||| S:11746 E:11749 ||| IN
growth  ||| S:11749 E:11756 ||| NN
factors  ||| S:11756 E:11764 ||| NNS
yielded  ||| S:11764 E:11772 ||| VBD
moderate  ||| S:11772 E:11781 ||| JJ
activation  ||| S:11781 E:11792 ||| NN
of  ||| S:11792 E:11805 ||| IN
ERK1 ||| S:11805 E:11809 ||| CD
/ ||| S:11809 E:11810 ||| CD
2 ||| S:11810 E:11811 ||| CD
,  ||| S:11811 E:11813 ||| ,
which  ||| S:11813 E:11819 ||| WDT
peaked  ||| S:11819 E:11826 ||| VBD
at  ||| S:11826 E:11829 ||| IN
30  ||| S:11829 E:11832 ||| CD
min  ||| S:11832 E:11836 ||| NNS
then  ||| S:11836 E:11841 ||| RB
decreased  ||| S:11841 E:11851 ||| VBD
somewhat  ||| S:11851 E:11870 ||| RB
over  ||| S:11870 E:11875 ||| IN
the  ||| S:11875 E:11879 ||| DT
next  ||| S:11879 E:11884 ||| JJ
30  ||| S:11884 E:11887 ||| CD
min  ||| S:11887 E:11891 ||| NN
of  ||| S:11891 E:11894 ||| IN
the  ||| S:11894 E:11898 ||| DT
experiment  ||| S:11898 E:11909 ||| NN
( ||| S:11909 E:11910 ||| -LRB-
Fig.  ||| S:11910 E:11915 ||| CD
5 ||| S:11915 E:11916 ||| CD
,  ||| S:11916 E:11918 ||| ,
bottom  ||| S:11918 E:11935 ||| JJ
panel ||| S:11935 E:11940 ||| NN
) ||| S:11940 E:11941 ||| -RRB-
.  ||| S:11941 E:11943 ||| .
However ||| S:11943 E:11950 ||| RB
,  ||| S:11950 E:11952 ||| ,
plating  ||| S:11952 E:11960 ||| JJ
cells  ||| S:11960 E:11966 ||| NNS
onto  ||| S:11966 E:11971 ||| IN
a  ||| S:11971 E:11973 ||| DT
III1-C  ||| S:11973 E:11980 ||| JJ
coated  ||| S:11980 E:11987 ||| JJ
dish  ||| S:11987 E:12002 ||| NN
gave  ||| S:12002 E:12007 ||| VBD
strong  ||| S:12007 E:12014 ||| JJ
activation  ||| S:12014 E:12025 ||| NN
of  ||| S:12025 E:12028 ||| IN
ERK1 ||| S:12028 E:12032 ||| CD
/ ||| S:12032 E:12033 ||| CD
2 ||| S:12033 E:12034 ||| CD
,  ||| S:12034 E:12036 ||| ,
which  ||| S:12036 E:12042 ||| WDT
peaked  ||| S:12042 E:12049 ||| VBD
at  ||| S:12049 E:12052 ||| IN
30  ||| S:12052 E:12055 ||| CD
min  ||| S:12055 E:12069 ||| NNS
and  ||| S:12069 E:12073 ||| CC
remained  ||| S:12073 E:12082 ||| VBD
relatively  ||| S:12082 E:12093 ||| RB
constant  ||| S:12093 E:12102 ||| JJ
for  ||| S:12102 E:12106 ||| IN
the  ||| S:12106 E:12110 ||| DT
subsequent  ||| S:12110 E:12121 ||| JJ
30  ||| S:12121 E:12134 ||| CD
min  ||| S:12134 E:12138 ||| NNS
( ||| S:12138 E:12139 ||| -LRB-
Fig.  ||| S:12139 E:12144 ||| CD
5 ||| S:12144 E:12145 ||| CD
,  ||| S:12145 E:12147 ||| ,
top  ||| S:12147 E:12151 ||| JJ
panel ||| S:12151 E:12156 ||| NN
) ||| S:12156 E:12157 ||| -RRB-
.  ||| S:12157 E:12159 ||| .
The  ||| S:12159 E:12163 ||| DT
control  ||| S:12163 E:12171 ||| NN
protein  ||| S:12171 E:12179 ||| NN
III  ||| S:12179 E:12183 ||| NNP
11-C  ||| S:12183 E:12188 ||| NNP
did  ||| S:12188 E:12202 ||| VBD
not  ||| S:12202 E:12206 ||| RB
appreciably  ||| S:12206 E:12218 ||| RB
stimulate  ||| S:12218 E:12228 ||| VB
ERK1 ||| S:12228 E:12232 ||| CD
/ ||| S:12232 E:12233 ||| CD
2  ||| S:12233 E:12235 ||| CD
phosphorylation  ||| S:12235 E:12251 ||| NNS
( ||| S:12251 E:12252 ||| -LRB-
Fig.  ||| S:12252 E:12257 ||| CD
5 ||| S:12257 E:12258 ||| CD
,  ||| S:12258 E:12270 ||| ,
11C  ||| S:12270 E:12274 ||| CD
lanes ||| S:12274 E:12279 ||| NNS
,  ||| S:12279 E:12281 ||| ,
both  ||| S:12281 E:12286 ||| DT
panels ||| S:12286 E:12292 ||| NNS
) ||| S:12292 E:12293 ||| -RRB-
.  ||| S:12293 E:12295 ||| .
Thus ||| S:12295 E:12299 ||| RB
,  ||| S:12299 E:12301 ||| ,
the  ||| S:12301 E:12305 ||| DT
adhesion  ||| S:12305 E:12314 ||| NN
of  ||| S:12314 E:12317 ||| IN
RASMCs  ||| S:12317 E:12324 ||| JJ
to  ||| S:12324 E:12337 ||| TO
III1-C  ||| S:12337 E:12344 ||| NNP
resulted  ||| S:12344 E:12353 ||| VBD
in  ||| S:12353 E:12356 ||| IN
robust  ||| S:12356 E:12363 ||| JJ
activation  ||| S:12363 E:12374 ||| NN
of  ||| S:12374 E:12377 ||| IN
ERK1 ||| S:12377 E:12381 ||| CD
/ ||| S:12381 E:12382 ||| CD
2  ||| S:12382 E:12384 ||| CD
that  ||| S:12384 E:12389 ||| WDT
was  ||| S:12389 E:12403 ||| VBD
comparable  ||| S:12403 E:12414 ||| JJ
to  ||| S:12414 E:12417 ||| TO
the  ||| S:12417 E:12421 ||| DT
activation  ||| S:12421 E:12432 ||| NN
obtained  ||| S:12432 E:12441 ||| VBN
with  ||| S:12441 E:12446 ||| IN
PDGF ||| S:12446 E:12450 ||| NNP
.  ||| S:12450 E:12480 ||| .
ERK  ||| S:12480 E:12484 ||| NNP
activation  ||| S:12484 E:12495 ||| NN
by  ||| S:12495 E:12498 ||| IN
III1-C  ||| S:12498 E:12505 ||| NNP
is  ||| S:12505 E:12508 ||| VBZ
dependent  ||| S:12508 E:12518 ||| JJ
on  ||| S:12518 E:12521 ||| IN
β1  ||| S:12521 E:12534 ||| CD
integrins  ||| S:12534 E:12554 ||| NN
As  ||| S:12554 E:12557 ||| IN
shown  ||| S:12557 E:12563 ||| VBN
above ||| S:12563 E:12568 ||| IN
,  ||| S:12568 E:12570 ||| ,
several  ||| S:12570 E:12578 ||| JJ
agents  ||| S:12578 E:12585 ||| NNS
that  ||| S:12585 E:12590 ||| IN
block  ||| S:12590 E:12596 ||| NN
β1  ||| S:12596 E:12599 ||| CD
integrin  ||| S:12599 E:12618 ||| NNS
function  ||| S:12618 E:12627 ||| VBP
partially  ||| S:12627 E:12637 ||| RB
inhibit  ||| S:12637 E:12645 ||| VB
cell  ||| S:12645 E:12650 ||| NN
attachment  ||| S:12650 E:12661 ||| NN
to  ||| S:12661 E:12664 ||| TO
III1-C ||| S:12664 E:12670 ||| CD
.  ||| S:12670 E:12672 ||| .
We  ||| S:12672 E:12685 ||| PRP
therefore  ||| S:12685 E:12695 ||| RB
tested  ||| S:12695 E:12702 ||| VBN
the  ||| S:12702 E:12706 ||| DT
effects  ||| S:12706 E:12714 ||| NNS
of  ||| S:12714 E:12717 ||| IN
these  ||| S:12717 E:12723 ||| DT
agents  ||| S:12723 E:12730 ||| NNS
on  ||| S:12730 E:12733 ||| IN
ERK1 ||| S:12733 E:12737 ||| CD
/ ||| S:12737 E:12738 ||| CD
2  ||| S:12738 E:12750 ||| CD
activation  ||| S:12750 E:12761 ||| NN
by  ||| S:12761 E:12764 ||| IN
III1-C ||| S:12764 E:12770 ||| CD
.  ||| S:12770 E:12772 ||| .
The  ||| S:12772 E:12776 ||| DT
results  ||| S:12776 E:12784 ||| NNS
obtained  ||| S:12784 E:12793 ||| VBN
with  ||| S:12793 E:12798 ||| IN
ERK1 ||| S:12798 E:12802 ||| CD
/ ||| S:12802 E:12803 ||| CD
2  ||| S:12803 E:12815 ||| CD
activation  ||| S:12815 E:12826 ||| NNS
closely  ||| S:12826 E:12834 ||| RB
paralleled  ||| S:12834 E:12845 ||| VB
the  ||| S:12845 E:12849 ||| DT
results  ||| S:12849 E:12857 ||| NNS
obtained  ||| S:12857 E:12866 ||| VBN
with  ||| S:12866 E:12881 ||| IN
cell  ||| S:12881 E:12886 ||| NN
attachment  ||| S:12886 E:12897 ||| NN
to  ||| S:12897 E:12900 ||| TO
III1-C ||| S:12900 E:12906 ||| CD
,  ||| S:12906 E:12908 ||| ,
except  ||| S:12908 E:12915 ||| IN
that  ||| S:12915 E:12920 ||| IN
the  ||| S:12920 E:12924 ||| DT
individual  ||| S:12924 E:12945 ||| JJ
blocking  ||| S:12945 E:12954 ||| VBG
agents  ||| S:12954 E:12961 ||| NNS
were  ||| S:12961 E:12966 ||| VBD
relatively  ||| S:12966 E:12977 ||| RB
more  ||| S:12977 E:12982 ||| RBR
efficient  ||| S:12982 E:12992 ||| JJ
at  ||| S:12992 E:13005 ||| IN
inhibiting  ||| S:13005 E:13016 ||| CD
ERK1 ||| S:13016 E:13020 ||| CD
/ ||| S:13020 E:13021 ||| CD
2  ||| S:13021 E:13023 ||| CD
activation ||| S:13023 E:13033 ||| NNS
.  ||| S:13033 E:13035 ||| .
For  ||| S:13035 E:13039 ||| IN
example ||| S:13039 E:13046 ||| NN
,  ||| S:13046 E:13048 ||| ,
heparin ||| S:13048 E:13055 ||| NN
,  ||| S:13055 E:13057 ||| ,
EDTA ||| S:13057 E:13061 ||| NNP
,  ||| S:13061 E:13073 ||| ,
anti-β1  ||| S:13073 E:13081 ||| NNP
mAb  ||| S:13081 E:13085 ||| NNP
and  ||| S:13085 E:13089 ||| CC
RGD  ||| S:13089 E:13093 ||| NNP
peptide  ||| S:13093 E:13101 ||| VBD
all  ||| S:13101 E:13105 ||| DT
significantly  ||| S:13105 E:13119 ||| RB
inhibited  ||| S:13119 E:13139 ||| VBD
ERK1 ||| S:13139 E:13143 ||| CD
/ ||| S:13143 E:13144 ||| CD
2  ||| S:13144 E:13146 ||| CD
activation  ||| S:13146 E:13157 ||| NN
by  ||| S:13157 E:13160 ||| IN
cell  ||| S:13160 E:13165 ||| NN
adhesion  ||| S:13165 E:13174 ||| NN
to  ||| S:13174 E:13177 ||| TO
III1-C  ||| S:13177 E:13184 ||| CD
( ||| S:13184 E:13185 ||| -LRB-
Fig.  ||| S:13185 E:13190 ||| CD
6 ||| S:13190 E:13191 ||| CD
) ||| S:13191 E:13192 ||| -RRB-
.  ||| S:13192 E:13204 ||| .
Heparin  ||| S:13204 E:13212 ||| NNP
was  ||| S:13212 E:13216 ||| VBD
most  ||| S:13216 E:13221 ||| RBS
effective  ||| S:13221 E:13231 ||| JJ
and  ||| S:13231 E:13235 ||| CC
completely  ||| S:13235 E:13246 ||| RB
blocked  ||| S:13246 E:13254 ||| VBD
ERK1 ||| S:13254 E:13258 ||| CD
/ ||| S:13258 E:13259 ||| CD
2  ||| S:13259 E:13271 ||| CD
activation ||| S:13271 E:13281 ||| NNS
.  ||| S:13281 E:13283 ||| .
( ||| S:13283 E:13284 ||| -LRB-
Fig.  ||| S:13284 E:13289 ||| CD
6 ||| S:13289 E:13290 ||| CD
) ||| S:13290 E:13291 ||| -RRB-
.  ||| S:13291 E:13293 ||| .
In  ||| S:13293 E:13296 ||| IN
contrast ||| S:13296 E:13304 ||| NN
,  ||| S:13304 E:13306 ||| ,
the  ||| S:13306 E:13310 ||| DT
negative  ||| S:13310 E:13319 ||| JJ
control  ||| S:13319 E:13337 ||| NN
RAD  ||| S:13337 E:13341 ||| NNP
peptide  ||| S:13341 E:13349 ||| NN
did  ||| S:13349 E:13353 ||| VBD
not  ||| S:13353 E:13357 ||| RB
inhibit  ||| S:13357 E:13365 ||| VB
ERK1 ||| S:13365 E:13369 ||| CD
/ ||| S:13369 E:13370 ||| CD
2  ||| S:13370 E:13372 ||| CD
activation  ||| S:13372 E:13383 ||| NN
by  ||| S:13383 E:13386 ||| IN
III1-C  ||| S:13386 E:13403 ||| NNP
( ||| S:13403 E:13404 ||| -LRB-
Fig.  ||| S:13404 E:13409 ||| CD
6 ||| S:13409 E:13410 ||| CD
,  ||| S:13410 E:13412 ||| ,
C+RAD  ||| S:13412 E:13418 ||| CD
lane ||| S:13418 E:13422 ||| CD
) ||| S:13422 E:13423 ||| -RRB-
.  ||| S:13423 E:13425 ||| .
These  ||| S:13425 E:13431 ||| DT
results  ||| S:13431 E:13439 ||| NNS
indicate  ||| S:13439 E:13448 ||| VBP
that  ||| S:13448 E:13453 ||| IN
both  ||| S:13453 E:13468 ||| DT
integrins  ||| S:13468 E:13478 ||| NN
and  ||| S:13478 E:13482 ||| CC
the  ||| S:13482 E:13486 ||| DT
class  ||| S:13486 E:13492 ||| NN
of  ||| S:13492 E:13495 ||| IN
receptors  ||| S:13495 E:13505 ||| JJ
inhibited  ||| S:13505 E:13515 ||| NN
by  ||| S:13515 E:13518 ||| IN
heparin  ||| S:13518 E:13536 ||| NN
were  ||| S:13536 E:13541 ||| VBD
required  ||| S:13541 E:13550 ||| VBN
for  ||| S:13550 E:13554 ||| IN
III1-C  ||| S:13554 E:13561 ||| CD
mediated  ||| S:13561 E:13570 ||| JJ
activation  ||| S:13570 E:13581 ||| NN
of  ||| S:13581 E:13594 ||| IN
ERK1 ||| S:13594 E:13598 ||| CD
/ ||| S:13598 E:13599 ||| CD
2 ||| S:13599 E:13600 ||| CD
.  ||| S:13600 E:13630 ||| .
Role  ||| S:13630 E:13635 ||| NN
of  ||| S:13635 E:13638 ||| IN
heparan  ||| S:13638 E:13646 ||| JJ
sulfate  ||| S:13646 E:13654 ||| JJ
proteoglycans  ||| S:13654 E:13668 ||| NN
in  ||| S:13668 E:13671 ||| IN
cell  ||| S:13671 E:13686 ||| NN
adhesion  ||| S:13686 E:13695 ||| NN
to  ||| S:13695 E:13698 ||| TO
III1-C  ||| S:13698 E:13705 ||| CD
and  ||| S:13705 E:13709 ||| CC
ERK1 ||| S:13709 E:13713 ||| CD
/ ||| S:13713 E:13714 ||| CD
2  ||| S:13714 E:13716 ||| CD
activation  ||| S:13716 E:13727 ||| NN
by  ||| S:13727 E:13730 ||| IN
III1-C  ||| S:13730 E:13747 ||| CD
Because  ||| S:13747 E:13755 ||| IN
heparin  ||| S:13755 E:13763 ||| NN
was  ||| S:13763 E:13767 ||| VBD
able  ||| S:13767 E:13772 ||| JJ
to  ||| S:13772 E:13775 ||| TO
inhibit  ||| S:13775 E:13783 ||| VB
the  ||| S:13783 E:13787 ||| DT
attachment  ||| S:13787 E:13798 ||| NN
of  ||| S:13798 E:13811 ||| IN
cells  ||| S:13811 E:13817 ||| NNS
to  ||| S:13817 E:13820 ||| TO
III1-C  ||| S:13820 E:13827 ||| CD
and  ||| S:13827 E:13831 ||| CC
the  ||| S:13831 E:13835 ||| DT
activation  ||| S:13835 E:13846 ||| NN
of  ||| S:13846 E:13849 ||| IN
ERK1 ||| S:13849 E:13853 ||| CD
/ ||| S:13853 E:13854 ||| CD
2  ||| S:13854 E:13856 ||| CD
by  ||| S:13856 E:13859 ||| IN
III1-C ||| S:13859 E:13865 ||| NNP
,  ||| S:13865 E:13877 ||| ,
we  ||| S:13877 E:13880 ||| PRP
tested  ||| S:13880 E:13887 ||| VBD
the  ||| S:13887 E:13891 ||| DT
effect  ||| S:13891 E:13898 ||| NN
of  ||| S:13898 E:13901 ||| IN
other  ||| S:13901 E:13907 ||| JJ
glycosaminoglycans  ||| S:13907 E:13926 ||| NN
on  ||| S:13926 E:13939 ||| IN
III1-C  ||| S:13939 E:13946 ||| CD
stimulated  ||| S:13946 E:13957 ||| CD
ERK1 ||| S:13957 E:13961 ||| CD
/ ||| S:13961 E:13962 ||| CD
2  ||| S:13962 E:13964 ||| CD
activity ||| S:13964 E:13972 ||| NN
.  ||| S:13972 E:13974 ||| .
Heparin ||| S:13974 E:13981 ||| NNP
,  ||| S:13981 E:13983 ||| ,
heparan  ||| S:13983 E:14001 ||| JJ
sulfate  ||| S:14001 E:14009 ||| NN
and  ||| S:14009 E:14013 ||| CC
dermatan  ||| S:14013 E:14022 ||| JJ
sulfate  ||| S:14022 E:14030 ||| NN
blocked  ||| S:14030 E:14038 ||| VBD
ERK1 ||| S:14038 E:14042 ||| CD
/ ||| S:14042 E:14043 ||| CD
2  ||| S:14043 E:14045 ||| CD
activation  ||| S:14045 E:14056 ||| NN
by  ||| S:14056 E:14069 ||| IN
III1-C  ||| S:14069 E:14076 ||| NNP
( ||| S:14076 E:14077 ||| -LRB-
Fig.  ||| S:14077 E:14082 ||| CD
7 ||| S:14082 E:14083 ||| CD
) ||| S:14083 E:14084 ||| -RRB-
,  ||| S:14084 E:14086 ||| ,
and  ||| S:14086 E:14090 ||| CC
cell  ||| S:14090 E:14095 ||| NN
adhesion  ||| S:14095 E:14104 ||| NN
to  ||| S:14104 E:14107 ||| TO
III1-C  ||| S:14107 E:14114 ||| CD
( ||| S:14114 E:14115 ||| -LRB-
not  ||| S:14115 E:14119 ||| RB
shown ||| S:14119 E:14124 ||| VBN
) ||| S:14124 E:14125 ||| -RRB-
.  ||| S:14125 E:14137 ||| .
In  ||| S:14137 E:14140 ||| IN
contrast ||| S:14140 E:14148 ||| NN
,  ||| S:14148 E:14150 ||| ,
hyaluronic  ||| S:14150 E:14161 ||| JJ
acid ||| S:14161 E:14165 ||| NN
,  ||| S:14165 E:14167 ||| ,
chondroitin-4-sulfate  ||| S:14167 E:14189 ||| NNP
and  ||| S:14189 E:14203 ||| CC
chondroitin-6-sulfate  ||| S:14203 E:14225 ||| NNP
had  ||| S:14225 E:14229 ||| VBD
no  ||| S:14229 E:14232 ||| DT
effect  ||| S:14232 E:14239 ||| NN
on  ||| S:14239 E:14242 ||| IN
the  ||| S:14242 E:14246 ||| DT
ability  ||| S:14246 E:14254 ||| NN
of  ||| S:14254 E:14267 ||| IN
III1-C  ||| S:14267 E:14274 ||| CD
to  ||| S:14274 E:14277 ||| TO
stimulate  ||| S:14277 E:14287 ||| VB
ERK1 ||| S:14287 E:14291 ||| CD
/ ||| S:14291 E:14292 ||| CD
2  ||| S:14292 E:14294 ||| CD
activity  ||| S:14294 E:14303 ||| NN
( ||| S:14303 E:14304 ||| -LRB-
Fig.  ||| S:14304 E:14309 ||| CD
7 ||| S:14309 E:14310 ||| CD
)  ||| S:14310 E:14312 ||| -RRB-
or  ||| S:14312 E:14315 ||| CC
on  ||| S:14315 E:14318 ||| IN
the  ||| S:14318 E:14332 ||| DT
adhesion  ||| S:14332 E:14341 ||| NN
of  ||| S:14341 E:14344 ||| IN
cells  ||| S:14344 E:14350 ||| NNS
to  ||| S:14350 E:14353 ||| TO
III1-C  ||| S:14353 E:14360 ||| CD
( ||| S:14360 E:14361 ||| -LRB-
not  ||| S:14361 E:14365 ||| RB
shown ||| S:14365 E:14370 ||| VBN
) ||| S:14370 E:14371 ||| -RRB-
.  ||| S:14371 E:14373 ||| .
It  ||| S:14373 E:14376 ||| PRP
is  ||| S:14376 E:14379 ||| VBZ
possible  ||| S:14379 E:14398 ||| JJ
that  ||| S:14398 E:14403 ||| IN
heparin ||| S:14403 E:14410 ||| NN
,  ||| S:14410 E:14412 ||| ,
heparan  ||| S:14412 E:14420 ||| JJ
sulfate  ||| S:14420 E:14428 ||| NN
and  ||| S:14428 E:14432 ||| CC
dermatan  ||| S:14432 E:14441 ||| FW
sulfate  ||| S:14441 E:14459 ||| FW
inhibit  ||| S:14459 E:14467 ||| FW
III1-C  ||| S:14467 E:14474 ||| FW
mediated  ||| S:14474 E:14483 ||| FW
cell  ||| S:14483 E:14488 ||| FW
adhesion  ||| S:14488 E:14497 ||| FW
and  ||| S:14497 E:14501 ||| CC
ERK1 ||| S:14501 E:14505 ||| CD
/ ||| S:14505 E:14506 ||| CD
2  ||| S:14506 E:14518 ||| CD
activation  ||| S:14518 E:14529 ||| CD
due  ||| S:14529 E:14533 ||| JJ
to  ||| S:14533 E:14536 ||| TO
common  ||| S:14536 E:14543 ||| JJ
chemical  ||| S:14543 E:14552 ||| NN
features ||| S:14552 E:14560 ||| NNS
.  ||| S:14560 E:14562 ||| .
For  ||| S:14562 E:14566 ||| IN
example ||| S:14566 E:14573 ||| NN
,  ||| S:14573 E:14585 ||| ,
heparin ||| S:14585 E:14592 ||| NN
,  ||| S:14592 E:14594 ||| ,
heparan  ||| S:14594 E:14602 ||| JJ
sulfate ||| S:14602 E:14609 ||| NN
,  ||| S:14609 E:14611 ||| ,
and  ||| S:14611 E:14615 ||| CC
dermatan  ||| S:14615 E:14624 ||| FW
sulfate  ||| S:14624 E:14632 ||| FW
all  ||| S:14632 E:14646 ||| FW
contain  ||| S:14646 E:14654 ||| FW
iduronic  ||| S:14654 E:14663 ||| FW
acid  ||| S:14663 E:14668 ||| FW
residues  ||| S:14668 E:14677 ||| FW
whereas  ||| S:14677 E:14685 ||| FW
chondroitin  ||| S:14685 E:14707 ||| FW
sulfate  ||| S:14707 E:14715 ||| FW
and  ||| S:14715 E:14719 ||| CC
hyaluronic  ||| S:14719 E:14730 ||| JJ
acid  ||| S:14730 E:14735 ||| NNS
do  ||| S:14735 E:14738 ||| VBP
not ||| S:14738 E:14741 ||| RB
.  ||| S:14741 E:14743 ||| .
The  ||| S:14743 E:14747 ||| DT
results  ||| S:14747 E:14755 ||| NNS
presented  ||| S:14755 E:14775 ||| VBD
above  ||| S:14775 E:14781 ||| RB
indicate  ||| S:14781 E:14790 ||| VB
that  ||| S:14790 E:14795 ||| IN
a  ||| S:14795 E:14797 ||| DT
heparan  ||| S:14797 E:14805 ||| FW
sulfate  ||| S:14805 E:14813 ||| FW
proteoglycan  ||| S:14813 E:14826 ||| FW
( ||| S:14826 E:14827 ||| -LRB-
HSPG ||| S:14827 E:14831 ||| NNP
)  ||| S:14831 E:14843 ||| -RRB-
or  ||| S:14843 E:14846 ||| CC
dermatan  ||| S:14846 E:14855 ||| JJ
sulfate  ||| S:14855 E:14863 ||| JJ
proteoglycan  ||| S:14863 E:14876 ||| NN
on  ||| S:14876 E:14879 ||| IN
the  ||| S:14879 E:14883 ||| DT
surface  ||| S:14883 E:14891 ||| NN
of  ||| S:14891 E:14894 ||| IN
RASMCs  ||| S:14894 E:14911 ||| NNP
may  ||| S:14911 E:14915 ||| MD
serve  ||| S:14915 E:14921 ||| VB
as  ||| S:14921 E:14924 ||| IN
a  ||| S:14924 E:14926 ||| DT
receptor  ||| S:14926 E:14935 ||| NN
for  ||| S:14935 E:14939 ||| IN
III1-C ||| S:14939 E:14945 ||| CD
.  ||| S:14945 E:14957 ||| .
To  ||| S:14957 E:14960 ||| TO
further  ||| S:14960 E:14968 ||| RB
explore  ||| S:14968 E:14976 ||| VB
the  ||| S:14976 E:14980 ||| DT
possibility  ||| S:14980 E:14992 ||| NN
that  ||| S:14992 E:14997 ||| IN
a  ||| S:14997 E:14999 ||| DT
cell  ||| S:14999 E:15004 ||| NN
surface  ||| S:15004 E:15022 ||| NN
proteoglycan  ||| S:15022 E:15035 ||| NN
serves  ||| S:15035 E:15042 ||| VBZ
as  ||| S:15042 E:15045 ||| IN
a  ||| S:15045 E:15047 ||| DT
receptor  ||| S:15047 E:15056 ||| NN
for  ||| S:15056 E:15060 ||| IN
III1-C ||| S:15060 E:15066 ||| NNP
,  ||| S:15066 E:15068 ||| ,
RASMCs  ||| S:15068 E:15075 ||| NNP
were  ||| S:15075 E:15090 ||| VBD
treated  ||| S:15090 E:15098 ||| VBN
with  ||| S:15098 E:15103 ||| IN
the  ||| S:15103 E:15107 ||| DT
glycosaminoglycan-degrading  ||| S:15107 E:15135 ||| JJ
enzymes  ||| S:15135 E:15153 ||| JJ
seeded  ||| S:15153 E:15160 ||| NN
onto  ||| S:15160 E:15165 ||| IN
III1-C ||| S:15165 E:15171 ||| NNP
,  ||| S:15171 E:15173 ||| ,
and  ||| S:15173 E:15177 ||| CC
analyzed  ||| S:15177 E:15186 ||| VBD
for  ||| S:15186 E:15190 ||| IN
the  ||| S:15190 E:15194 ||| DT
activation  ||| S:15194 E:15205 ||| NN
of  ||| S:15205 E:15218 ||| IN
ERK1 ||| S:15218 E:15222 ||| CD
/ ||| S:15222 E:15223 ||| CD
2 ||| S:15223 E:15224 ||| CD
.  ||| S:15224 E:15226 ||| .
Heparitinase  ||| S:15226 E:15239 ||| JJ
treatment ||| S:15239 E:15248 ||| NN
,  ||| S:15248 E:15250 ||| ,
but  ||| S:15250 E:15254 ||| CC
not  ||| S:15254 E:15258 ||| RB
chondroitinase  ||| S:15258 E:15283 ||| JJ
ABC  ||| S:15283 E:15287 ||| NNP
treatment  ||| S:15287 E:15297 ||| NN
decreased  ||| S:15297 E:15307 ||| VBD
the  ||| S:15307 E:15311 ||| DT
amount  ||| S:15311 E:15318 ||| NN
of  ||| S:15318 E:15321 ||| IN
ERK1 ||| S:15321 E:15325 ||| CD
/ ||| S:15325 E:15326 ||| CD
2  ||| S:15326 E:15328 ||| CD
activation  ||| S:15328 E:15349 ||| NN
by  ||| S:15349 E:15352 ||| IN
III1-C  ||| S:15352 E:15359 ||| NNP
( ||| S:15359 E:15360 ||| -LRB-
Fig.  ||| S:15360 E:15365 ||| CD
8 ||| S:15365 E:15366 ||| CD
) ||| S:15366 E:15367 ||| -RRB-
.  ||| S:15367 E:15369 ||| .
Heparitinase  ||| S:15369 E:15382 ||| JJ
treatment  ||| S:15382 E:15392 ||| NN
also  ||| S:15392 E:15397 ||| RB
inhibited  ||| S:15397 E:15417 ||| JJ
cell  ||| S:15417 E:15422 ||| NN
adhesion  ||| S:15422 E:15431 ||| NN
by  ||| S:15431 E:15434 ||| IN
25-40 ||| S:15434 E:15439 ||| CD
% ||| S:15439 E:15440 ||| NN
,  ||| S:15440 E:15442 ||| ,
while  ||| S:15442 E:15448 ||| IN
chondroitinase  ||| S:15448 E:15463 ||| JJ
ABC  ||| S:15463 E:15477 ||| NNP
treatment  ||| S:15477 E:15487 ||| NN
did  ||| S:15487 E:15491 ||| VBD
not  ||| S:15491 E:15495 ||| RB
inhibit  ||| S:15495 E:15503 ||| VB
cell  ||| S:15503 E:15508 ||| NN
adhesion  ||| S:15508 E:15517 ||| NN
to  ||| S:15517 E:15520 ||| TO
III1-C  ||| S:15520 E:15527 ||| CD
( ||| S:15527 E:15528 ||| -LRB-
not  ||| S:15528 E:15542 ||| RB
shown ||| S:15542 E:15547 ||| VBN
) ||| S:15547 E:15548 ||| -RRB-
.  ||| S:15548 E:15550 ||| .
This  ||| S:15550 E:15555 ||| DT
result  ||| S:15555 E:15562 ||| NN
is  ||| S:15562 E:15565 ||| VBZ
consistent  ||| S:15565 E:15576 ||| JJ
with  ||| S:15576 E:15581 ||| IN
the  ||| S:15581 E:15585 ||| DT
idea  ||| S:15585 E:15590 ||| NN
that  ||| S:15590 E:15605 ||| IN
HSPGs  ||| S:15605 E:15611 ||| JJ
but  ||| S:15611 E:15615 ||| CC
not  ||| S:15615 E:15619 ||| RB
chondroitin  ||| S:15619 E:15631 ||| JJ
sulfate  ||| S:15631 E:15639 ||| JJ
proteoglycans  ||| S:15639 E:15653 ||| NNS
serve  ||| S:15653 E:15659 ||| VBP
as  ||| S:15659 E:15672 ||| RB
signaling  ||| S:15672 E:15682 ||| VBG
receptors  ||| S:15682 E:15692 ||| NNS
for  ||| S:15692 E:15696 ||| IN
III1-C ||| S:15696 E:15702 ||| CD
.  ||| S:15702 E:15714 ||| .
To  ||| S:15714 E:15717 ||| TO
identify  ||| S:15717 E:15726 ||| VB
the  ||| S:15726 E:15730 ||| DT
cell  ||| S:15730 E:15735 ||| NN
surface  ||| S:15735 E:15743 ||| NN
proteoglycans  ||| S:15743 E:15757 ||| NNS
that  ||| S:15757 E:15762 ||| WDT
may  ||| S:15762 E:15776 ||| MD
serve  ||| S:15776 E:15782 ||| VB
as  ||| S:15782 E:15785 ||| IN
receptors  ||| S:15785 E:15795 ||| NNS
for  ||| S:15795 E:15799 ||| IN
III1-C ||| S:15799 E:15805 ||| NNP
,  ||| S:15805 E:15807 ||| ,
RASMCs  ||| S:15807 E:15814 ||| NNP
were  ||| S:15814 E:15819 ||| VBD
labeled  ||| S:15819 E:15827 ||| VBN
with  ||| S:15827 E:15842 ||| IN
35SO  ||| S:15842 E:15858 ||| CD
4  ||| S:15858 E:15860 ||| CD
and  ||| S:15860 E:15864 ||| CC
cell  ||| S:15864 E:15869 ||| NN
lysates  ||| S:15869 E:15877 ||| NNS
were  ||| S:15877 E:15882 ||| VBD
applied  ||| S:15882 E:15890 ||| VBN
to  ||| S:15890 E:15903 ||| TO
III1-C  ||| S:15903 E:15910 ||| CD
and  ||| S:15910 E:15914 ||| CC
III  ||| S:15914 E:15918 ||| NNP
11-C  ||| S:15918 E:15923 ||| NNP
columns ||| S:15923 E:15930 ||| NNS
.  ||| S:15930 E:15932 ||| .
The  ||| S:15932 E:15936 ||| DT
most  ||| S:15936 E:15941 ||| RBS
highly  ||| S:15941 E:15948 ||| RB
labeled  ||| S:15948 E:15966 ||| VBN
band ||| S:15966 E:15970 ||| NN
,  ||| S:15970 E:15972 ||| ,
migrating  ||| S:15972 E:15982 ||| VBG
in  ||| S:15982 E:15985 ||| IN
a  ||| S:15985 E:15987 ||| DT
smear  ||| S:15987 E:15993 ||| NN
at  ||| S:15993 E:15996 ||| IN
about  ||| S:15996 E:16002 ||| IN
450  ||| S:16002 E:16006 ||| CD
kDa ||| S:16006 E:16009 ||| NN
,  ||| S:16009 E:16011 ||| ,
bound  ||| S:16011 E:16027 ||| VBN
efficiently  ||| S:16027 E:16039 ||| RB
to  ||| S:16039 E:16042 ||| TO
the  ||| S:16042 E:16046 ||| DT
III1-C  ||| S:16046 E:16053 ||| JJ
column  ||| S:16053 E:16060 ||| NN
( ||| S:16060 E:16061 ||| -LRB-
Fig.  ||| S:16061 E:16066 ||| NNP
9A ||| S:16066 E:16068 ||| NNP
,  ||| S:16068 E:16070 ||| ,
compare  ||| S:16070 E:16078 ||| JJ
flow  ||| S:16078 E:16093 ||| NN
through  ||| S:16093 E:16101 ||| IN
and  ||| S:16101 E:16105 ||| CC
elution  ||| S:16105 E:16113 ||| JJ
lanes ||| S:16113 E:16118 ||| NNS
) ||| S:16118 E:16119 ||| -RRB-
.  ||| S:16119 E:16121 ||| .
This  ||| S:16121 E:16126 ||| DT
proteoglycan  ||| S:16126 E:16139 ||| NN
resisted  ||| S:16139 E:16158 ||| VBD
elution  ||| S:16158 E:16166 ||| VBN
by  ||| S:16166 E:16169 ||| IN
8  ||| S:16169 E:16171 ||| CD
M  ||| S:16171 E:16173 ||| NNP
urea  ||| S:16173 E:16178 ||| NN
but  ||| S:16178 E:16182 ||| CC
was  ||| S:16182 E:16186 ||| VBD
eluted  ||| S:16186 E:16193 ||| VBN
by  ||| S:16193 E:16196 ||| IN
boiling  ||| S:16196 E:16204 ||| VBG
the  ||| S:16204 E:16218 ||| DT
Sepharose  ||| S:16218 E:16228 ||| JJ
beads  ||| S:16228 E:16234 ||| NN
in  ||| S:16234 E:16237 ||| IN
SDS  ||| S:16237 E:16241 ||| NNP
( ||| S:16241 E:16242 ||| -LRB-
Fig.  ||| S:16242 E:16247 ||| NNP
9A ||| S:16247 E:16249 ||| NNP
) ||| S:16249 E:16250 ||| -RRB-
.  ||| S:16250 E:16252 ||| .
This  ||| S:16252 E:16257 ||| DT
same  ||| S:16257 E:16262 ||| JJ
proteoglycan  ||| S:16262 E:16285 ||| NN
did  ||| S:16285 E:16289 ||| VBD
not  ||| S:16289 E:16293 ||| RB
bind  ||| S:16293 E:16298 ||| JJ
appreciably  ||| S:16298 E:16310 ||| NN
to  ||| S:16310 E:16313 ||| TO
the  ||| S:16313 E:16317 ||| DT
III  ||| S:16317 E:16321 ||| NNP
11-C  ||| S:16321 E:16326 ||| NNP
column  ||| S:16326 E:16333 ||| NN
( ||| S:16333 E:16334 ||| -LRB-
Fig.  ||| S:16334 E:16349 ||| NNP
9A ||| S:16349 E:16351 ||| NNP
) ||| S:16351 E:16352 ||| -RRB-
.  ||| S:16352 E:16354 ||| .
Heparitinase  ||| S:16354 E:16367 ||| NNP
and  ||| S:16367 E:16371 ||| CC
chondroitinase  ||| S:16371 E:16386 ||| JJ
ABC  ||| S:16386 E:16390 ||| NNP
treatment  ||| S:16390 E:16400 ||| NN
of  ||| S:16400 E:16403 ||| IN
the  ||| S:16403 E:16417 ||| DT
35SO  ||| S:16417 E:16433 ||| CD
4  ||| S:16433 E:16435 ||| CD
labeled  ||| S:16435 E:16443 ||| CD
samples  ||| S:16443 E:16451 ||| NNS
revealed  ||| S:16451 E:16460 ||| VBD
that  ||| S:16460 E:16465 ||| IN
the  ||| S:16465 E:16479 ||| DT
450  ||| S:16479 E:16483 ||| CD
kDa  ||| S:16483 E:16487 ||| JJ
proteoglycan  ||| S:16487 E:16500 ||| NN
was  ||| S:16500 E:16504 ||| VBD
composed  ||| S:16504 E:16513 ||| VBN
mostly  ||| S:16513 E:16520 ||| RB
of  ||| S:16520 E:16523 ||| IN
HSPGs  ||| S:16523 E:16529 ||| NNP
( ||| S:16529 E:16530 ||| -LRB-
Fig.  ||| S:16530 E:16545 ||| NNP
9B ||| S:16545 E:16547 ||| NNP
) ||| S:16547 E:16548 ||| -RRB-
.  ||| S:16548 E:16550 ||| .
These  ||| S:16550 E:16556 ||| DT
results  ||| S:16556 E:16564 ||| NNS
indicate  ||| S:16564 E:16573 ||| VBP
that  ||| S:16573 E:16578 ||| IN
most  ||| S:16578 E:16583 ||| JJS
of  ||| S:16583 E:16586 ||| IN
the  ||| S:16586 E:16590 ||| DT
cell  ||| S:16590 E:16595 ||| NN
surface  ||| S:16595 E:16613 ||| NN
HSPGs  ||| S:16613 E:16619 ||| NN
of  ||| S:16619 E:16622 ||| IN
RASMCs  ||| S:16622 E:16629 ||| NNP
can  ||| S:16629 E:16633 ||| MD
bind  ||| S:16633 E:16638 ||| VB
to  ||| S:16638 E:16641 ||| TO
III1-C  ||| S:16641 E:16648 ||| CD
in  ||| S:16648 E:16651 ||| IN
affinity  ||| S:16651 E:16670 ||| JJ
chromatography ||| S:16670 E:16684 ||| NN
.  ||| S:16684 E:16696 ||| .
RASMC  ||| S:16696 E:16702 ||| NNP
HSPGs  ||| S:16702 E:16708 ||| NNP
were  ||| S:16708 E:16713 ||| VBD
analyzed  ||| S:16713 E:16722 ||| VBN
further  ||| S:16722 E:16730 ||| RBR
by  ||| S:16730 E:16733 ||| IN
immunoblotting  ||| S:16733 E:16758 ||| NN
with  ||| S:16758 E:16763 ||| IN
the  ||| S:16763 E:16767 ||| DT
monoclonal  ||| S:16767 E:16778 ||| JJ
antibody  ||| S:16778 E:16787 ||| NN
3G10  ||| S:16787 E:16792 ||| NN
which  ||| S:16792 E:16798 ||| WDT
specifically  ||| S:16798 E:16821 ||| RB
recognizes  ||| S:16821 E:16832 ||| VBZ
desaturated  ||| S:16832 E:16844 ||| JJ
uronates  ||| S:16844 E:16853 ||| NN
on  ||| S:16853 E:16856 ||| IN
the  ||| S:16856 E:16860 ||| DT
heparan  ||| S:16860 E:16868 ||| JJ
sulfate  ||| S:16868 E:16886 ||| JJ
stubs  ||| S:16886 E:16892 ||| NN
that  ||| S:16892 E:16897 ||| WDT
remain  ||| S:16897 E:16904 ||| VBP
associated  ||| S:16904 E:16915 ||| VBN
with  ||| S:16915 E:16920 ||| IN
core  ||| S:16920 E:16925 ||| JJ
proteins  ||| S:16925 E:16934 ||| NNS
after  ||| S:16934 E:16950 ||| IN
heparitinase  ||| S:16950 E:16963 ||| JJ
digestion  ||| S:16963 E:16973 ||| NNS
[  ||| S:16973 E:16975 ||| -LRB-
37  ||| S:16975 E:16978 ||| CD
]  ||| S:16978 E:16980 ||| -RRB-
.  ||| S:16980 E:16982 ||| .
Complete  ||| S:16982 E:16991 ||| JJ
digestion  ||| S:16991 E:17001 ||| NN
of  ||| S:17001 E:17014 ||| IN
RASMC  ||| S:17014 E:17020 ||| NNP
lysates  ||| S:17020 E:17028 ||| NN
with  ||| S:17028 E:17033 ||| IN
heparitinase  ||| S:17033 E:17046 ||| NN
reveals  ||| S:17046 E:17054 ||| VBZ
major  ||| S:17054 E:17060 ||| JJ
bands  ||| S:17060 E:17066 ||| NNS
at  ||| S:17066 E:17069 ||| IN
46  ||| S:17069 E:17082 ||| CD
kDa  ||| S:17082 E:17086 ||| JJ
and  ||| S:17086 E:17090 ||| CC
70  ||| S:17090 E:17093 ||| CD
kDa ||| S:17093 E:17096 ||| NN
,  ||| S:17096 E:17098 ||| ,
indicating  ||| S:17098 E:17109 ||| VBG
that  ||| S:17109 E:17114 ||| IN
these  ||| S:17114 E:17120 ||| DT
are  ||| S:17120 E:17124 ||| VBP
the  ||| S:17124 E:17128 ||| DT
sizes  ||| S:17128 E:17134 ||| NN
of  ||| S:17134 E:17147 ||| IN
the  ||| S:17147 E:17151 ||| DT
major  ||| S:17151 E:17157 ||| JJ
HSPG  ||| S:17157 E:17162 ||| NNP
core  ||| S:17162 E:17167 ||| NN
proteins  ||| S:17167 E:17176 ||| NNS
( ||| S:17176 E:17177 ||| -LRB-
not  ||| S:17177 E:17181 ||| RB
shown ||| S:17181 E:17186 ||| VBN
) ||| S:17186 E:17187 ||| -RRB-
.  ||| S:17187 E:17189 ||| .
RASMC  ||| S:17189 E:17195 ||| NNP
lysates  ||| S:17195 E:17213 ||| NN
were  ||| S:17213 E:17218 ||| VBD
subjected  ||| S:17218 E:17228 ||| VBN
to  ||| S:17228 E:17231 ||| TO
partial  ||| S:17231 E:17239 ||| JJ
heparitinase  ||| S:17239 E:17252 ||| JJ
treatment  ||| S:17252 E:17262 ||| NN
( ||| S:17262 E:17263 ||| -LRB-
full  ||| S:17263 E:17278 ||| JJ
digestion  ||| S:17278 E:17288 ||| NN
was  ||| S:17288 E:17292 ||| VBD
not  ||| S:17292 E:17296 ||| RB
performed  ||| S:17296 E:17306 ||| VBN
in  ||| S:17306 E:17309 ||| IN
order  ||| S:17309 E:17315 ||| NN
to  ||| S:17315 E:17318 ||| TO
allow  ||| S:17318 E:17324 ||| VB
some  ||| S:17324 E:17329 ||| DT
GAGs  ||| S:17329 E:17344 ||| JJ
to  ||| S:17344 E:17347 ||| TO
remain  ||| S:17347 E:17354 ||| VB
associated  ||| S:17354 E:17365 ||| VBN
with  ||| S:17365 E:17370 ||| IN
the  ||| S:17370 E:17374 ||| DT
core  ||| S:17374 E:17379 ||| NN
proteins ||| S:17379 E:17387 ||| NNS
)  ||| S:17387 E:17389 ||| -RRB-
then  ||| S:17389 E:17394 ||| RB
applied  ||| S:17394 E:17412 ||| VBN
to  ||| S:17412 E:17415 ||| TO
either  ||| S:17415 E:17422 ||| DT
III1-C  ||| S:17422 E:17429 ||| NNP
or  ||| S:17429 E:17432 ||| CC
III  ||| S:17432 E:17436 ||| NNP
11-C  ||| S:17436 E:17441 ||| NNP
Sepharose ||| S:17441 E:17450 ||| NNP
.  ||| S:17450 E:17452 ||| .
As  ||| S:17452 E:17455 ||| RB
shown  ||| S:17455 E:17461 ||| VBN
in  ||| S:17461 E:17464 ||| IN
Fig.  ||| S:17464 E:17479 ||| CD
10 ||| S:17479 E:17481 ||| CD
,  ||| S:17481 E:17483 ||| ,
most  ||| S:17483 E:17488 ||| JJS
of  ||| S:17488 E:17491 ||| IN
the  ||| S:17491 E:17495 ||| DT
46  ||| S:17495 E:17498 ||| CD
kDa  ||| S:17498 E:17502 ||| JJ
and  ||| S:17502 E:17506 ||| CC
70  ||| S:17506 E:17509 ||| CD
kDa  ||| S:17509 E:17513 ||| JJ
HSPGs  ||| S:17513 E:17519 ||| NN
bound  ||| S:17519 E:17525 ||| VBN
to  ||| S:17525 E:17528 ||| TO
III1-C  ||| S:17528 E:17545 ||| NNP
Sepharose  ||| S:17545 E:17555 ||| NNP
but  ||| S:17555 E:17559 ||| CC
not  ||| S:17559 E:17563 ||| RB
to  ||| S:17563 E:17566 ||| TO
III  ||| S:17566 E:17570 ||| NNP
11-C  ||| S:17570 E:17575 ||| NNP
Sepharose ||| S:17575 E:17584 ||| NNP
.  ||| S:17584 E:17586 ||| .
In  ||| S:17586 E:17589 ||| IN
addition ||| S:17589 E:17597 ||| NN
,  ||| S:17597 E:17599 ||| ,
the  ||| S:17599 E:17613 ||| DT
presence  ||| S:17613 E:17622 ||| NN
of  ||| S:17622 E:17625 ||| IN
heparin  ||| S:17625 E:17633 ||| NN
in  ||| S:17633 E:17636 ||| IN
the  ||| S:17636 E:17640 ||| DT
lysate  ||| S:17640 E:17647 ||| NN
inhibited  ||| S:17647 E:17657 ||| VBD
the  ||| S:17657 E:17661 ||| DT
46  ||| S:17661 E:17664 ||| CD
kDa  ||| S:17664 E:17678 ||| JJ
and  ||| S:17678 E:17682 ||| CC
70  ||| S:17682 E:17685 ||| CD
kDa  ||| S:17685 E:17689 ||| JJ
HSPGs  ||| S:17689 E:17695 ||| NN
from  ||| S:17695 E:17700 ||| IN
binding  ||| S:17700 E:17708 ||| VBG
to  ||| S:17708 E:17711 ||| TO
the  ||| S:17711 E:17715 ||| DT
III1-C  ||| S:17715 E:17722 ||| JJ
column  ||| S:17722 E:17729 ||| NN
( ||| S:17729 E:17730 ||| -LRB-
Fig.  ||| S:17730 E:17745 ||| CD
10 ||| S:17745 E:17747 ||| CD
,  ||| S:17747 E:17749 ||| ,
compare  ||| S:17749 E:17757 ||| VBP
C  ||| S:17757 E:17759 ||| NNP
and  ||| S:17759 E:17763 ||| CC
C•H  ||| S:17763 E:17767 ||| CD
lanes ||| S:17767 E:17772 ||| NNS
) ||| S:17772 E:17773 ||| -RRB-
.  ||| S:17773 E:17775 ||| .
The  ||| S:17775 E:17779 ||| DT
inhibition  ||| S:17779 E:17790 ||| NN
of  ||| S:17790 E:17793 ||| IN
46  ||| S:17793 E:17796 ||| CD
kDa  ||| S:17796 E:17810 ||| JJ
and  ||| S:17810 E:17814 ||| CC
70  ||| S:17814 E:17817 ||| CD
kDa  ||| S:17817 E:17821 ||| JJ
binding  ||| S:17821 E:17829 ||| NN
to  ||| S:17829 E:17832 ||| TO
III1-C  ||| S:17832 E:17839 ||| CD
by  ||| S:17839 E:17842 ||| IN
heparin  ||| S:17842 E:17850 ||| NN
suggests  ||| S:17850 E:17859 ||| VBZ
that  ||| S:17859 E:17874 ||| IN
these  ||| S:17874 E:17880 ||| DT
HSPGs  ||| S:17880 E:17886 ||| NN
may  ||| S:17886 E:17890 ||| MD
serve  ||| S:17890 E:17896 ||| VB
as  ||| S:17896 E:17899 ||| IN
receptors  ||| S:17899 E:17909 ||| NNS
for  ||| S:17909 E:17913 ||| IN
III1-C  ||| S:17913 E:17920 ||| CD
in  ||| S:17920 E:17923 ||| IN
cell  ||| S:17923 E:17938 ||| NN
adhesion  ||| S:17938 E:17947 ||| NNS
and  ||| S:17947 E:17951 ||| CC
ERK1 ||| S:17951 E:17955 ||| CD
/ ||| S:17955 E:17956 ||| CD
2  ||| S:17956 E:17958 ||| CD
signaling ||| S:17958 E:17967 ||| NNS
.  ||| S:17967 E:18000 ||| .
Discussion  ||| S:18000 E:18019 ||| NN
We  ||| S:18019 E:18022 ||| PRP
have  ||| S:18022 E:18027 ||| VBP
found  ||| S:18027 E:18033 ||| VBN
that  ||| S:18033 E:18038 ||| IN
cells  ||| S:18038 E:18044 ||| NNS
can  ||| S:18044 E:18048 ||| MD
interact  ||| S:18048 E:18057 ||| VB
with  ||| S:18057 E:18062 ||| IN
a  ||| S:18062 E:18064 ||| DT
portion  ||| S:18064 E:18072 ||| NN
of  ||| S:18072 E:18083 ||| IN
the  ||| S:18083 E:18087 ||| DT
fibronectin  ||| S:18087 E:18099 ||| JJ
first  ||| S:18099 E:18105 ||| JJ
type  ||| S:18105 E:18110 ||| NN
III  ||| S:18110 E:18114 ||| NNP
repeat ||| S:18114 E:18120 ||| NN
,  ||| S:18120 E:18122 ||| ,
leading  ||| S:18122 E:18130 ||| VBG
to  ||| S:18130 E:18133 ||| TO
cell  ||| S:18133 E:18146 ||| NN
adhesion  ||| S:18146 E:18155 ||| NNS
and  ||| S:18155 E:18159 ||| CC
activation  ||| S:18159 E:18170 ||| NN
of  ||| S:18170 E:18173 ||| IN
ERK ||| S:18173 E:18176 ||| NNP
,  ||| S:18176 E:18178 ||| ,
and  ||| S:18178 E:18182 ||| CC
that  ||| S:18182 E:18187 ||| IN
this  ||| S:18187 E:18192 ||| DT
signaling  ||| S:18192 E:18210 ||| NN
requires  ||| S:18210 E:18219 ||| VBZ
both  ||| S:18219 E:18224 ||| DT
cell  ||| S:18224 E:18229 ||| NN
surface  ||| S:18229 E:18237 ||| NN
HSPGs  ||| S:18237 E:18243 ||| NN
and  ||| S:18243 E:18247 ||| CC
integrins ||| S:18247 E:18256 ||| NN
.  ||| S:18256 E:18258 ||| .
RASMCs  ||| S:18258 E:18265 ||| NNS
are  ||| S:18265 E:18277 ||| VBP
able  ||| S:18277 E:18282 ||| JJ
to  ||| S:18282 E:18285 ||| TO
adhere  ||| S:18285 E:18292 ||| VB
to  ||| S:18292 E:18295 ||| TO
and  ||| S:18295 E:18299 ||| CC
spread  ||| S:18299 E:18306 ||| NN
on  ||| S:18306 E:18309 ||| IN
III1-C ||| S:18309 E:18315 ||| CD
.  ||| S:18315 E:18317 ||| .
Adhesion  ||| S:18317 E:18326 ||| JJ
to  ||| S:18326 E:18329 ||| TO
III1-C  ||| S:18329 E:18344 ||| CD
results  ||| S:18344 E:18352 ||| NNS
in  ||| S:18352 E:18355 ||| IN
robust  ||| S:18355 E:18362 ||| JJ
activation  ||| S:18362 E:18373 ||| NN
of  ||| S:18373 E:18376 ||| IN
ERK ||| S:18376 E:18379 ||| NNP
;  ||| S:18379 E:18381 ||| :
comparable  ||| S:18381 E:18392 ||| JJ
to  ||| S:18392 E:18395 ||| TO
that  ||| S:18395 E:18408 ||| DT
seen  ||| S:18408 E:18413 ||| VBN
with  ||| S:18413 E:18418 ||| IN
PDGF  ||| S:18418 E:18423 ||| NNP
stimulation ||| S:18423 E:18434 ||| NN
.  ||| S:18434 E:18436 ||| .
Several  ||| S:18436 E:18444 ||| JJ
independent  ||| S:18444 E:18456 ||| JJ
lines  ||| S:18456 E:18462 ||| NNS
of  ||| S:18462 E:18473 ||| IN
evidence  ||| S:18473 E:18482 ||| NN
indicate  ||| S:18482 E:18491 ||| VBP
that  ||| S:18491 E:18496 ||| DT
cell  ||| S:18496 E:18501 ||| NN
surface  ||| S:18501 E:18509 ||| NN
HSPGs  ||| S:18509 E:18515 ||| NN
and  ||| S:18515 E:18519 ||| CC
β1  ||| S:18519 E:18522 ||| CD
integrins  ||| S:18522 E:18540 ||| JJ
act  ||| S:18540 E:18544 ||| NN
as  ||| S:18544 E:18547 ||| IN
receptors  ||| S:18547 E:18557 ||| NNS
for  ||| S:18557 E:18561 ||| IN
III1-C  ||| S:18561 E:18568 ||| NNP
and  ||| S:18568 E:18572 ||| CC
are  ||| S:18572 E:18576 ||| VBP
required  ||| S:18576 E:18585 ||| VBN
for  ||| S:18585 E:18589 ||| IN
cell  ||| S:18589 E:18602 ||| NN
adhesion  ||| S:18602 E:18611 ||| NNS
and  ||| S:18611 E:18615 ||| CC
ERK  ||| S:18615 E:18619 ||| NNP
activation  ||| S:18619 E:18630 ||| NN
by  ||| S:18630 E:18633 ||| IN
III1-C ||| S:18633 E:18639 ||| CD
.  ||| S:18639 E:18641 ||| .
For  ||| S:18641 E:18645 ||| IN
example ||| S:18645 E:18652 ||| NN
,  ||| S:18652 E:18654 ||| ,
various  ||| S:18654 E:18670 ||| JJ
β1  ||| S:18670 E:18673 ||| NN
integrin  ||| S:18673 E:18682 ||| VBZ
blocking  ||| S:18682 E:18691 ||| VBG
agents  ||| S:18691 E:18698 ||| NNS
inhibit  ||| S:18698 E:18706 ||| VBP
cell  ||| S:18706 E:18711 ||| NN
attachment  ||| S:18711 E:18722 ||| NN
to  ||| S:18722 E:18733 ||| TO
III1-C  ||| S:18733 E:18740 ||| CD
and  ||| S:18740 E:18744 ||| CC
ERK  ||| S:18744 E:18748 ||| NNP
activation  ||| S:18748 E:18759 ||| NN
by  ||| S:18759 E:18762 ||| IN
III1-C ||| S:18762 E:18768 ||| CD
.  ||| S:18768 E:18770 ||| .
In  ||| S:18770 E:18773 ||| IN
addition ||| S:18773 E:18781 ||| NN
,  ||| S:18781 E:18791 ||| ,
inhibition  ||| S:18791 E:18802 ||| VBG
by  ||| S:18802 E:18805 ||| IN
heparin ||| S:18805 E:18812 ||| NN
,  ||| S:18812 E:18814 ||| ,
heparan-sulfate ||| S:18814 E:18829 ||| NNP
,  ||| S:18829 E:18831 ||| ,
and  ||| S:18831 E:18835 ||| CC
heparitinase ||| S:18835 E:18847 ||| NN
,  ||| S:18847 E:18857 ||| ,
but  ||| S:18857 E:18861 ||| CC
not  ||| S:18861 E:18865 ||| RB
by  ||| S:18865 E:18868 ||| IN
chondroitin  ||| S:18868 E:18880 ||| JJ
sulfates  ||| S:18880 E:18889 ||| NN
or  ||| S:18889 E:18892 ||| CC
chondroitinase  ||| S:18892 E:18907 ||| JJ
ABC  ||| S:18907 E:18911 ||| NNP
all  ||| S:18911 E:18923 ||| DT
point  ||| S:18923 E:18929 ||| NN
to  ||| S:18929 E:18932 ||| TO
the  ||| S:18932 E:18936 ||| DT
importance  ||| S:18936 E:18947 ||| NN
of  ||| S:18947 E:18950 ||| IN
HSPGs  ||| S:18950 E:18956 ||| JJ
as  ||| S:18956 E:18959 ||| IN
receptors ||| S:18959 E:18968 ||| NNS
.  ||| S:18968 E:18970 ||| .
Affinity  ||| S:18970 E:18987 ||| JJ
chromatography  ||| S:18987 E:19002 ||| NN
with  ||| S:19002 E:19007 ||| IN
125I  ||| S:19007 E:19012 ||| CD
surface  ||| S:19012 E:19020 ||| NN
labeled  ||| S:19020 E:19028 ||| VBN
proteins  ||| S:19028 E:19037 ||| NNS
resulted  ||| S:19037 E:19054 ||| VBD
in  ||| S:19054 E:19057 ||| IN
the  ||| S:19057 E:19061 ||| DT
binding  ||| S:19061 E:19069 ||| NN
of  ||| S:19069 E:19072 ||| IN
proteins  ||| S:19072 E:19081 ||| NNS
of  ||| S:19081 E:19084 ||| IN
the  ||| S:19084 E:19088 ||| DT
appropriate  ||| S:19088 E:19100 ||| JJ
sizes  ||| S:19100 E:19106 ||| NNS
of  ||| S:19106 E:19109 ||| IN
β1  ||| S:19109 E:19120 ||| CD
integrins  ||| S:19120 E:19130 ||| NN
to  ||| S:19130 E:19133 ||| TO
both  ||| S:19133 E:19138 ||| DT
FN  ||| S:19138 E:19141 ||| NNP
and  ||| S:19141 E:19145 ||| CC
III1-C  ||| S:19145 E:19152 ||| CD
columns ||| S:19152 E:19159 ||| NNS
.  ||| S:19159 E:19161 ||| .
Moreover ||| S:19161 E:19169 ||| RB
,  ||| S:19169 E:19171 ||| ,
affinity  ||| S:19171 E:19188 ||| JJ
chromatography  ||| S:19188 E:19203 ||| NN
with  ||| S:19203 E:19208 ||| IN
35SO  ||| S:19208 E:19222 ||| CD
4  ||| S:19222 E:19224 ||| CD
-labeled  ||| S:19224 E:19233 ||| JJ
cells  ||| S:19233 E:19239 ||| NNS
suggests  ||| S:19239 E:19248 ||| VBZ
that  ||| S:19248 E:19253 ||| DT
HSPGs  ||| S:19253 E:19267 ||| JJ
with  ||| S:19267 E:19272 ||| IN
core  ||| S:19272 E:19277 ||| JJ
protein  ||| S:19277 E:19285 ||| NN
sizes  ||| S:19285 E:19291 ||| NNS
of  ||| S:19291 E:19294 ||| IN
46  ||| S:19294 E:19297 ||| CD
kDa  ||| S:19297 E:19301 ||| JJ
and  ||| S:19301 E:19305 ||| CC
70  ||| S:19305 E:19308 ||| CD
kDa  ||| S:19308 E:19312 ||| NNS
serve  ||| S:19312 E:19318 ||| VBP
as  ||| S:19318 E:19329 ||| IN
III1-C  ||| S:19329 E:19336 ||| CD
receptors ||| S:19336 E:19345 ||| NNS
.  ||| S:19345 E:19347 ||| .
Taken  ||| S:19347 E:19353 ||| VBN
together ||| S:19353 E:19361 ||| RB
,  ||| S:19361 E:19363 ||| ,
these  ||| S:19363 E:19369 ||| DT
results  ||| S:19369 E:19377 ||| NNS
indicate  ||| S:19377 E:19394 ||| VBP
that  ||| S:19394 E:19399 ||| IN
the  ||| S:19399 E:19403 ||| DT
first  ||| S:19403 E:19409 ||| JJ
type  ||| S:19409 E:19414 ||| NN
III  ||| S:19414 E:19418 ||| NNP
repeat  ||| S:19418 E:19425 ||| NN
of  ||| S:19425 E:19428 ||| IN
fibronectin  ||| S:19428 E:19440 ||| NNS
can  ||| S:19440 E:19444 ||| MD
serve  ||| S:19444 E:19450 ||| VB
as  ||| S:19450 E:19461 ||| IN
a  ||| S:19461 E:19463 ||| DT
cell  ||| S:19463 E:19468 ||| NN
binding  ||| S:19468 E:19476 ||| JJ
domain  ||| S:19476 E:19483 ||| NN
and  ||| S:19483 E:19487 ||| CC
that  ||| S:19487 E:19492 ||| IN
both  ||| S:19492 E:19497 ||| DT
integrins  ||| S:19497 E:19507 ||| NN
and  ||| S:19507 E:19511 ||| CC
cell  ||| S:19511 E:19524 ||| NN
surface  ||| S:19524 E:19532 ||| NN
HSPGs  ||| S:19532 E:19538 ||| JJ
function  ||| S:19538 E:19547 ||| NN
as  ||| S:19547 E:19550 ||| IN
receptors  ||| S:19550 E:19560 ||| NNS
for  ||| S:19560 E:19564 ||| IN
this  ||| S:19564 E:19569 ||| DT
type  ||| S:19569 E:19574 ||| NN
III  ||| S:19574 E:19586 ||| NNP
repeat ||| S:19586 E:19592 ||| NN
.  ||| S:19592 E:19602 ||| .
Our  ||| S:19602 E:19606 ||| PRP$
results  ||| S:19606 E:19614 ||| NNS
demonstrate  ||| S:19614 E:19626 ||| VBP
that  ||| S:19626 E:19631 ||| IN
both  ||| S:19631 E:19636 ||| DT
integrins  ||| S:19636 E:19646 ||| NN
and  ||| S:19646 E:19650 ||| CC
cell  ||| S:19650 E:19663 ||| NN
surface  ||| S:19663 E:19671 ||| NN
HSPGs  ||| S:19671 E:19677 ||| NNS
are  ||| S:19677 E:19681 ||| VBP
required  ||| S:19681 E:19690 ||| VBN
for  ||| S:19690 E:19694 ||| IN
robust  ||| S:19694 E:19701 ||| JJ
ERK  ||| S:19701 E:19705 ||| NNP
1 ||| S:19705 E:19706 ||| CD
/ ||| S:19706 E:19707 ||| CD
2  ||| S:19707 E:19709 ||| CD
activation  ||| S:19709 E:19728 ||| NN
when  ||| S:19728 E:19733 ||| WRB
cells  ||| S:19733 E:19739 ||| NNS
adhere  ||| S:19739 E:19746 ||| VBP
to  ||| S:19746 E:19749 ||| TO
III1-C ||| S:19749 E:19755 ||| CD
.  ||| S:19755 E:19757 ||| .
These  ||| S:19757 E:19763 ||| DT
results  ||| S:19763 E:19771 ||| NNS
are  ||| S:19771 E:19775 ||| VBP
one  ||| S:19775 E:19779 ||| CD
of  ||| S:19779 E:19782 ||| IN
the  ||| S:19782 E:19794 ||| DT
first  ||| S:19794 E:19800 ||| JJ
demonstrations  ||| S:19800 E:19815 ||| NNS
that  ||| S:19815 E:19820 ||| IN
HSPGs  ||| S:19820 E:19826 ||| NNP
can  ||| S:19826 E:19830 ||| MD
activate  ||| S:19830 E:19839 ||| VB
the  ||| S:19839 E:19843 ||| DT
ERK  ||| S:19843 E:19855 ||| NNP
signaling  ||| S:19855 E:19865 ||| VBG
pathway ||| S:19865 E:19872 ||| NNS
.  ||| S:19872 E:19874 ||| .
Another  ||| S:19874 E:19882 ||| DT
example  ||| S:19882 E:19890 ||| NN
of  ||| S:19890 E:19893 ||| IN
this  ||| S:19893 E:19898 ||| DT
closely  ||| S:19898 E:19914 ||| RB
parallels  ||| S:19914 E:19924 ||| VBZ
our  ||| S:19924 E:19928 ||| PRP$
findings  ||| S:19928 E:19937 ||| NNS
[  ||| S:19937 E:19939 ||| -LRB-
38  ||| S:19939 E:19942 ||| CD
]  ||| S:19942 E:19944 ||| -RRB-
.  ||| S:19944 E:19946 ||| .
The  ||| S:19946 E:19950 ||| DT
adhesion  ||| S:19950 E:19959 ||| NN
of  ||| S:19959 E:19962 ||| IN
Jurkat  ||| S:19962 E:19969 ||| NNP
T  ||| S:19969 E:19979 ||| NN
cells  ||| S:19979 E:19985 ||| NNS
to  ||| S:19985 E:19988 ||| TO
thrombospondin-1  ||| S:19988 E:20005 ||| NNP
has  ||| S:20005 E:20009 ||| VBZ
been  ||| S:20009 E:20014 ||| VBN
shown  ||| S:20014 E:20020 ||| VBN
to  ||| S:20020 E:20023 ||| TO
require  ||| S:20023 E:20031 ||| VB
the  ||| S:20031 E:20043 ||| DT
cooperation  ||| S:20043 E:20055 ||| NN
of  ||| S:20055 E:20058 ||| IN
three  ||| S:20058 E:20064 ||| CD
classes  ||| S:20064 E:20072 ||| NNS
of  ||| S:20072 E:20075 ||| IN
receptors ||| S:20075 E:20084 ||| NNS
;  ||| S:20084 E:20086 ||| :
β1  ||| S:20086 E:20089 ||| CD
integrins ||| S:20089 E:20098 ||| NN
,  ||| S:20098 E:20108 ||| ,
CD47  ||| S:20108 E:20113 ||| NNP
and  ||| S:20113 E:20117 ||| CC
HSPGs  ||| S:20117 E:20123 ||| NNP
[  ||| S:20123 E:20125 ||| -LRB-
38  ||| S:20125 E:20128 ||| CD
]  ||| S:20128 E:20130 ||| -RRB-
.  ||| S:20130 E:20132 ||| .
Adhesion  ||| S:20132 E:20141 ||| NNP
of  ||| S:20141 E:20144 ||| IN
the  ||| S:20144 E:20148 ||| DT
Jurkat  ||| S:20148 E:20155 ||| JJ
T  ||| S:20155 E:20157 ||| NN
cells  ||| S:20157 E:20163 ||| NNS
to  ||| S:20163 E:20174 ||| TO
thrombospondin-1  ||| S:20174 E:20191 ||| CD
stimulates  ||| S:20191 E:20202 ||| CD
ERK1 ||| S:20202 E:20206 ||| CD
/ ||| S:20206 E:20207 ||| CD
2  ||| S:20207 E:20209 ||| CD
activation  ||| S:20209 E:20220 ||| NNS
and  ||| S:20220 E:20224 ||| CC
the  ||| S:20224 E:20236 ||| DT
binding  ||| S:20236 E:20244 ||| NN
of  ||| S:20244 E:20247 ||| IN
HSPGs  ||| S:20247 E:20253 ||| JJ
to  ||| S:20253 E:20256 ||| TO
thrombospondin-1  ||| S:20256 E:20273 ||| NNP
is  ||| S:20273 E:20276 ||| VBZ
required  ||| S:20276 E:20285 ||| VBN
for  ||| S:20285 E:20289 ||| IN
this  ||| S:20289 E:20302 ||| DT
signaling ||| S:20302 E:20311 ||| NN
.  ||| S:20311 E:20313 ||| .
The  ||| S:20313 E:20317 ||| DT
particular  ||| S:20317 E:20328 ||| JJ
HSPGs  ||| S:20328 E:20334 ||| NN
that  ||| S:20334 E:20339 ||| IN
mediate  ||| S:20339 E:20347 ||| CD
ERK1 ||| S:20347 E:20351 ||| CD
/ ||| S:20351 E:20352 ||| CD
2  ||| S:20352 E:20362 ||| CD
activation  ||| S:20362 E:20373 ||| NN
in  ||| S:20373 E:20376 ||| IN
Jurkat  ||| S:20376 E:20383 ||| NNP
T  ||| S:20383 E:20385 ||| NN
cells  ||| S:20385 E:20391 ||| NNS
have  ||| S:20391 E:20396 ||| VBP
not  ||| S:20396 E:20400 ||| RB
been  ||| S:20400 E:20405 ||| VBN
identified ||| S:20405 E:20415 ||| VBN
,  ||| S:20415 E:20425 ||| ,
however ||| S:20425 E:20432 ||| RB
,  ||| S:20432 E:20434 ||| ,
the  ||| S:20434 E:20438 ||| DT
authors  ||| S:20438 E:20446 ||| NNS
speculate  ||| S:20446 E:20456 ||| VBP
that  ||| S:20456 E:20461 ||| DT
syndecans  ||| S:20461 E:20471 ||| NN
may  ||| S:20471 E:20483 ||| MD
participate  ||| S:20483 E:20495 ||| VB
in  ||| S:20495 E:20498 ||| IN
the  ||| S:20498 E:20502 ||| DT
adhesion  ||| S:20502 E:20511 ||| NN
and  ||| S:20511 E:20515 ||| CC
signaling  ||| S:20515 E:20525 ||| VBG
in  ||| S:20525 E:20528 ||| IN
that  ||| S:20528 E:20533 ||| DT
system  ||| S:20533 E:20540 ||| NN
[  ||| S:20540 E:20550 ||| -LRB-
38  ||| S:20550 E:20553 ||| CD
]  ||| S:20553 E:20555 ||| -RRB-
.  ||| S:20555 E:20557 ||| .
This  ||| S:20557 E:20562 ||| DT
may  ||| S:20562 E:20566 ||| MD
also  ||| S:20566 E:20571 ||| RB
be  ||| S:20571 E:20574 ||| VB
the  ||| S:20574 E:20578 ||| DT
case  ||| S:20578 E:20583 ||| NN
in  ||| S:20583 E:20586 ||| IN
our  ||| S:20586 E:20590 ||| PRP$
system ||| S:20590 E:20596 ||| NN
,  ||| S:20596 E:20598 ||| ,
as  ||| S:20598 E:20609 ||| RB
described  ||| S:20609 E:20619 ||| VBN
below ||| S:20619 E:20624 ||| RB
.  ||| S:20624 E:20634 ||| .
One  ||| S:20634 E:20638 ||| CD
major  ||| S:20638 E:20644 ||| JJ
family  ||| S:20644 E:20651 ||| NN
of  ||| S:20651 E:20654 ||| IN
cell  ||| S:20654 E:20659 ||| NN
surface  ||| S:20659 E:20667 ||| NN
HSPGs  ||| S:20667 E:20673 ||| NN
is  ||| S:20673 E:20676 ||| VBZ
the  ||| S:20676 E:20680 ||| DT
syndecan  ||| S:20680 E:20697 ||| JJ
family ||| S:20697 E:20703 ||| NN
.  ||| S:20703 E:20705 ||| .
There  ||| S:20705 E:20711 ||| EX
are  ||| S:20711 E:20715 ||| VBP
4  ||| S:20715 E:20717 ||| CD
members  ||| S:20717 E:20725 ||| NNS
in  ||| S:20725 E:20728 ||| IN
the  ||| S:20728 E:20732 ||| DT
syndecan  ||| S:20732 E:20741 ||| JJ
family  ||| S:20741 E:20756 ||| NN
( ||| S:20756 E:20757 ||| -LRB-
syndecan-1  ||| S:20757 E:20768 ||| NNP
through-4 ||| S:20768 E:20777 ||| NNP
)  ||| S:20777 E:20779 ||| -RRB-
[  ||| S:20779 E:20781 ||| -LRB-
39  ||| S:20781 E:20784 ||| CD
40  ||| S:20784 E:20787 ||| CD
]  ||| S:20787 E:20789 ||| -RRB-
.  ||| S:20789 E:20791 ||| .
Syndecan-1 ||| S:20791 E:20801 ||| NNP
,  ||| S:20801 E:20803 ||| ,
-2  ||| S:20803 E:20806 ||| NNP
and  ||| S:20806 E:20810 ||| CC
-4  ||| S:20810 E:20821 ||| NNP
are  ||| S:20821 E:20825 ||| VBP
known  ||| S:20825 E:20831 ||| VBN
to  ||| S:20831 E:20834 ||| TO
bind  ||| S:20834 E:20839 ||| VB
to  ||| S:20839 E:20842 ||| TO
extracellular  ||| S:20842 E:20856 ||| VB
matrix  ||| S:20856 E:20863 ||| JJ
proteins  ||| S:20863 E:20872 ||| NNS
and  ||| S:20872 E:20884 ||| CC
syndecan-1  ||| S:20884 E:20895 ||| NNP
and  ||| S:20895 E:20899 ||| CC
-4  ||| S:20899 E:20902 ||| NNP
have  ||| S:20902 E:20907 ||| VBP
been  ||| S:20907 E:20912 ||| VBN
shown  ||| S:20912 E:20918 ||| VBN
to  ||| S:20918 E:20921 ||| TO
support  ||| S:20921 E:20929 ||| VB
stress  ||| S:20929 E:20936 ||| NN
fiber  ||| S:20936 E:20950 ||| NN
formation  ||| S:20950 E:20960 ||| NN
in  ||| S:20960 E:20963 ||| IN
conjunction  ||| S:20963 E:20975 ||| NN
with  ||| S:20975 E:20980 ||| IN
integrins  ||| S:20980 E:20990 ||| NNS
[  ||| S:20990 E:20992 ||| -LRB-
41  ||| S:20992 E:20995 ||| CD
42  ||| S:20995 E:20998 ||| CD
43  ||| S:20998 E:21001 ||| CD
44  ||| S:21001 E:21004 ||| CD
45  ||| S:21004 E:21007 ||| CD
]  ||| S:21007 E:21017 ||| -RRB-
.  ||| S:21017 E:21019 ||| .
The  ||| S:21019 E:21023 ||| DT
HSPGs  ||| S:21023 E:21029 ||| JJ
we  ||| S:21029 E:21032 ||| PRP
have  ||| S:21032 E:21037 ||| VBP
identified  ||| S:21037 E:21048 ||| VBN
as  ||| S:21048 E:21051 ||| IN
III1-C  ||| S:21051 E:21058 ||| CD
receptors  ||| S:21058 E:21068 ||| NNS
have  ||| S:21068 E:21081 ||| VBP
core  ||| S:21081 E:21086 ||| JJ
proteins  ||| S:21086 E:21095 ||| NNS
that  ||| S:21095 E:21100 ||| IN
migrate  ||| S:21100 E:21108 ||| NN
at  ||| S:21108 E:21111 ||| IN
the  ||| S:21111 E:21115 ||| DT
approximate  ||| S:21115 E:21127 ||| JJ
sizes  ||| S:21127 E:21133 ||| NNS
of  ||| S:21133 E:21144 ||| IN
syndecan-1  ||| S:21144 E:21155 ||| NNP
( ||| S:21155 E:21156 ||| -LRB-
~69  ||| S:21156 E:21160 ||| CD
kDa  ||| S:21160 E:21164 ||| JJ
core  ||| S:21164 E:21169 ||| NN
protein ||| S:21169 E:21176 ||| NN
)  ||| S:21176 E:21178 ||| -RRB-
and  ||| S:21178 E:21182 ||| CC
syndecan-2  ||| S:21182 E:21193 ||| NNP
( ||| S:21193 E:21194 ||| -LRB-
~48  ||| S:21194 E:21198 ||| CD
kDa  ||| S:21198 E:21210 ||| JJ
core  ||| S:21210 E:21215 ||| NN
protein ||| S:21215 E:21222 ||| NN
)  ||| S:21222 E:21224 ||| -RRB-
[  ||| S:21224 E:21226 ||| -LRB-
40  ||| S:21226 E:21229 ||| CD
]  ||| S:21229 E:21231 ||| -RRB-
.  ||| S:21231 E:21233 ||| .
It  ||| S:21233 E:21236 ||| PRP
is  ||| S:21236 E:21239 ||| VBZ
therefore  ||| S:21239 E:21249 ||| RB
possible  ||| S:21249 E:21258 ||| JJ
that  ||| S:21258 E:21263 ||| IN
our  ||| S:21263 E:21267 ||| PRP$
46  ||| S:21267 E:21278 ||| CD
kDa  ||| S:21278 E:21282 ||| JJ
and  ||| S:21282 E:21286 ||| CC
70  ||| S:21286 E:21289 ||| CD
kDa  ||| S:21289 E:21293 ||| JJ
HSPGs  ||| S:21293 E:21299 ||| NNS
represent  ||| S:21299 E:21309 ||| VBP
syndecan  ||| S:21309 E:21318 ||| JJ
family  ||| S:21318 E:21325 ||| NN
members ||| S:21325 E:21332 ||| NNS
.  ||| S:21332 E:21334 ||| .
As  ||| S:21334 E:21345 ||| RB
described  ||| S:21345 E:21355 ||| VBN
above ||| S:21355 E:21360 ||| IN
,  ||| S:21360 E:21362 ||| ,
the  ||| S:21362 E:21366 ||| DT
syndecans  ||| S:21366 E:21376 ||| NN
may  ||| S:21376 E:21380 ||| MD
cooperate  ||| S:21380 E:21390 ||| VB
with  ||| S:21390 E:21395 ||| IN
β1  ||| S:21395 E:21406 ||| CD
integrins  ||| S:21406 E:21416 ||| NNS
and  ||| S:21416 E:21420 ||| CC
CD47  ||| S:21420 E:21425 ||| CD
to  ||| S:21425 E:21428 ||| TO
activate  ||| S:21428 E:21437 ||| VB
the  ||| S:21437 E:21441 ||| DT
ERK  ||| S:21441 E:21445 ||| NNP
signaling  ||| S:21445 E:21455 ||| VBG
pathway  ||| S:21455 E:21463 ||| NN
in  ||| S:21463 E:21474 ||| IN
T  ||| S:21474 E:21476 ||| NN
cells  ||| S:21476 E:21482 ||| NNS
[  ||| S:21482 E:21484 ||| -LRB-
38  ||| S:21484 E:21487 ||| CD
]  ||| S:21487 E:21489 ||| -RRB-
.  ||| S:21489 E:21491 ||| .
A  ||| S:21491 E:21493 ||| DT
similar  ||| S:21493 E:21501 ||| JJ
mechanism  ||| S:21501 E:21511 ||| NN
may  ||| S:21511 E:21515 ||| MD
apply  ||| S:21515 E:21521 ||| VB
to  ||| S:21521 E:21524 ||| TO
the  ||| S:21524 E:21536 ||| DT
adhesion  ||| S:21536 E:21545 ||| NN
of  ||| S:21545 E:21548 ||| IN
RASMCs  ||| S:21548 E:21555 ||| JJ
to  ||| S:21555 E:21558 ||| TO
III1-C ||| S:21558 E:21564 ||| CD
.  ||| S:21564 E:21566 ||| .
Future  ||| S:21566 E:21573 ||| JJ
studies  ||| S:21573 E:21581 ||| NNS
will  ||| S:21581 E:21586 ||| MD
determine  ||| S:21586 E:21604 ||| VB
the  ||| S:21604 E:21608 ||| DT
identity  ||| S:21608 E:21617 ||| NN
of  ||| S:21617 E:21620 ||| IN
the  ||| S:21620 E:21624 ||| DT
HSPGs  ||| S:21624 E:21630 ||| JJ
that  ||| S:21630 E:21635 ||| IN
act  ||| S:21635 E:21639 ||| NN
as  ||| S:21639 E:21642 ||| IN
III1-C  ||| S:21642 E:21649 ||| CD
receptors ||| S:21649 E:21658 ||| NNS
.  ||| S:21658 E:21668 ||| .
The  ||| S:21668 E:21672 ||| DT
Ras ||| S:21672 E:21675 ||| NNP
/ ||| S:21675 E:21676 ||| NNP
MAPK  ||| S:21676 E:21681 ||| NNP
pathway  ||| S:21681 E:21689 ||| NN
is  ||| S:21689 E:21692 ||| VBZ
typically  ||| S:21692 E:21702 ||| RB
thought  ||| S:21702 E:21710 ||| VBN
to  ||| S:21710 E:21713 ||| TO
be  ||| S:21713 E:21716 ||| VB
a  ||| S:21716 E:21718 ||| DT
part  ||| S:21718 E:21731 ||| NN
of  ||| S:21731 E:21734 ||| IN
a  ||| S:21734 E:21736 ||| DT
mitogenic  ||| S:21736 E:21746 ||| JJ
pathway  ||| S:21746 E:21754 ||| NNS
[  ||| S:21754 E:21756 ||| -LRB-
36  ||| S:21756 E:21759 ||| CD
]  ||| S:21759 E:21761 ||| -RRB-
.  ||| S:21761 E:21763 ||| .
However ||| S:21763 E:21770 ||| RB
,  ||| S:21770 E:21772 ||| ,
we  ||| S:21772 E:21775 ||| PRP
and  ||| S:21775 E:21779 ||| CC
others  ||| S:21779 E:21786 ||| NNS
have  ||| S:21786 E:21799 ||| VBP
shown  ||| S:21799 E:21805 ||| VBN
that  ||| S:21805 E:21810 ||| IN
prolonged  ||| S:21810 E:21820 ||| JJ
treatment  ||| S:21820 E:21830 ||| NN
with  ||| S:21830 E:21835 ||| IN
III1-C  ||| S:21835 E:21842 ||| NNP
can  ||| S:21842 E:21846 ||| MD
inhibit  ||| S:21846 E:21854 ||| VB
cell  ||| S:21854 E:21867 ||| NN
proliferation  ||| S:21867 E:21881 ||| NN
[  ||| S:21881 E:21883 ||| -LRB-
3  ||| S:21883 E:21885 ||| CD
4  ||| S:21885 E:21887 ||| CD
]  ||| S:21887 E:21889 ||| -RRB-
,  ||| S:21889 E:21891 ||| ,
and  ||| S:21891 E:21895 ||| CC
here  ||| S:21895 E:21900 ||| RB
we  ||| S:21900 E:21903 ||| PRP
show  ||| S:21903 E:21908 ||| VBP
that  ||| S:21908 E:21913 ||| DT
cell  ||| S:21913 E:21918 ||| NN
adhesion  ||| S:21918 E:21935 ||| NN
to  ||| S:21935 E:21938 ||| TO
III1-C  ||| S:21938 E:21945 ||| NNP
can  ||| S:21945 E:21949 ||| MD
activate  ||| S:21949 E:21958 ||| VB
ERK1 ||| S:21958 E:21962 ||| CD
/ ||| S:21962 E:21963 ||| CD
2 ||| S:21963 E:21964 ||| CD
.  ||| S:21964 E:21966 ||| .
One  ||| S:21966 E:21970 ||| CD
possible  ||| S:21970 E:21979 ||| JJ
explanation  ||| S:21979 E:21991 ||| NN
for  ||| S:21991 E:22003 ||| IN
this  ||| S:22003 E:22008 ||| DT
apparent  ||| S:22008 E:22017 ||| JJ
discrepancy  ||| S:22017 E:22029 ||| NN
is  ||| S:22029 E:22032 ||| VBZ
that  ||| S:22032 E:22037 ||| IN
although  ||| S:22037 E:22046 ||| IN
ERK1 ||| S:22046 E:22050 ||| CD
/ ||| S:22050 E:22051 ||| CD
2  ||| S:22051 E:22053 ||| CD
are  ||| S:22053 E:22057 ||| VBP
often  ||| S:22057 E:22071 ||| RB
involved  ||| S:22071 E:22080 ||| VBN
in  ||| S:22080 E:22083 ||| IN
mitogenesis ||| S:22083 E:22094 ||| NN
,  ||| S:22094 E:22096 ||| ,
in  ||| S:22096 E:22099 ||| IN
SMCs  ||| S:22099 E:22104 ||| NNP
ERK  ||| S:22104 E:22108 ||| NNP
activation  ||| S:22108 E:22119 ||| NN
can  ||| S:22119 E:22123 ||| MD
lead  ||| S:22123 E:22128 ||| VB
to  ||| S:22128 E:22139 ||| TO
inhibition  ||| S:22139 E:22150 ||| VB
of  ||| S:22150 E:22153 ||| IN
proliferation  ||| S:22153 E:22167 ||| NN
[  ||| S:22167 E:22169 ||| -LRB-
46  ||| S:22169 E:22172 ||| CD
]  ||| S:22172 E:22174 ||| -RRB-
.  ||| S:22174 E:22176 ||| .
This  ||| S:22176 E:22181 ||| DT
occurs  ||| S:22181 E:22188 ||| NN
through  ||| S:22188 E:22204 ||| IN
ERK-mediated  ||| S:22204 E:22217 ||| JJ
stimulation  ||| S:22217 E:22229 ||| NN
of  ||| S:22229 E:22232 ||| IN
PGE  ||| S:22232 E:22245 ||| NNP
2  ||| S:22245 E:22247 ||| CD
production ||| S:22247 E:22257 ||| NN
,  ||| S:22257 E:22259 ||| ,
which  ||| S:22259 E:22265 ||| WDT
then  ||| S:22265 E:22270 ||| RB
inhibits  ||| S:22270 E:22279 ||| VB
the  ||| S:22279 E:22291 ||| DT
proliferation  ||| S:22291 E:22305 ||| NN
of  ||| S:22305 E:22308 ||| IN
SMCs  ||| S:22308 E:22313 ||| NNP
[  ||| S:22313 E:22315 ||| -LRB-
46  ||| S:22315 E:22318 ||| CD
]  ||| S:22318 E:22320 ||| -RRB-
.  ||| S:22320 E:22322 ||| .
Further  ||| S:22322 E:22330 ||| JJ
experiments  ||| S:22330 E:22342 ||| NNS
will  ||| S:22342 E:22355 ||| MD
determine  ||| S:22355 E:22365 ||| VB
whether  ||| S:22365 E:22373 ||| IN
RASMCs  ||| S:22373 E:22380 ||| JJ
produce  ||| S:22380 E:22388 ||| NN
PGE  ||| S:22388 E:22401 ||| NNP
2  ||| S:22401 E:22403 ||| CD
after  ||| S:22403 E:22409 ||| IN
treatment  ||| S:22409 E:22419 ||| NN
with  ||| S:22419 E:22424 ||| IN
III1-C ||| S:22424 E:22430 ||| CD
.  ||| S:22430 E:22432 ||| .
Another  ||| S:22432 E:22448 ||| DT
possibility  ||| S:22448 E:22460 ||| NN
is  ||| S:22460 E:22463 ||| VBZ
that  ||| S:22463 E:22468 ||| IN
III1-C  ||| S:22468 E:22475 ||| CD
stimulates  ||| S:22475 E:22486 ||| CD
other  ||| S:22486 E:22492 ||| JJ
signaling  ||| S:22492 E:22510 ||| NNS
pathways  ||| S:22510 E:22519 ||| VBP
apart  ||| S:22519 E:22525 ||| RB
from  ||| S:22525 E:22530 ||| IN
the  ||| S:22530 E:22534 ||| DT
ERK  ||| S:22534 E:22538 ||| NNP
pathway ||| S:22538 E:22545 ||| NN
,  ||| S:22545 E:22547 ||| ,
and  ||| S:22547 E:22551 ||| CC
that  ||| S:22551 E:22556 ||| IN
one  ||| S:22556 E:22560 ||| CD
of  ||| S:22560 E:22563 ||| IN
the  ||| S:22563 E:22575 ||| DT
other  ||| S:22575 E:22581 ||| JJ
signaling  ||| S:22581 E:22591 ||| NNS
pathways  ||| S:22591 E:22600 ||| VBP
inhibits  ||| S:22600 E:22609 ||| JJ
proliferation  ||| S:22609 E:22623 ||| NN
of  ||| S:22623 E:22626 ||| IN
the  ||| S:22626 E:22638 ||| DT
cells ||| S:22638 E:22643 ||| NNS
.  ||| S:22643 E:22645 ||| .
The  ||| S:22645 E:22649 ||| DT
relationship  ||| S:22649 E:22662 ||| NN
between  ||| S:22662 E:22670 ||| IN
ERK  ||| S:22670 E:22674 ||| NNP
activation ||| S:22674 E:22684 ||| NN
,  ||| S:22684 E:22686 ||| ,
stimulation  ||| S:22686 E:22706 ||| NN
of  ||| S:22706 E:22709 ||| IN
other  ||| S:22709 E:22715 ||| JJ
signaling  ||| S:22715 E:22725 ||| JJ
pathways  ||| S:22725 E:22734 ||| NN
and  ||| S:22734 E:22738 ||| CC
growth  ||| S:22738 E:22745 ||| NN
inhibition  ||| S:22745 E:22756 ||| NN
by  ||| S:22756 E:22759 ||| IN
III1-C  ||| S:22759 E:22774 ||| NNP
will  ||| S:22774 E:22779 ||| MD
be  ||| S:22779 E:22782 ||| VB
elucidated  ||| S:22782 E:22793 ||| VBN
by  ||| S:22793 E:22796 ||| IN
future  ||| S:22796 E:22803 ||| JJ
experiments ||| S:22803 E:22814 ||| NNS
.  ||| S:22814 E:22824 ||| .
The  ||| S:22824 E:22828 ||| DT
III1-C  ||| S:22828 E:22835 ||| JJ
protein  ||| S:22835 E:22843 ||| NN
has  ||| S:22843 E:22847 ||| VBZ
recently  ||| S:22847 E:22856 ||| RB
been  ||| S:22856 E:22861 ||| VBN
shown  ||| S:22861 E:22867 ||| VBN
to  ||| S:22867 E:22870 ||| TO
inhibit  ||| S:22870 E:22886 ||| VB
angiogenesis ||| S:22886 E:22898 ||| NNS
,  ||| S:22898 E:22900 ||| ,
tumor  ||| S:22900 E:22906 ||| NN
growth  ||| S:22906 E:22913 ||| NN
and  ||| S:22913 E:22917 ||| CC
metastasis  ||| S:22917 E:22928 ||| NNS
[  ||| S:22928 E:22930 ||| -LRB-
25  ||| S:22930 E:22933 ||| CD
]  ||| S:22933 E:22935 ||| -RRB-
.  ||| S:22935 E:22937 ||| .
Those  ||| S:22937 E:22951 ||| DT
findings ||| S:22951 E:22959 ||| NNS
,  ||| S:22959 E:22961 ||| ,
along  ||| S:22961 E:22967 ||| RB
with  ||| S:22967 E:22972 ||| IN
our  ||| S:22972 E:22976 ||| PRP$
present  ||| S:22976 E:22984 ||| JJ
findings  ||| S:22984 E:22993 ||| NNS
reveal  ||| S:22993 E:23000 ||| VBP
some  ||| S:23000 E:23013 ||| DT
intriguing  ||| S:23013 E:23024 ||| JJ
parallels  ||| S:23024 E:23034 ||| NNS
between  ||| S:23034 E:23042 ||| IN
III1-C  ||| S:23042 E:23049 ||| NNP
and  ||| S:23049 E:23053 ||| CC
the  ||| S:23053 E:23057 ||| DT
angiogenesis  ||| S:23057 E:23078 ||| FW
inhibitor  ||| S:23078 E:23088 ||| FW
endostatin  ||| S:23088 E:23099 ||| FW
[  ||| S:23099 E:23101 ||| -LRB-
47  ||| S:23101 E:23104 ||| CD
]  ||| S:23104 E:23106 ||| -RRB-
.  ||| S:23106 E:23108 ||| .
For  ||| S:23108 E:23112 ||| IN
example ||| S:23112 E:23119 ||| NN
,  ||| S:23119 E:23121 ||| ,
both  ||| S:23121 E:23126 ||| DT
III1-C  ||| S:23126 E:23133 ||| NNP
and  ||| S:23133 E:23145 ||| CC
endostatin  ||| S:23145 E:23156 ||| NNS
are  ||| S:23156 E:23160 ||| VBP
fragments  ||| S:23160 E:23170 ||| VBN
of  ||| S:23170 E:23173 ||| IN
matrix  ||| S:23173 E:23180 ||| JJ
proteins  ||| S:23180 E:23189 ||| NNS
and  ||| S:23189 E:23193 ||| CC
can  ||| S:23193 E:23197 ||| MD
inhibit  ||| S:23197 E:23213 ||| VB
angiogenesis  ||| S:23213 E:23226 ||| NNS
and  ||| S:23226 E:23230 ||| CC
tumor  ||| S:23230 E:23236 ||| NN
growth ||| S:23236 E:23242 ||| NN
.  ||| S:23242 E:23244 ||| .
In  ||| S:23244 E:23247 ||| IN
addition ||| S:23247 E:23255 ||| NN
,  ||| S:23255 E:23257 ||| ,
recent  ||| S:23257 E:23264 ||| JJ
work  ||| S:23264 E:23269 ||| NN
has  ||| S:23269 E:23281 ||| VBZ
shown  ||| S:23281 E:23287 ||| VBN
that  ||| S:23287 E:23292 ||| IN
cells  ||| S:23292 E:23298 ||| NNS
interact  ||| S:23298 E:23307 ||| VBN
with  ||| S:23307 E:23312 ||| IN
endostatin  ||| S:23312 E:23323 ||| NN
through  ||| S:23323 E:23331 ||| IN
two  ||| S:23331 E:23343 ||| CD
classes  ||| S:23343 E:23351 ||| NNS
of  ||| S:23351 E:23354 ||| IN
receptors ||| S:23354 E:23363 ||| NNS
;  ||| S:23363 E:23365 ||| :
integrins  ||| S:23365 E:23375 ||| NNS
and  ||| S:23375 E:23379 ||| CC
glypicans  ||| S:23379 E:23389 ||| NNS
( ||| S:23389 E:23390 ||| -LRB-
cell  ||| S:23390 E:23395 ||| NN
surface  ||| S:23395 E:23411 ||| NN
HSPGs ||| S:23411 E:23416 ||| NN
)  ||| S:23416 E:23418 ||| -RRB-
[  ||| S:23418 E:23420 ||| -LRB-
48  ||| S:23420 E:23423 ||| CD
49  ||| S:23423 E:23426 ||| CD
]  ||| S:23426 E:23428 ||| -RRB-
.  ||| S:23428 E:23430 ||| .
This  ||| S:23430 E:23435 ||| DT
parallels  ||| S:23435 E:23445 ||| VBZ
our  ||| S:23445 E:23449 ||| PRP$
findings  ||| S:23449 E:23458 ||| NNS
in  ||| S:23458 E:23461 ||| IN
this  ||| S:23461 E:23474 ||| DT
present  ||| S:23474 E:23482 ||| JJ
report ||| S:23482 E:23488 ||| NN
,  ||| S:23488 E:23490 ||| ,
that  ||| S:23490 E:23495 ||| WDT
cells  ||| S:23495 E:23501 ||| NNS
interact  ||| S:23501 E:23510 ||| VBN
with  ||| S:23510 E:23515 ||| IN
III1-C  ||| S:23515 E:23522 ||| CD
through  ||| S:23522 E:23538 ||| IN
integrins  ||| S:23538 E:23548 ||| NN
and  ||| S:23548 E:23552 ||| CC
cell  ||| S:23552 E:23557 ||| NN
surface  ||| S:23557 E:23565 ||| NN
HSPGs ||| S:23565 E:23570 ||| NN
.  ||| S:23570 E:23572 ||| .
Therefore ||| S:23572 E:23581 ||| RB
,  ||| S:23581 E:23583 ||| ,
III1-C  ||| S:23583 E:23590 ||| NNP
and  ||| S:23590 E:23602 ||| CC
endostatin  ||| S:23602 E:23613 ||| NNS
may  ||| S:23613 E:23617 ||| MD
inhibit  ||| S:23617 E:23625 ||| VB
angiogenesis  ||| S:23625 E:23638 ||| VBN
through  ||| S:23638 E:23646 ||| IN
related  ||| S:23646 E:23662 ||| JJ
mechanisms  ||| S:23662 E:23673 ||| NNS
involving  ||| S:23673 E:23683 ||| VBG
both  ||| S:23683 E:23688 ||| DT
integrins  ||| S:23688 E:23698 ||| NN
and  ||| S:23698 E:23702 ||| CC
HSPGs ||| S:23702 E:23707 ||| JJ
.  ||| S:23707 E:23709 ||| .
Future  ||| S:23709 E:23716 ||| JJ
work  ||| S:23716 E:23729 ||| NN
will  ||| S:23729 E:23734 ||| MD
determine  ||| S:23734 E:23744 ||| VB
the  ||| S:23744 E:23748 ||| DT
relative  ||| S:23748 E:23757 ||| JJ
contributions  ||| S:23757 E:23771 ||| NNS
of  ||| S:23771 E:23774 ||| IN
these  ||| S:23774 E:23780 ||| DT
two  ||| S:23780 E:23792 ||| CD
classes  ||| S:23792 E:23800 ||| NNS
of  ||| S:23800 E:23803 ||| IN
receptors  ||| S:23803 E:23813 ||| NNS
in  ||| S:23813 E:23816 ||| IN
the  ||| S:23816 E:23820 ||| DT
biological  ||| S:23820 E:23831 ||| JJ
effects  ||| S:23831 E:23839 ||| NNS
of  ||| S:23839 E:23850 ||| IN
III1-C ||| S:23850 E:23856 ||| CD
.  ||| S:23856 E:23880 ||| .
Conclusions  ||| S:23880 E:23900 ||| NNS
We  ||| S:23900 E:23903 ||| PRP
have  ||| S:23903 E:23908 ||| VBP
found  ||| S:23908 E:23914 ||| VBN
that  ||| S:23914 E:23919 ||| IN
cells  ||| S:23919 E:23925 ||| NNS
can  ||| S:23925 E:23929 ||| MD
interact  ||| S:23929 E:23938 ||| VB
with  ||| S:23938 E:23943 ||| IN
the  ||| S:23943 E:23955 ||| DT
fibronectin  ||| S:23955 E:23967 ||| JJ
first  ||| S:23967 E:23973 ||| JJ
type  ||| S:23973 E:23978 ||| NN
III  ||| S:23978 E:23982 ||| NNP
repeat ||| S:23982 E:23988 ||| NN
,  ||| S:23988 E:23990 ||| ,
leading  ||| S:23990 E:23998 ||| VBG
to  ||| S:23998 E:24001 ||| TO
cell  ||| S:24001 E:24006 ||| NN
adhesion  ||| S:24006 E:24023 ||| NNS
and  ||| S:24023 E:24027 ||| CC
activation  ||| S:24027 E:24038 ||| NN
of  ||| S:24038 E:24041 ||| IN
ERK ||| S:24041 E:24044 ||| NNP
,  ||| S:24044 E:24046 ||| ,
and  ||| S:24046 E:24050 ||| CC
that  ||| S:24050 E:24055 ||| IN
this  ||| S:24055 E:24060 ||| DT
signaling  ||| S:24060 E:24070 ||| NN
requires  ||| S:24070 E:24087 ||| VBZ
both  ||| S:24087 E:24092 ||| DT
cell  ||| S:24092 E:24097 ||| NN
surface  ||| S:24097 E:24105 ||| NN
HSPGs  ||| S:24105 E:24111 ||| NN
and  ||| S:24111 E:24115 ||| CC
integrins ||| S:24115 E:24124 ||| NN
.  ||| S:24124 E:24126 ||| .
Results  ||| S:24126 E:24134 ||| NNS
from  ||| S:24134 E:24139 ||| IN
various  ||| S:24139 E:24155 ||| JJ
independent  ||| S:24155 E:24167 ||| JJ
types  ||| S:24167 E:24173 ||| NNS
of  ||| S:24173 E:24176 ||| IN
experiments  ||| S:24176 E:24188 ||| NNS
indicate  ||| S:24188 E:24197 ||| VBP
that  ||| S:24197 E:24202 ||| IN
the  ||| S:24202 E:24206 ||| DT
first  ||| S:24206 E:24220 ||| JJ
type  ||| S:24220 E:24225 ||| NN
III  ||| S:24225 E:24229 ||| NNP
repeat  ||| S:24229 E:24236 ||| NN
of  ||| S:24236 E:24239 ||| IN
fibronectin  ||| S:24239 E:24251 ||| NNS
can  ||| S:24251 E:24255 ||| MD
serve  ||| S:24255 E:24261 ||| VB
as  ||| S:24261 E:24264 ||| IN
a  ||| S:24264 E:24266 ||| DT
cell  ||| S:24266 E:24271 ||| NN
binding  ||| S:24271 E:24287 ||| JJ
domain  ||| S:24287 E:24294 ||| NN
and  ||| S:24294 E:24298 ||| CC
that  ||| S:24298 E:24303 ||| IN
both  ||| S:24303 E:24308 ||| DT
integrins  ||| S:24308 E:24318 ||| NN
and  ||| S:24318 E:24322 ||| CC
cell  ||| S:24322 E:24327 ||| NN
surface  ||| S:24327 E:24335 ||| NN
HSPGs  ||| S:24335 E:24349 ||| JJ
function  ||| S:24349 E:24358 ||| NN
as  ||| S:24358 E:24361 ||| IN
receptors  ||| S:24361 E:24371 ||| NNS
for  ||| S:24371 E:24375 ||| IN
this  ||| S:24375 E:24380 ||| DT
type  ||| S:24380 E:24385 ||| NN
III  ||| S:24385 E:24389 ||| NNP
repeat ||| S:24389 E:24395 ||| NN
.  ||| S:24395 E:24419 ||| .
Materials  ||| S:24419 E:24429 ||| NNS
and  ||| S:24429 E:24433 ||| CC
Methods  ||| S:24433 E:24460 ||| NNP
Materials  ||| S:24460 E:24480 ||| NNPS
DMEM  ||| S:24480 E:24485 ||| NNP
and  ||| S:24485 E:24489 ||| CC
glutamine  ||| S:24489 E:24499 ||| JJ
Pen-Strep  ||| S:24499 E:24509 ||| NN
were  ||| S:24509 E:24514 ||| VBD
obtained  ||| S:24514 E:24523 ||| VBN
from  ||| S:24523 E:24528 ||| IN
Life  ||| S:24528 E:24543 ||| NNP
Technologies ||| S:24543 E:24555 ||| NNPS
,  ||| S:24555 E:24557 ||| ,
Inc ||| S:24557 E:24560 ||| NNP
.  ||| S:24560 E:24562 ||| .
FBS  ||| S:24562 E:24566 ||| NNP
was  ||| S:24566 E:24570 ||| VBD
purchased  ||| S:24570 E:24580 ||| VBN
from  ||| S:24580 E:24585 ||| IN
HyClone  ||| S:24585 E:24603 ||| NNP
Laboratories ||| S:24603 E:24615 ||| NNPS
,  ||| S:24615 E:24617 ||| ,
Inc ||| S:24617 E:24620 ||| NNP
.  ||| S:24620 E:24622 ||| .
Plasma  ||| S:24622 E:24629 ||| JJ
fibronectin  ||| S:24629 E:24641 ||| NN
was  ||| S:24641 E:24645 ||| VBD
purified  ||| S:24645 E:24654 ||| VBN
from  ||| S:24654 E:24669 ||| IN
human  ||| S:24669 E:24675 ||| JJ
plasma  ||| S:24675 E:24682 ||| NN
by  ||| S:24682 E:24685 ||| IN
gelatin-agarose  ||| S:24685 E:24701 ||| JJ
affinity  ||| S:24701 E:24710 ||| JJ
chromatography  ||| S:24710 E:24725 ||| NNS
[  ||| S:24725 E:24737 ||| -LRB-
50  ||| S:24737 E:24740 ||| CD
]  ||| S:24740 E:24742 ||| -RRB-
.  ||| S:24742 E:24744 ||| .
4-20 ||| S:24744 E:24748 ||| CD
%  ||| S:24748 E:24750 ||| NN
gradient  ||| S:24750 E:24759 ||| VBZ
SDS-PAGE  ||| S:24759 E:24768 ||| JJ
gels  ||| S:24768 E:24773 ||| NN
were  ||| S:24773 E:24778 ||| VBD
from  ||| S:24778 E:24783 ||| IN
Novex ||| S:24783 E:24788 ||| NNP
.  ||| S:24788 E:24800 ||| .
Anti-phospho-p44 ||| S:24800 E:24816 ||| CD
/ ||| S:24816 E:24817 ||| CD
42  ||| S:24817 E:24820 ||| CD
MAPK  ||| S:24820 E:24825 ||| JJ
polyclonal  ||| S:24825 E:24836 ||| JJ
antibody  ||| S:24836 E:24845 ||| NN
and  ||| S:24845 E:24859 ||| CC
anti-p44 ||| S:24859 E:24867 ||| CD
/ ||| S:24867 E:24868 ||| CD
42  ||| S:24868 E:24871 ||| CD
ERK  ||| S:24871 E:24875 ||| JJ
polyclonal  ||| S:24875 E:24886 ||| JJ
antibody  ||| S:24886 E:24895 ||| NN
were  ||| S:24895 E:24900 ||| VBD
purchased  ||| S:24900 E:24910 ||| VBN
from  ||| S:24910 E:24925 ||| IN
New  ||| S:24925 E:24929 ||| NNP
England  ||| S:24929 E:24937 ||| NNP
Biolabs ||| S:24937 E:24944 ||| NNP
.  ||| S:24944 E:24946 ||| .
Anti-β1  ||| S:24946 E:24954 ||| NNP
blocking  ||| S:24954 E:24963 ||| VBG
antibody  ||| S:24963 E:24972 ||| NN
( ||| S:24972 E:24973 ||| -LRB-
Ha2 ||| S:24973 E:24976 ||| CD
/ ||| S:24976 E:24977 ||| CD
5 ||| S:24977 E:24978 ||| CD
)  ||| S:24978 E:24990 ||| -RRB-
was  ||| S:24990 E:24994 ||| VBD
from  ||| S:24994 E:24999 ||| IN
PharMingen ||| S:24999 E:25009 ||| JJ
.  ||| S:25009 E:25011 ||| .
Peptides  ||| S:25011 E:25020 ||| NNP
GRGDSP  ||| S:25020 E:25027 ||| NNP
and  ||| S:25027 E:25031 ||| CC
GRADSP  ||| S:25031 E:25038 ||| NNP
were  ||| S:25038 E:25053 ||| VBD
purchased  ||| S:25053 E:25063 ||| VBN
from  ||| S:25063 E:25068 ||| IN
Life  ||| S:25068 E:25073 ||| NNP
Technologies ||| S:25073 E:25085 ||| NNPS
,  ||| S:25085 E:25087 ||| ,
Inc ||| S:25087 E:25090 ||| NNP
.  ||| S:25090 E:25092 ||| .
Texas  ||| S:25092 E:25098 ||| NNP
red  ||| S:25098 E:25102 ||| NN
and  ||| S:25102 E:25106 ||| CC
FITC  ||| S:25106 E:25121 ||| NNP
labeled  ||| S:25121 E:25129 ||| VBD
secondary  ||| S:25129 E:25139 ||| JJ
antibodies  ||| S:25139 E:25150 ||| NNS
and  ||| S:25150 E:25154 ||| CC
35SO  ||| S:25154 E:25170 ||| CD
4  ||| S:25170 E:25172 ||| CD
were  ||| S:25172 E:25177 ||| VBD
from  ||| S:25177 E:25182 ||| IN
ICN ||| S:25182 E:25185 ||| NNP
.  ||| S:25185 E:25187 ||| .
Heparitinase ||| S:25187 E:25199 ||| NNP
,  ||| S:25199 E:25211 ||| ,
chondroitinase  ||| S:25211 E:25226 ||| VBG
ABC  ||| S:25226 E:25230 ||| NNP
and  ||| S:25230 E:25234 ||| CC
mAb  ||| S:25234 E:25238 ||| NNP
3G10  ||| S:25238 E:25243 ||| NNP
were  ||| S:25243 E:25248 ||| VBD
from  ||| S:25248 E:25253 ||| IN
Seikagaku ||| S:25253 E:25262 ||| NNP
.  ||| S:25262 E:25274 ||| .
Anti-FN  ||| S:25274 E:25282 ||| JJ
antibodies  ||| S:25282 E:25293 ||| NNS
were  ||| S:25293 E:25298 ||| VBD
a  ||| S:25298 E:25300 ||| DT
gift  ||| S:25300 E:25305 ||| NN
of  ||| S:25305 E:25308 ||| IN
Dr.  ||| S:25308 E:25312 ||| NNP
Erkki  ||| S:25312 E:25318 ||| NNP
Ruoslahti  ||| S:25318 E:25338 ||| NNP
( ||| S:25338 E:25339 ||| -LRB-
Burnham  ||| S:25339 E:25347 ||| NNP
Institute ||| S:25347 E:25356 ||| NNP
) ||| S:25356 E:25357 ||| -RRB-
.  ||| S:25357 E:25359 ||| .
ECL  ||| S:25359 E:25363 ||| NNP
plus  ||| S:25363 E:25368 ||| CC
reagent  ||| S:25368 E:25376 ||| NNS
and  ||| S:25376 E:25380 ||| CC
Hyperfilm  ||| S:25380 E:25390 ||| NNP
were  ||| S:25390 E:25405 ||| VBD
obtained  ||| S:25405 E:25414 ||| VBN
from  ||| S:25414 E:25419 ||| IN
Amersham ||| S:25419 E:25427 ||| NNP
.  ||| S:25427 E:25429 ||| .
Complete™  ||| S:25429 E:25439 ||| NNP
protease  ||| S:25439 E:25448 ||| VBD
inhibitor  ||| S:25448 E:25468 ||| JJ
cocktail  ||| S:25468 E:25477 ||| NN
tablets  ||| S:25477 E:25485 ||| NNS
were  ||| S:25485 E:25490 ||| VBD
purchased  ||| S:25490 E:25500 ||| VBN
from  ||| S:25500 E:25505 ||| IN
Boehringer  ||| S:25505 E:25516 ||| NNP
Mannheim  ||| S:25516 E:25535 ||| NNP
Biochemicals ||| S:25535 E:25547 ||| NNP
.  ||| S:25547 E:25549 ||| .
The  ||| S:25549 E:25553 ||| DT
expression  ||| S:25553 E:25564 ||| NN
vector  ||| S:25564 E:25571 ||| NN
pQE-12  ||| S:25571 E:25578 ||| NN
was  ||| S:25578 E:25582 ||| VBD
obtained  ||| S:25582 E:25601 ||| VBN
from  ||| S:25601 E:25606 ||| IN
Qiagen ||| S:25606 E:25612 ||| NNP
.  ||| S:25612 E:25614 ||| .
Heparin  ||| S:25614 E:25622 ||| NNP
and  ||| S:25622 E:25626 ||| CC
all  ||| S:25626 E:25630 ||| DT
other  ||| S:25630 E:25636 ||| JJ
chemicals  ||| S:25636 E:25646 ||| NNS
were  ||| S:25646 E:25661 ||| VBD
obtained  ||| S:25661 E:25670 ||| VBN
from  ||| S:25670 E:25675 ||| IN
Sigma ||| S:25675 E:25680 ||| NNP
.  ||| S:25680 E:25692 ||| .
The  ||| S:25692 E:25696 ||| DT
purified  ||| S:25696 E:25705 ||| JJ
glycosaminoglycans  ||| S:25705 E:25724 ||| NNS
used  ||| S:25724 E:25729 ||| VBN
in  ||| S:25729 E:25732 ||| IN
this  ||| S:25732 E:25737 ||| DT
study  ||| S:25737 E:25753 ||| NN
were  ||| S:25753 E:25758 ||| VBD
a  ||| S:25758 E:25760 ||| DT
generous  ||| S:25760 E:25769 ||| JJ
gift  ||| S:25769 E:25774 ||| NN
of  ||| S:25774 E:25777 ||| IN
Dr.  ||| S:25777 E:25781 ||| NNP
Nancy  ||| S:25781 E:25787 ||| NNP
Schwartz  ||| S:25787 E:25796 ||| NNP
( ||| S:25796 E:25797 ||| -LRB-
Univ.  ||| S:25797 E:25803 ||| NNP
of  ||| S:25803 E:25816 ||| IN
Chicago ||| S:25816 E:25823 ||| NNP
) ||| S:25823 E:25824 ||| -RRB-
.  ||| S:25824 E:25826 ||| .
The  ||| S:25826 E:25830 ||| DT
glycosaminoglycans  ||| S:25830 E:25849 ||| NN
were  ||| S:25849 E:25854 ||| VBD
produced  ||| S:25854 E:25863 ||| VBN
under  ||| S:25863 E:25869 ||| IN
a  ||| S:25869 E:25881 ||| DT
contract  ||| S:25881 E:25890 ||| NN
from  ||| S:25890 E:25895 ||| IN
the  ||| S:25895 E:25899 ||| DT
National  ||| S:25899 E:25908 ||| NNP
Institute  ||| S:25908 E:25918 ||| NNP
of  ||| S:25918 E:25921 ||| IN
Arthritis  ||| S:25921 E:25931 ||| NNP
and  ||| S:25931 E:25945 ||| CC
Musculoskeletal  ||| S:25945 E:25961 ||| NNP
and  ||| S:25961 E:25965 ||| CC
Skin  ||| S:25965 E:25970 ||| NNP
Diseases  ||| S:25970 E:25979 ||| NNP
( ||| S:25979 E:25980 ||| -LRB-
NIH ||| S:25980 E:25983 ||| NNP
)  ||| S:25983 E:25985 ||| -RRB-
and  ||| S:25985 E:25989 ||| CC
serve  ||| S:25989 E:25995 ||| VB
as  ||| S:25995 E:26008 ||| IN
reference  ||| S:26008 E:26018 ||| NN
standards ||| S:26018 E:26027 ||| NNS
.  ||| S:26027 E:26029 ||| .
The  ||| S:26029 E:26033 ||| DT
tissue  ||| S:26033 E:26040 ||| NN
sources  ||| S:26040 E:26048 ||| NNS
of  ||| S:26048 E:26051 ||| IN
the  ||| S:26051 E:26065 ||| DT
glycosaminoglycans  ||| S:26065 E:26084 ||| NN
were  ||| S:26084 E:26089 ||| VBD
as  ||| S:26089 E:26092 ||| RB
follows ||| S:26092 E:26099 ||| VBZ
:  ||| S:26099 E:26101 ||| :
hyaluronic  ||| S:26101 E:26112 ||| JJ
acid ||| S:26112 E:26116 ||| NN
,  ||| S:26116 E:26128 ||| ,
human  ||| S:26128 E:26134 ||| JJ
umbilical  ||| S:26134 E:26144 ||| JJ
cord ||| S:26144 E:26148 ||| NN
;  ||| S:26148 E:26150 ||| :
heparan  ||| S:26150 E:26158 ||| JJ
sulfate ||| S:26158 E:26165 ||| NN
,  ||| S:26165 E:26167 ||| ,
beef  ||| S:26167 E:26172 ||| NN
lung ||| S:26172 E:26176 ||| NN
;  ||| S:26176 E:26188 ||| :
dermatan  ||| S:26188 E:26197 ||| JJ
sulfate ||| S:26197 E:26204 ||| NN
,  ||| S:26204 E:26206 ||| ,
hog  ||| S:26206 E:26210 ||| NN
mucosa ||| S:26210 E:26216 ||| NNS
;  ||| S:26216 E:26218 ||| :
chondroitin-4-sulfate ||| S:26218 E:26239 ||| CD
,  ||| S:26239 E:26251 ||| ,
notochord  ||| S:26251 E:26261 ||| VBG
from  ||| S:26261 E:26266 ||| IN
river  ||| S:26266 E:26272 ||| NN
sturgeon  ||| S:26272 E:26281 ||| NNS
( ||| S:26281 E:26282 ||| -LRB-
S.  ||| S:26282 E:26285 ||| NNP
platorhynchus ||| S:26285 E:26298 ||| CD
) ||| S:26298 E:26299 ||| -RRB-
,  ||| S:26299 E:26301 ||| ,
and  ||| S:26301 E:26315 ||| CC
chondroitin-6-sulfate ||| S:26315 E:26336 ||| NNP
,  ||| S:26336 E:26338 ||| ,
cranial  ||| S:26338 E:26346 ||| JJ
cartilage  ||| S:26346 E:26356 ||| NN
of  ||| S:26356 E:26359 ||| IN
river  ||| S:26359 E:26375 ||| NN
sturgeon ||| S:26375 E:26383 ||| NN
.  ||| S:26383 E:26413 ||| .
Cell  ||| S:26413 E:26418 ||| NN
culture  ||| S:26418 E:26436 ||| NN
Primary  ||| S:26436 E:26444 ||| JJ
rat  ||| S:26444 E:26448 ||| NN
aortic  ||| S:26448 E:26455 ||| VBZ
smooth  ||| S:26455 E:26462 ||| JJ
muscle  ||| S:26462 E:26469 ||| NN
cells  ||| S:26469 E:26475 ||| NNS
( ||| S:26475 E:26476 ||| -LRB-
RASMCs ||| S:26476 E:26482 ||| NNP
)  ||| S:26482 E:26484 ||| -RRB-
were  ||| S:26484 E:26499 ||| VBD
isolated  ||| S:26499 E:26508 ||| VBN
from  ||| S:26508 E:26513 ||| IN
12-16  ||| S:26513 E:26519 ||| CD
week  ||| S:26519 E:26524 ||| NN
old  ||| S:26524 E:26528 ||| JJ
Sprague-Dawley  ||| S:26528 E:26543 ||| JJ
rats  ||| S:26543 E:26548 ||| NNS
as  ||| S:26548 E:26561 ||| RB
described  ||| S:26561 E:26571 ||| VBN
previously  ||| S:26571 E:26582 ||| RB
[  ||| S:26582 E:26584 ||| -LRB-
51  ||| S:26584 E:26587 ||| CD
]  ||| S:26587 E:26589 ||| -RRB-
.  ||| S:26589 E:26591 ||| .
RASMCs  ||| S:26591 E:26598 ||| NNP
were  ||| S:26598 E:26603 ||| VBD
cultured  ||| S:26603 E:26612 ||| VBN
in  ||| S:26612 E:26625 ||| IN
DMEM  ||| S:26625 E:26630 ||| NNP
supplemented  ||| S:26630 E:26643 ||| NN
with  ||| S:26643 E:26648 ||| IN
10 ||| S:26648 E:26650 ||| CD
%  ||| S:26650 E:26652 ||| NN
FBS  ||| S:26652 E:26656 ||| NNP
and  ||| S:26656 E:26660 ||| CC
glutamine  ||| S:26660 E:26670 ||| JJ
Pen-Strep ||| S:26670 E:26679 ||| NN
.  ||| S:26679 E:26691 ||| .
RASMCs  ||| S:26691 E:26698 ||| NNP
were  ||| S:26698 E:26703 ||| VBD
typically  ||| S:26703 E:26713 ||| RB
between  ||| S:26713 E:26721 ||| IN
passages  ||| S:26721 E:26730 ||| CD
2  ||| S:26730 E:26732 ||| CD
and  ||| S:26732 E:26736 ||| CC
7  ||| S:26736 E:26738 ||| CD
for  ||| S:26738 E:26752 ||| IN
experiments ||| S:26752 E:26763 ||| NNS
.  ||| S:26763 E:26793 ||| .
Recombinant  ||| S:26793 E:26805 ||| JJ
protein  ||| S:26805 E:26813 ||| NN
production  ||| S:26813 E:26834 ||| NN
Proteins  ||| S:26834 E:26843 ||| NNP
III1-C  ||| S:26843 E:26850 ||| NNP
and  ||| S:26850 E:26854 ||| CC
III  ||| S:26854 E:26858 ||| NNP
11-C  ||| S:26858 E:26863 ||| NNP
( ||| S:26863 E:26864 ||| -LRB-
previously  ||| S:26864 E:26875 ||| RB
called  ||| S:26875 E:26882 ||| VBN
III  ||| S:26882 E:26897 ||| NNP
11  ||| S:26897 E:26900 ||| CD
)  ||| S:26900 E:26902 ||| -RRB-
were  ||| S:26902 E:26907 ||| VBD
produced  ||| S:26907 E:26916 ||| VBN
in  ||| S:26916 E:26919 ||| IN
bacteria  ||| S:26919 E:26928 ||| NNS
and  ||| S:26928 E:26942 ||| CC
purified  ||| S:26942 E:26951 ||| VBP
as  ||| S:26951 E:26954 ||| RB
described  ||| S:26954 E:26964 ||| VBN
previously  ||| S:26964 E:26975 ||| RB
[  ||| S:26975 E:26977 ||| -LRB-
2  ||| S:26977 E:26979 ||| LS
]  ||| S:26979 E:26981 ||| -RRB-
.  ||| S:26981 E:26983 ||| .
III1-C  ||| S:26983 E:27000 ||| FW
encompasses  ||| S:27000 E:27012 ||| FW
fibronectin  ||| S:27012 E:27024 ||| FW
amino  ||| S:27024 E:27030 ||| FW
acids  ||| S:27030 E:27036 ||| FW
600-674  ||| S:27036 E:27054 ||| FW
( ||| S:27054 E:27055 ||| -LRB-
Asn-Ala-Pro-Gln-...Thr-Ser-Thr-Pro ||| S:27055 E:27089 ||| NNP
) ||| S:27089 E:27090 ||| -RRB-
,  ||| S:27090 E:27092 ||| ,
and  ||| S:27092 E:27096 ||| CC
III  ||| S:27096 E:27100 ||| NNP
11-C  ||| S:27100 E:27105 ||| FW
amino  ||| S:27105 E:27121 ||| FW
acids  ||| S:27121 E:27127 ||| FW
1,532-1,599  ||| S:27127 E:27139 ||| FW
( ||| S:27139 E:27140 ||| -LRB-
Leu-Pro-Ser-Ser-...Thr-Ala-Val-Thr ||| S:27140 E:27174 ||| NNP
) ||| S:27174 E:27175 ||| -RRB-
,  ||| S:27175 E:27187 ||| ,
according  ||| S:27187 E:27197 ||| VBG
to  ||| S:27197 E:27200 ||| TO
the  ||| S:27200 E:27204 ||| DT
previously  ||| S:27204 E:27215 ||| RB
published  ||| S:27215 E:27225 ||| VBN
numbering  ||| S:27225 E:27235 ||| JJ
method  ||| S:27235 E:27242 ||| NN
[  ||| S:27242 E:27254 ||| -LRB-
52  ||| S:27254 E:27257 ||| CD
]  ||| S:27257 E:27259 ||| -RRB-
.  ||| S:27259 E:27261 ||| .
The  ||| S:27261 E:27265 ||| DT
recombinant  ||| S:27265 E:27277 ||| JJ
proteins  ||| S:27277 E:27286 ||| NNS
were  ||| S:27286 E:27291 ||| VBD
expressed  ||| S:27291 E:27301 ||| VBN
by  ||| S:27301 E:27304 ||| IN
the  ||| S:27304 E:27318 ||| DT
pQE-12  ||| S:27318 E:27325 ||| JJ
vector ||| S:27325 E:27331 ||| NN
,  ||| S:27331 E:27333 ||| ,
which  ||| S:27333 E:27339 ||| WDT
places  ||| S:27339 E:27346 ||| VBZ
a  ||| S:27346 E:27348 ||| DT
6-His  ||| S:27348 E:27354 ||| JJ
coding  ||| S:27354 E:27361 ||| JJ
sequence  ||| S:27361 E:27370 ||| NN
at  ||| S:27370 E:27383 ||| IN
the  ||| S:27383 E:27387 ||| DT
C-terminus  ||| S:27387 E:27398 ||| JJ
of  ||| S:27398 E:27401 ||| IN
each  ||| S:27401 E:27406 ||| DT
protein ||| S:27406 E:27413 ||| NN
.  ||| S:27413 E:27415 ||| .
The  ||| S:27415 E:27419 ||| DT
proteins  ||| S:27419 E:27428 ||| NNS
were  ||| S:27428 E:27443 ||| VBD
purified  ||| S:27443 E:27452 ||| VBN
on  ||| S:27452 E:27455 ||| IN
Ni-agarose  ||| S:27455 E:27466 ||| JJ
columns  ||| S:27466 E:27474 ||| NNS
and  ||| S:27474 E:27478 ||| CC
were  ||| S:27478 E:27483 ||| VBD
> ||| S:27483 E:27484 ||| CD
98 ||| S:27484 E:27486 ||| CD
%  ||| S:27486 E:27488 ||| NN
pure  ||| S:27488 E:27493 ||| VBZ
as  ||| S:27493 E:27506 ||| RB
judged  ||| S:27506 E:27513 ||| VBN
by  ||| S:27513 E:27516 ||| IN
SDS-PAGE  ||| S:27516 E:27525 ||| JJ
and  ||| S:27525 E:27529 ||| CC
coomassie  ||| S:27529 E:27539 ||| JJ
staining ||| S:27539 E:27547 ||| NN
.  ||| S:27547 E:27549 ||| .
Stock  ||| S:27549 E:27555 ||| NN
protein  ||| S:27555 E:27573 ||| NN
solutions  ||| S:27573 E:27583 ||| NNS
were  ||| S:27583 E:27588 ||| VBD
typically  ||| S:27588 E:27598 ||| RB
700  ||| S:27598 E:27602 ||| CD
μM  ||| S:27602 E:27605 ||| NN
for  ||| S:27605 E:27609 ||| IN
III1-C  ||| S:27609 E:27616 ||| NNP
and  ||| S:27616 E:27620 ||| CC
520  ||| S:27620 E:27624 ||| CD
μM  ||| S:27624 E:27627 ||| NN
for  ||| S:27627 E:27641 ||| IN
III  ||| S:27641 E:27645 ||| NNP
11-C  ||| S:27645 E:27650 ||| NNP
in  ||| S:27650 E:27653 ||| IN
PBS ||| S:27653 E:27656 ||| NNP
.  ||| S:27656 E:27668 ||| .
Anti-III1-C  ||| S:27668 E:27680 ||| NNP
antibodies  ||| S:27680 E:27691 ||| NNS
were  ||| S:27691 E:27696 ||| VBD
produced  ||| S:27696 E:27705 ||| VBN
by  ||| S:27705 E:27708 ||| IN
immunizing  ||| S:27708 E:27729 ||| JJ
rabbits  ||| S:27729 E:27737 ||| NN
with  ||| S:27737 E:27742 ||| IN
III1-C ||| S:27742 E:27748 ||| CD
.  ||| S:27748 E:27750 ||| .
After  ||| S:27750 E:27756 ||| IN
one  ||| S:27756 E:27760 ||| CD
month  ||| S:27760 E:27766 ||| NN
the  ||| S:27766 E:27770 ||| DT
rabbits  ||| S:27770 E:27778 ||| NN
were  ||| S:27778 E:27793 ||| VBD
boosted  ||| S:27793 E:27801 ||| VBN
and  ||| S:27801 E:27805 ||| CC
serum  ||| S:27805 E:27811 ||| JJ
samples  ||| S:27811 E:27819 ||| NNS
were  ||| S:27819 E:27824 ||| VBD
collected  ||| S:27824 E:27834 ||| VBN
every  ||| S:27834 E:27840 ||| DT
two  ||| S:27840 E:27844 ||| CD
weeks ||| S:27844 E:27849 ||| NNS
.  ||| S:27849 E:27861 ||| .
The  ||| S:27861 E:27865 ||| DT
rabbit  ||| S:27865 E:27872 ||| JJ
serum  ||| S:27872 E:27878 ||| NN
was  ||| S:27878 E:27882 ||| VBD
applied  ||| S:27882 E:27890 ||| VBN
to  ||| S:27890 E:27893 ||| TO
an  ||| S:27893 E:27896 ||| DT
affinity  ||| S:27896 E:27905 ||| JJ
column  ||| S:27905 E:27912 ||| NN
to  ||| S:27912 E:27925 ||| TO
purify  ||| S:27925 E:27932 ||| VB
the  ||| S:27932 E:27936 ||| DT
anti-III  ||| S:27936 E:27945 ||| JJ
1-C  ||| S:27945 E:27949 ||| CD
antibodies ||| S:27949 E:27959 ||| NNS
.  ||| S:27959 E:27961 ||| .
In  ||| S:27961 E:27964 ||| IN
order  ||| S:27964 E:27970 ||| NN
to  ||| S:27970 E:27973 ||| TO
avoid  ||| S:27973 E:27989 ||| VB
purifying  ||| S:27989 E:27999 ||| JJ
antibodies  ||| S:27999 E:28010 ||| NNS
to  ||| S:28010 E:28013 ||| TO
the  ||| S:28013 E:28017 ||| DT
6-His  ||| S:28017 E:28023 ||| JJ
tag  ||| S:28023 E:28027 ||| NN
in  ||| S:28027 E:28030 ||| IN
III1-C ||| S:28030 E:28036 ||| NNP
,  ||| S:28036 E:28038 ||| ,
the  ||| S:28038 E:28052 ||| DT
affinity  ||| S:28052 E:28061 ||| JJ
column  ||| S:28061 E:28068 ||| NN
was  ||| S:28068 E:28072 ||| VBD
made  ||| S:28072 E:28077 ||| VBN
with  ||| S:28077 E:28082 ||| IN
a  ||| S:28082 E:28084 ||| DT
GST  ||| S:28084 E:28088 ||| NNP
fusion  ||| S:28088 E:28095 ||| NN
protein ||| S:28095 E:28102 ||| NN
.  ||| S:28102 E:28104 ||| .
The  ||| S:28104 E:28108 ||| DT
1  ||| S:28108 E:28120 ||| CD
sttype  ||| S:28120 E:28127 ||| JJ
III  ||| S:28127 E:28131 ||| NNP
repeat  ||| S:28131 E:28138 ||| NN
of  ||| S:28138 E:28141 ||| IN
fibronectin  ||| S:28141 E:28153 ||| NN
was  ||| S:28153 E:28157 ||| VBD
expressed  ||| S:28157 E:28167 ||| VBN
as  ||| S:28167 E:28170 ||| IN
a  ||| S:28170 E:28182 ||| DT
fusion  ||| S:28182 E:28189 ||| NN
protein  ||| S:28189 E:28197 ||| NN
coupled  ||| S:28197 E:28205 ||| VBN
to  ||| S:28205 E:28208 ||| TO
GST ||| S:28208 E:28211 ||| NNP
,  ||| S:28211 E:28213 ||| ,
and  ||| S:28213 E:28217 ||| CC
this  ||| S:28217 E:28222 ||| DT
GST-3FN1  ||| S:28222 E:28231 ||| JJ
fusion  ||| S:28231 E:28248 ||| NN
protein  ||| S:28248 E:28256 ||| NN
was  ||| S:28256 E:28260 ||| VBD
coupled  ||| S:28260 E:28268 ||| VBN
to  ||| S:28268 E:28271 ||| TO
Sepharose  ||| S:28271 E:28281 ||| NNP
and  ||| S:28281 E:28285 ||| CC
used  ||| S:28285 E:28290 ||| VBN
in  ||| S:28290 E:28293 ||| IN
affinity  ||| S:28293 E:28312 ||| JJ
purification ||| S:28312 E:28324 ||| NN
.  ||| S:28324 E:28326 ||| .
Bound  ||| S:28326 E:28332 ||| JJ
antibodies  ||| S:28332 E:28343 ||| NNS
were  ||| S:28343 E:28348 ||| VBD
eluted  ||| S:28348 E:28355 ||| VBN
with  ||| S:28355 E:28360 ||| IN
100  ||| S:28360 E:28364 ||| CD
mM  ||| S:28364 E:28377 ||| JJ
triethylamine ||| S:28377 E:28390 ||| NN
,  ||| S:28390 E:28392 ||| ,
pH  ||| S:28392 E:28395 ||| JJ
11.5  ||| S:28395 E:28400 ||| CD
and  ||| S:28400 E:28404 ||| CC
the  ||| S:28404 E:28408 ||| DT
pH  ||| S:28408 E:28411 ||| NN
was  ||| S:28411 E:28415 ||| VBD
neutralized  ||| S:28415 E:28427 ||| VBN
with  ||| S:28427 E:28432 ||| IN
1  ||| S:28432 E:28444 ||| CD
M  ||| S:28444 E:28446 ||| NNP
Tris ||| S:28446 E:28450 ||| NNP
,  ||| S:28450 E:28452 ||| ,
pH  ||| S:28452 E:28455 ||| JJ
8 ||| S:28455 E:28456 ||| CD
;  ||| S:28456 E:28458 ||| :
( ||| S:28458 E:28459 ||| -LRB-
the  ||| S:28459 E:28463 ||| DT
antibody  ||| S:28463 E:28472 ||| NN
concentration  ||| S:28472 E:28486 ||| NN
was  ||| S:28486 E:28490 ||| VBD
0.4  ||| S:28490 E:28494 ||| CD
mg ||| S:28494 E:28496 ||| CD
/ ||| S:28496 E:28497 ||| CD
ml ||| S:28497 E:28499 ||| CD
) ||| S:28499 E:28500 ||| -RRB-
.  ||| S:28500 E:28512 ||| .
BSA  ||| S:28512 E:28516 ||| NNP
( ||| S:28516 E:28517 ||| -LRB-
0.5  ||| S:28517 E:28521 ||| CD
mg ||| S:28521 E:28523 ||| CD
/ ||| S:28523 E:28524 ||| CD
ml ||| S:28524 E:28526 ||| CD
)  ||| S:28526 E:28528 ||| -RRB-
was  ||| S:28528 E:28532 ||| VBD
added  ||| S:28532 E:28538 ||| VBN
to  ||| S:28538 E:28541 ||| TO
stabilize  ||| S:28541 E:28551 ||| VB
the  ||| S:28551 E:28555 ||| DT
antibody  ||| S:28555 E:28564 ||| NN
for  ||| S:28564 E:28578 ||| IN
subsequent  ||| S:28578 E:28589 ||| JJ
handling ||| S:28589 E:28597 ||| NN
.  ||| S:28597 E:28599 ||| .
The  ||| S:28599 E:28603 ||| DT
antibody  ||| S:28603 E:28612 ||| NN
prep  ||| S:28612 E:28617 ||| NNS
was  ||| S:28617 E:28621 ||| VBD
dialyzed  ||| S:28621 E:28640 ||| JJ
extensively  ||| S:28640 E:28652 ||| NN
against  ||| S:28652 E:28660 ||| IN
PBS  ||| S:28660 E:28664 ||| NNP
before  ||| S:28664 E:28671 ||| IN
use ||| S:28671 E:28674 ||| NN
.  ||| S:28674 E:28704 ||| .
Cell  ||| S:28704 E:28709 ||| NN
attachment  ||| S:28709 E:28720 ||| NN
and  ||| S:28720 E:28724 ||| CC
spreading  ||| S:28724 E:28734 ||| VBG
assays  ||| S:28734 E:28751 ||| NN
For  ||| S:28751 E:28755 ||| IN
the  ||| S:28755 E:28759 ||| DT
cell  ||| S:28759 E:28764 ||| NN
spreading  ||| S:28764 E:28774 ||| VBG
assay  ||| S:28774 E:28780 ||| NNS
shown  ||| S:28780 E:28786 ||| VBN
in  ||| S:28786 E:28789 ||| IN
Fig.  ||| S:28789 E:28794 ||| CD
1 ||| S:28794 E:28795 ||| CD
,  ||| S:28795 E:28807 ||| ,
fibronectin  ||| S:28807 E:28819 ||| NNS
( ||| S:28819 E:28820 ||| -LRB-
20  ||| S:28820 E:28823 ||| CD
μg ||| S:28823 E:28825 ||| CD
/ ||| S:28825 E:28826 ||| CD
ml ||| S:28826 E:28828 ||| CD
)  ||| S:28828 E:28830 ||| -RRB-
was  ||| S:28830 E:28834 ||| VBD
coated  ||| S:28834 E:28841 ||| VBN
onto  ||| S:28841 E:28846 ||| IN
24-well  ||| S:28846 E:28854 ||| CD
dishes  ||| S:28854 E:28861 ||| NNS
for  ||| S:28861 E:28875 ||| IN
1  ||| S:28875 E:28877 ||| CD
hr  ||| S:28877 E:28880 ||| NN
at  ||| S:28880 E:28883 ||| IN
RT ||| S:28883 E:28885 ||| NNP
.  ||| S:28885 E:28887 ||| .
The  ||| S:28887 E:28891 ||| DT
wells  ||| S:28891 E:28897 ||| NNS
were  ||| S:28897 E:28902 ||| VBD
washed  ||| S:28902 E:28909 ||| VBN
3  ||| S:28909 E:28911 ||| CD
times  ||| S:28911 E:28917 ||| NNS
with  ||| S:28917 E:28922 ||| IN
PBS  ||| S:28922 E:28926 ||| NNP
before  ||| S:28926 E:28943 ||| IN
adding  ||| S:28943 E:28950 ||| VBG
cells ||| S:28950 E:28955 ||| NNS
.  ||| S:28955 E:28957 ||| .
Growing  ||| S:28957 E:28965 ||| VBG
RASMCs  ||| S:28965 E:28972 ||| NN
were  ||| S:28972 E:28977 ||| VBD
harvested  ||| S:28977 E:28987 ||| VBN
by  ||| S:28987 E:29000 ||| IN
trypsinization  ||| S:29000 E:29015 ||| NN
and  ||| S:29015 E:29019 ||| CC
collected  ||| S:29019 E:29029 ||| VBN
into  ||| S:29029 E:29034 ||| IN
DMEM  ||| S:29034 E:29039 ||| NNP
+  ||| S:29039 E:29041 ||| CD
0.5 ||| S:29041 E:29044 ||| CD
%  ||| S:29044 E:29046 ||| NN
BSA  ||| S:29046 E:29050 ||| FW
+  ||| S:29050 E:29062 ||| FW
soybean  ||| S:29062 E:29070 ||| FW
trypsin  ||| S:29070 E:29078 ||| FW
inhibitor ||| S:29078 E:29087 ||| FW
.  ||| S:29087 E:29089 ||| .
Cells  ||| S:29089 E:29095 ||| NNS
were  ||| S:29095 E:29100 ||| VBD
washed  ||| S:29100 E:29107 ||| VBN
3  ||| S:29107 E:29109 ||| CD
times  ||| S:29109 E:29115 ||| NNS
with  ||| S:29115 E:29130 ||| IN
DMEM  ||| S:29130 E:29135 ||| NNP
+  ||| S:29135 E:29137 ||| CD
0.5 ||| S:29137 E:29140 ||| CD
%  ||| S:29140 E:29142 ||| NN
BSA ||| S:29142 E:29145 ||| NNP
,  ||| S:29145 E:29147 ||| ,
then  ||| S:29147 E:29152 ||| RB
resuspended  ||| S:29152 E:29164 ||| VBN
at  ||| S:29164 E:29167 ||| IN
1  ||| S:29167 E:29169 ||| CD
×  ||| S:29169 E:29171 ||| CD
10  ||| S:29171 E:29174 ||| CD
5cells ||| S:29174 E:29180 ||| CD
/ ||| S:29180 E:29181 ||| CD
ml  ||| S:29181 E:29184 ||| NN
in  ||| S:29184 E:29197 ||| IN
DMEM  ||| S:29197 E:29202 ||| NNP
+  ||| S:29202 E:29204 ||| CD
0.5 ||| S:29204 E:29207 ||| CD
%  ||| S:29207 E:29209 ||| NN
BSA ||| S:29209 E:29212 ||| NNP
,  ||| S:29212 E:29214 ||| ,
in  ||| S:29214 E:29217 ||| IN
the  ||| S:29217 E:29221 ||| DT
absence  ||| S:29221 E:29229 ||| NN
or  ||| S:29229 E:29232 ||| CC
presence  ||| S:29232 E:29241 ||| NN
of  ||| S:29241 E:29244 ||| IN
25  ||| S:29244 E:29247 ||| CD
μM  ||| S:29247 E:29260 ||| JJ
III1-C  ||| S:29260 E:29267 ||| NN
or  ||| S:29267 E:29270 ||| CC
25  ||| S:29270 E:29273 ||| CD
μM  ||| S:29273 E:29276 ||| JJ
III  ||| S:29276 E:29280 ||| NNP
11-C  ||| S:29280 E:29285 ||| NNP
in  ||| S:29285 E:29288 ||| IN
the  ||| S:29288 E:29292 ||| DT
medium ||| S:29292 E:29298 ||| NN
.  ||| S:29298 E:29300 ||| .
Cells  ||| S:29300 E:29306 ||| NNS
were  ||| S:29306 E:29311 ||| VBD
seeded  ||| S:29311 E:29328 ||| VBN
onto  ||| S:29328 E:29333 ||| IN
the  ||| S:29333 E:29337 ||| DT
wells  ||| S:29337 E:29343 ||| NNS
( ||| S:29343 E:29344 ||| -LRB-
0.5  ||| S:29344 E:29348 ||| CD
ml ||| S:29348 E:29350 ||| NNS
/ ||| S:29350 E:29351 ||| VBP
well ||| S:29351 E:29355 ||| RB
,  ||| S:29355 E:29357 ||| ,
~30 ||| S:29357 E:29360 ||| CD
%  ||| S:29360 E:29362 ||| NN
confluence ||| S:29362 E:29372 ||| NN
) ||| S:29372 E:29373 ||| -RRB-
,  ||| S:29373 E:29375 ||| ,
placed  ||| S:29375 E:29382 ||| VBN
in  ||| S:29382 E:29395 ||| IN
a  ||| S:29395 E:29397 ||| DT
37°C  ||| S:29397 E:29402 ||| CD
incubator  ||| S:29402 E:29412 ||| NNS
and  ||| S:29412 E:29416 ||| CC
allowed  ||| S:29416 E:29424 ||| VBN
to  ||| S:29424 E:29427 ||| TO
adhere  ||| S:29427 E:29434 ||| VB
for  ||| S:29434 E:29438 ||| IN
either  ||| S:29438 E:29445 ||| DT
7 ||| S:29445 E:29446 ||| CD
,  ||| S:29446 E:29448 ||| ,
15 ||| S:29448 E:29450 ||| CD
,  ||| S:29450 E:29462 ||| ,
30 ||| S:29462 E:29464 ||| CD
,  ||| S:29464 E:29466 ||| ,
60 ||| S:29466 E:29468 ||| CD
,  ||| S:29468 E:29470 ||| ,
120  ||| S:29470 E:29474 ||| CD
or  ||| S:29474 E:29477 ||| CC
240  ||| S:29477 E:29481 ||| CD
min ||| S:29481 E:29484 ||| NNS
.  ||| S:29484 E:29486 ||| .
Cells  ||| S:29486 E:29492 ||| NNS
were  ||| S:29492 E:29497 ||| VBD
then  ||| S:29497 E:29502 ||| RB
fixed  ||| S:29502 E:29508 ||| VBN
with  ||| S:29508 E:29513 ||| IN
3.7 ||| S:29513 E:29516 ||| CD
%  ||| S:29516 E:29528 ||| NN
paraformaldehyde ||| S:29528 E:29544 ||| NN
,  ||| S:29544 E:29546 ||| ,
60  ||| S:29546 E:29549 ||| CD
mM  ||| S:29549 E:29552 ||| JJ
sucrose  ||| S:29552 E:29560 ||| NN
in  ||| S:29560 E:29563 ||| IN
TBS ||| S:29563 E:29566 ||| NNP
,  ||| S:29566 E:29568 ||| ,
followed  ||| S:29568 E:29577 ||| VBN
by  ||| S:29577 E:29590 ||| IN
staining  ||| S:29590 E:29599 ||| NN
with  ||| S:29599 E:29604 ||| IN
Coomassie  ||| S:29604 E:29614 ||| NNP
Blue  ||| S:29614 E:29619 ||| NNP
dye  ||| S:29619 E:29623 ||| NNS
( ||| S:29623 E:29624 ||| -LRB-
1  ||| S:29624 E:29626 ||| CD
mg ||| S:29626 E:29628 ||| CD
/ ||| S:29628 E:29629 ||| CD
ml  ||| S:29629 E:29632 ||| JJ
Coomassie  ||| S:29632 E:29652 ||| NNP
Brilliant  ||| S:29652 E:29662 ||| NNP
Blue ||| S:29662 E:29666 ||| NNP
,  ||| S:29666 E:29668 ||| ,
45 ||| S:29668 E:29670 ||| CD
%  ||| S:29670 E:29672 ||| NN
MeOH ||| S:29672 E:29676 ||| NN
,  ||| S:29676 E:29678 ||| ,
10 ||| S:29678 E:29680 ||| CD
%  ||| S:29680 E:29682 ||| NN
acetic  ||| S:29682 E:29689 ||| NN
acid ||| S:29689 E:29693 ||| NN
) ||| S:29693 E:29694 ||| -RRB-
.  ||| S:29694 E:29696 ||| .
Cells  ||| S:29696 E:29702 ||| NNS
were  ||| S:29702 E:29717 ||| VBD
destained  ||| S:29717 E:29727 ||| VBN
with  ||| S:29727 E:29732 ||| IN
water ||| S:29732 E:29737 ||| NN
,  ||| S:29737 E:29739 ||| ,
air-dried ||| S:29739 E:29748 ||| NNP
,  ||| S:29748 E:29750 ||| ,
then  ||| S:29750 E:29755 ||| RB
photographed  ||| S:29755 E:29768 ||| VBN
with  ||| S:29768 E:29773 ||| IN
a  ||| S:29773 E:29785 ||| DT
Leica  ||| S:29785 E:29791 ||| NNP
DM  ||| S:29791 E:29794 ||| NNP
IRB  ||| S:29794 E:29798 ||| NNP
phase  ||| S:29798 E:29804 ||| NN
microscope  ||| S:29804 E:29815 ||| VBZ
connected  ||| S:29815 E:29825 ||| VBN
to  ||| S:29825 E:29828 ||| TO
a  ||| S:29828 E:29830 ||| DT
Polaroid  ||| S:29830 E:29839 ||| NNP
CCD  ||| S:29839 E:29853 ||| NNP
camera  ||| S:29853 E:29860 ||| NN
and  ||| S:29860 E:29864 ||| CC
an  ||| S:29864 E:29867 ||| DT
Apple  ||| S:29867 E:29873 ||| NNP
Macintosh  ||| S:29873 E:29883 ||| NNP
computer  ||| S:29883 E:29892 ||| NN
for  ||| S:29892 E:29896 ||| IN
capturing  ||| S:29896 E:29916 ||| VBG
images ||| S:29916 E:29922 ||| NNS
.  ||| S:29922 E:29924 ||| .
To  ||| S:29924 E:29927 ||| TO
quantitate  ||| S:29927 E:29938 ||| VB
the  ||| S:29938 E:29942 ||| DT
amount  ||| S:29942 E:29949 ||| NN
of  ||| S:29949 E:29952 ||| IN
spreading ||| S:29952 E:29961 ||| VBG
,  ||| S:29961 E:29963 ||| ,
each  ||| S:29963 E:29968 ||| DT
image  ||| S:29968 E:29984 ||| NN
was  ||| S:29984 E:29988 ||| VBD
analyzed  ||| S:29988 E:29997 ||| VBN
with  ||| S:29997 E:30002 ||| IN
the  ||| S:30002 E:30006 ||| DT
NIH  ||| S:30006 E:30010 ||| NNP
Image  ||| S:30010 E:30016 ||| NNP
1.61  ||| S:30016 E:30021 ||| CD
application  ||| S:30021 E:30033 ||| NN
to  ||| S:30033 E:30046 ||| TO
determine  ||| S:30046 E:30056 ||| VB
the  ||| S:30056 E:30060 ||| DT
total  ||| S:30060 E:30066 ||| JJ
amount  ||| S:30066 E:30073 ||| NN
of  ||| S:30073 E:30076 ||| IN
area  ||| S:30076 E:30081 ||| NN
covered  ||| S:30081 E:30089 ||| VBN
by  ||| S:30089 E:30092 ||| IN
cells  ||| S:30092 E:30098 ||| NNS
and  ||| S:30098 E:30112 ||| CC
this  ||| S:30112 E:30117 ||| DT
number  ||| S:30117 E:30124 ||| NN
was  ||| S:30124 E:30128 ||| VBD
divided  ||| S:30128 E:30136 ||| VBN
by  ||| S:30136 E:30139 ||| IN
the  ||| S:30139 E:30143 ||| DT
total  ||| S:30143 E:30149 ||| JJ
number  ||| S:30149 E:30156 ||| NN
of  ||| S:30156 E:30159 ||| IN
cells  ||| S:30159 E:30165 ||| NNS
in  ||| S:30165 E:30178 ||| IN
the  ||| S:30178 E:30182 ||| DT
image  ||| S:30182 E:30188 ||| NN
to  ||| S:30188 E:30191 ||| TO
give  ||| S:30191 E:30196 ||| VB
an  ||| S:30196 E:30199 ||| DT
average  ||| S:30199 E:30207 ||| JJ
area  ||| S:30207 E:30212 ||| NN
per  ||| S:30212 E:30216 ||| IN
cell  ||| S:30216 E:30221 ||| NN
( ||| S:30221 E:30222 ||| -LRB-
in  ||| S:30222 E:30225 ||| IN
pixels  ||| S:30225 E:30242 ||| CD
2 ||| S:30242 E:30243 ||| CD
/ ||| S:30243 E:30244 ||| CD
cell ||| S:30244 E:30248 ||| NN
) ||| S:30248 E:30249 ||| -RRB-
.  ||| S:30249 E:30261 ||| .
Cell  ||| S:30261 E:30266 ||| NN
attachment  ||| S:30266 E:30277 ||| NNS
assays  ||| S:30277 E:30284 ||| VBP
shown  ||| S:30284 E:30290 ||| VBN
in  ||| S:30290 E:30293 ||| IN
Fig.  ||| S:30293 E:30298 ||| CD
2and  ||| S:30298 E:30303 ||| CD
3were  ||| S:30303 E:30309 ||| CD
done  ||| S:30309 E:30324 ||| VBN
essentially  ||| S:30324 E:30336 ||| RB
as  ||| S:30336 E:30339 ||| RB
described  ||| S:30339 E:30349 ||| VBN
previously  ||| S:30349 E:30360 ||| RB
[  ||| S:30360 E:30362 ||| -LRB-
2  ||| S:30362 E:30364 ||| LS
]  ||| S:30364 E:30366 ||| -RRB-
.  ||| S:30366 E:30368 ||| .
Briefly ||| S:30368 E:30375 ||| RB
,  ||| S:30375 E:30387 ||| ,
fibronectin ||| S:30387 E:30398 ||| NN
,  ||| S:30398 E:30400 ||| ,
III1-C  ||| S:30400 E:30407 ||| NNP
or  ||| S:30407 E:30410 ||| CC
III  ||| S:30410 E:30414 ||| NNP
11-C  ||| S:30414 E:30419 ||| NNP
at  ||| S:30419 E:30422 ||| IN
various  ||| S:30422 E:30430 ||| JJ
concentrations  ||| S:30430 E:30455 ||| NNS
were  ||| S:30455 E:30460 ||| VBD
coated  ||| S:30460 E:30467 ||| VBN
onto  ||| S:30467 E:30472 ||| IN
96-well  ||| S:30472 E:30480 ||| CD
dishes  ||| S:30480 E:30487 ||| NNS
for  ||| S:30487 E:30491 ||| IN
1  ||| S:30491 E:30493 ||| CD
hr  ||| S:30493 E:30496 ||| NN
at  ||| S:30496 E:30499 ||| IN
RT ||| S:30499 E:30501 ||| NNP
.  ||| S:30501 E:30503 ||| .
The  ||| S:30503 E:30507 ||| DT
wells  ||| S:30507 E:30523 ||| NNS
were  ||| S:30523 E:30528 ||| VBD
then  ||| S:30528 E:30533 ||| RB
washed  ||| S:30533 E:30540 ||| VBD
3  ||| S:30540 E:30542 ||| CD
times  ||| S:30542 E:30548 ||| NNS
with  ||| S:30548 E:30553 ||| IN
PBS  ||| S:30553 E:30557 ||| NNP
before  ||| S:30557 E:30564 ||| IN
adding  ||| S:30564 E:30571 ||| VBG
cells ||| S:30571 E:30576 ||| NNS
.  ||| S:30576 E:30588 ||| .
Growing  ||| S:30588 E:30596 ||| VBG
RASMCs  ||| S:30596 E:30603 ||| NN
were  ||| S:30603 E:30608 ||| VBD
harvested  ||| S:30608 E:30618 ||| VBN
by  ||| S:30618 E:30621 ||| IN
trypsinization  ||| S:30621 E:30636 ||| NN
and  ||| S:30636 E:30650 ||| CC
collected  ||| S:30650 E:30660 ||| VBN
into  ||| S:30660 E:30665 ||| IN
DMEM  ||| S:30665 E:30670 ||| NNP
+  ||| S:30670 E:30672 ||| CD
0.5 ||| S:30672 E:30675 ||| CD
%  ||| S:30675 E:30677 ||| NN
BSA  ||| S:30677 E:30681 ||| FW
+  ||| S:30681 E:30683 ||| FW
soybean  ||| S:30683 E:30691 ||| FW
trypsin  ||| S:30691 E:30709 ||| FW
inhibitor ||| S:30709 E:30718 ||| FW
.  ||| S:30718 E:30720 ||| .
Cells  ||| S:30720 E:30726 ||| NNS
were  ||| S:30726 E:30731 ||| VBD
washed  ||| S:30731 E:30738 ||| VBN
3  ||| S:30738 E:30740 ||| CD
times  ||| S:30740 E:30746 ||| NNS
with  ||| S:30746 E:30751 ||| IN
DMEM  ||| S:30751 E:30756 ||| NNP
+  ||| S:30756 E:30758 ||| CD
0.5 ||| S:30758 E:30761 ||| CD
%  ||| S:30761 E:30773 ||| NN
BSA ||| S:30773 E:30776 ||| NNP
,  ||| S:30776 E:30778 ||| ,
then  ||| S:30778 E:30783 ||| RB
resuspended  ||| S:30783 E:30795 ||| VBN
at  ||| S:30795 E:30798 ||| IN
4  ||| S:30798 E:30800 ||| CD
×  ||| S:30800 E:30802 ||| CD
10  ||| S:30802 E:30805 ||| CD
5cells ||| S:30805 E:30811 ||| CD
/ ||| S:30811 E:30812 ||| CD
ml  ||| S:30812 E:30815 ||| NN
in  ||| S:30815 E:30818 ||| IN
DMEM  ||| S:30818 E:30823 ||| NNP
+  ||| S:30823 E:30825 ||| CD
0.5 ||| S:30825 E:30828 ||| CD
%  ||| S:30828 E:30840 ||| NN
BSA  ||| S:30840 E:30844 ||| NN
with  ||| S:30844 E:30849 ||| IN
or  ||| S:30849 E:30852 ||| CC
without  ||| S:30852 E:30860 ||| IN
inhibitors ||| S:30860 E:30870 ||| NN
,  ||| S:30870 E:30872 ||| ,
as  ||| S:30872 E:30875 ||| RB
indicated  ||| S:30875 E:30885 ||| VBN
in  ||| S:30885 E:30888 ||| IN
the  ||| S:30888 E:30902 ||| DT
figures ||| S:30902 E:30909 ||| NNS
.  ||| S:30909 E:30911 ||| .
Cells  ||| S:30911 E:30917 ||| NNS
were  ||| S:30917 E:30922 ||| VBD
seeded  ||| S:30922 E:30929 ||| VBN
onto  ||| S:30929 E:30934 ||| IN
the  ||| S:30934 E:30938 ||| DT
coated  ||| S:30938 E:30945 ||| JJ
wells  ||| S:30945 E:30951 ||| NNS
and  ||| S:30951 E:30965 ||| CC
allowed  ||| S:30965 E:30973 ||| VBN
to  ||| S:30973 E:30976 ||| TO
adhere  ||| S:30976 E:30983 ||| VB
for  ||| S:30983 E:30987 ||| IN
30  ||| S:30987 E:30990 ||| CD
min  ||| S:30990 E:30994 ||| NN
at  ||| S:30994 E:30997 ||| IN
37°C ||| S:30997 E:31001 ||| CD
.  ||| S:31001 E:31003 ||| .
The  ||| S:31003 E:31007 ||| DT
cells  ||| S:31007 E:31013 ||| NNS
were  ||| S:31013 E:31018 ||| VBD
then  ||| S:31018 E:31033 ||| RB
fixed  ||| S:31033 E:31039 ||| VBN
with  ||| S:31039 E:31044 ||| IN
3.7 ||| S:31044 E:31047 ||| CD
%  ||| S:31047 E:31049 ||| NN
paraformaldehyde ||| S:31049 E:31065 ||| NN
,  ||| S:31065 E:31067 ||| ,
60  ||| S:31067 E:31070 ||| CD
mM  ||| S:31070 E:31073 ||| JJ
sucrose  ||| S:31073 E:31081 ||| NN
in  ||| S:31081 E:31084 ||| IN
TBS ||| S:31084 E:31087 ||| NNP
,  ||| S:31087 E:31099 ||| ,
followed  ||| S:31099 E:31108 ||| VBN
by  ||| S:31108 E:31111 ||| IN
20 ||| S:31111 E:31113 ||| CD
%  ||| S:31113 E:31115 ||| NN
methanol ||| S:31115 E:31123 ||| NN
,  ||| S:31123 E:31125 ||| ,
and  ||| S:31125 E:31129 ||| CC
staining  ||| S:31129 E:31138 ||| NN
in  ||| S:31138 E:31141 ||| IN
0.5 ||| S:31141 E:31144 ||| CD
%  ||| S:31144 E:31146 ||| NN
crystal  ||| S:31146 E:31164 ||| NN
violet  ||| S:31164 E:31171 ||| NN
in  ||| S:31171 E:31174 ||| IN
20 ||| S:31174 E:31176 ||| CD
%  ||| S:31176 E:31178 ||| NN
methanol ||| S:31178 E:31186 ||| NN
.  ||| S:31186 E:31188 ||| .
Stained  ||| S:31188 E:31196 ||| JJ
cells  ||| S:31196 E:31202 ||| NNS
were  ||| S:31202 E:31207 ||| VBD
washed  ||| S:31207 E:31214 ||| VBN
with  ||| S:31214 E:31229 ||| IN
water  ||| S:31229 E:31235 ||| NN
and  ||| S:31235 E:31239 ||| CC
the  ||| S:31239 E:31243 ||| DT
dye  ||| S:31243 E:31247 ||| NN
was  ||| S:31247 E:31251 ||| VBD
solubilized  ||| S:31251 E:31263 ||| VBN
with  ||| S:31263 E:31268 ||| IN
0.1  ||| S:31268 E:31272 ||| CD
M  ||| S:31272 E:31274 ||| NNP
sodium  ||| S:31274 E:31291 ||| NN
citrate ||| S:31291 E:31298 ||| NN
,  ||| S:31298 E:31300 ||| ,
pH  ||| S:31300 E:31303 ||| JJ
4.2 ||| S:31303 E:31306 ||| CD
,  ||| S:31306 E:31308 ||| ,
50 ||| S:31308 E:31310 ||| CD
%  ||| S:31310 E:31312 ||| NN
ethanol ||| S:31312 E:31319 ||| NN
.  ||| S:31319 E:31321 ||| .
Attachment  ||| S:31321 E:31332 ||| NNP
was  ||| S:31332 E:31336 ||| VBD
quantitated  ||| S:31336 E:31358 ||| VBN
by  ||| S:31358 E:31361 ||| IN
measuring  ||| S:31361 E:31371 ||| VBG
the  ||| S:31371 E:31375 ||| DT
absorbance  ||| S:31375 E:31386 ||| NN
at  ||| S:31386 E:31389 ||| IN
600  ||| S:31389 E:31393 ||| CD
nm.  ||| S:31393 E:31425 ||| CD
125I  ||| S:31425 E:31430 ||| CD
cell  ||| S:31430 E:31435 ||| NN
surface  ||| S:31435 E:31443 ||| NN
labeling  ||| S:31443 E:31452 ||| NNS
and  ||| S:31452 E:31456 ||| CC
affinity  ||| S:31456 E:31475 ||| NNS
chromatography  ||| S:31475 E:31500 ||| VBP
The  ||| S:31500 E:31504 ||| DT
procedure  ||| S:31504 E:31514 ||| NN
was  ||| S:31514 E:31518 ||| VBD
a  ||| S:31518 E:31520 ||| DT
modification  ||| S:31520 E:31533 ||| NN
of  ||| S:31533 E:31536 ||| IN
the  ||| S:31536 E:31540 ||| DT
procedure  ||| S:31540 E:31550 ||| NN
used  ||| S:31550 E:31565 ||| VBN
to  ||| S:31565 E:31568 ||| TO
isolate  ||| S:31568 E:31576 ||| VB
the  ||| S:31576 E:31580 ||| DT
fibronectin  ||| S:31580 E:31592 ||| JJ
receptor  ||| S:31592 E:31601 ||| NN
and  ||| S:31601 E:31605 ||| CC
other  ||| S:31605 E:31611 ||| JJ
integrins  ||| S:31611 E:31621 ||| NNS
[  ||| S:31621 E:31633 ||| -LRB-
27  ||| S:31633 E:31636 ||| CD
28  ||| S:31636 E:31639 ||| CD
]  ||| S:31639 E:31641 ||| -RRB-
.  ||| S:31641 E:31643 ||| .
The  ||| S:31643 E:31647 ||| DT
affinity  ||| S:31647 E:31656 ||| JJ
resins  ||| S:31656 E:31663 ||| NNS
were  ||| S:31663 E:31668 ||| VBD
prepared  ||| S:31668 E:31677 ||| VBN
by  ||| S:31677 E:31680 ||| IN
coupling  ||| S:31680 E:31699 ||| JJ
fibronectin ||| S:31699 E:31710 ||| NN
,  ||| S:31710 E:31712 ||| ,
III1-C  ||| S:31712 E:31719 ||| NNP
or  ||| S:31719 E:31722 ||| CC
III  ||| S:31722 E:31726 ||| NNP
11-C  ||| S:31726 E:31731 ||| NNP
to  ||| S:31731 E:31734 ||| TO
CNBr-activated  ||| S:31734 E:31759 ||| NNP
Sepharose  ||| S:31759 E:31769 ||| NNP
CL-4B  ||| S:31769 E:31775 ||| NNP
according  ||| S:31775 E:31785 ||| VBG
to  ||| S:31785 E:31788 ||| TO
the  ||| S:31788 E:31792 ||| DT
manufacturer ||| S:31792 E:31804 ||| NN
's  ||| S:31804 E:31817 ||| POS
recommendations ||| S:31817 E:31832 ||| NNS
.  ||| S:31832 E:31834 ||| .
The  ||| S:31834 E:31838 ||| DT
concentration  ||| S:31838 E:31852 ||| NN
of  ||| S:31852 E:31855 ||| IN
protein  ||| S:31855 E:31863 ||| NN
was  ||| S:31863 E:31877 ||| VBD
typically  ||| S:31877 E:31887 ||| RB
4-5  ||| S:31887 E:31891 ||| CD
mg  ||| S:31891 E:31894 ||| CD
fibronectin ||| S:31894 E:31905 ||| CD
/ ||| S:31905 E:31906 ||| CD
ml  ||| S:31906 E:31909 ||| NN
of  ||| S:31909 E:31912 ||| IN
resin ||| S:31912 E:31917 ||| NN
,  ||| S:31917 E:31919 ||| ,
or  ||| S:31919 E:31922 ||| CC
8-10  ||| S:31922 E:31927 ||| CD
mg  ||| S:31927 E:31940 ||| CD
protein ||| S:31940 E:31947 ||| CD
/ ||| S:31947 E:31948 ||| CD
ml  ||| S:31948 E:31951 ||| NN
of  ||| S:31951 E:31954 ||| IN
resin  ||| S:31954 E:31960 ||| NN
for  ||| S:31960 E:31964 ||| IN
III1-C  ||| S:31964 E:31971 ||| NNP
and  ||| S:31971 E:31975 ||| CC
III  ||| S:31975 E:31979 ||| NNP
11-C ||| S:31979 E:31983 ||| NNP
.  ||| S:31983 E:31985 ||| .
Ten  ||| S:31985 E:31989 ||| CD
15-cm  ||| S:31989 E:32005 ||| CD
dishes  ||| S:32005 E:32012 ||| NNS
of  ||| S:32012 E:32015 ||| IN
RASMCs  ||| S:32015 E:32022 ||| NNP
were  ||| S:32022 E:32027 ||| VBD
washed  ||| S:32027 E:32034 ||| VBN
twice  ||| S:32034 E:32040 ||| RB
with  ||| S:32040 E:32045 ||| IN
PBS ||| S:32045 E:32048 ||| NNP
,  ||| S:32048 E:32050 ||| ,
then  ||| S:32050 E:32065 ||| RB
harvested  ||| S:32065 E:32075 ||| VBN
by  ||| S:32075 E:32078 ||| IN
detachment  ||| S:32078 E:32089 ||| NN
of  ||| S:32089 E:32092 ||| IN
cells  ||| S:32092 E:32098 ||| NNS
in  ||| S:32098 E:32101 ||| IN
PBS  ||| S:32101 E:32105 ||| NNP
+  ||| S:32105 E:32107 ||| CD
10  ||| S:32107 E:32110 ||| CD
mM  ||| S:32110 E:32113 ||| JJ
EDTA ||| S:32113 E:32117 ||| NNP
.  ||| S:32117 E:32119 ||| .
The  ||| S:32119 E:32133 ||| DT
cells  ||| S:32133 E:32139 ||| NNS
were  ||| S:32139 E:32144 ||| VBD
washed  ||| S:32144 E:32151 ||| VBN
twice  ||| S:32151 E:32157 ||| RB
more  ||| S:32157 E:32162 ||| JJR
with  ||| S:32162 E:32167 ||| IN
PBS ||| S:32167 E:32170 ||| NNP
,  ||| S:32170 E:32172 ||| ,
then  ||| S:32172 E:32177 ||| RB
resuspended  ||| S:32177 E:32199 ||| VBN
at  ||| S:32199 E:32202 ||| IN
4  ||| S:32202 E:32204 ||| CD
×  ||| S:32204 E:32206 ||| CD
10  ||| S:32206 E:32209 ||| CD
7cells ||| S:32209 E:32215 ||| CD
/ ||| S:32215 E:32216 ||| CD
ml  ||| S:32216 E:32219 ||| NN
in  ||| S:32219 E:32222 ||| IN
PBS ||| S:32222 E:32225 ||| NNP
.  ||| S:32225 E:32227 ||| .
Cells  ||| S:32227 E:32233 ||| NNS
were  ||| S:32233 E:32238 ||| VBD
labeled  ||| S:32238 E:32246 ||| VBN
with  ||| S:32246 E:32251 ||| IN
1  ||| S:32251 E:32253 ||| CD
mCi  ||| S:32253 E:32267 ||| JJ
Na  ||| S:32267 E:32270 ||| NNP
125I  ||| S:32270 E:32275 ||| NNP
and  ||| S:32275 E:32279 ||| CC
lactoperoxidase-H  ||| S:32279 E:32308 ||| JJ
2  ||| S:32308 E:32310 ||| CD
O  ||| S:32310 E:32323 ||| CD
2  ||| S:32323 E:32325 ||| CD
,  ||| S:32325 E:32327 ||| ,
as  ||| S:32327 E:32330 ||| RB
previously  ||| S:32330 E:32341 ||| RB
described  ||| S:32341 E:32351 ||| VBN
[  ||| S:32351 E:32353 ||| -LRB-
27  ||| S:32353 E:32356 ||| CD
]  ||| S:32356 E:32358 ||| -RRB-
.  ||| S:32358 E:32370 ||| .
After  ||| S:32370 E:32376 ||| IN
labeling  ||| S:32376 E:32385 ||| VBG
the  ||| S:32385 E:32389 ||| DT
cell  ||| S:32389 E:32394 ||| NN
pellet  ||| S:32394 E:32401 ||| NNS
was  ||| S:32401 E:32405 ||| VBD
washed  ||| S:32405 E:32412 ||| VBN
with  ||| S:32412 E:32417 ||| IN
ice-cold  ||| S:32417 E:32436 ||| NNP
PBS  ||| S:32436 E:32440 ||| NNP
+  ||| S:32440 E:32442 ||| NNP
NaN  ||| S:32442 E:32457 ||| NNP
3  ||| S:32457 E:32459 ||| CD
,  ||| S:32459 E:32461 ||| ,
then  ||| S:32461 E:32466 ||| RB
lysed  ||| S:32466 E:32472 ||| VBN
in  ||| S:32472 E:32475 ||| IN
2  ||| S:32475 E:32477 ||| CD
volumes  ||| S:32477 E:32485 ||| NNS
of  ||| S:32485 E:32488 ||| IN
OG  ||| S:32488 E:32501 ||| NNP
Lysis  ||| S:32501 E:32507 ||| NNP
Buffer  ||| S:32507 E:32514 ||| NNP
( ||| S:32514 E:32515 ||| -LRB-
200  ||| S:32515 E:32519 ||| CD
mM  ||| S:32519 E:32522 ||| JJ
octylglucoside ||| S:32522 E:32536 ||| NN
,  ||| S:32536 E:32538 ||| ,
1  ||| S:32538 E:32540 ||| CD
mM  ||| S:32540 E:32543 ||| JJ
CaCl  ||| S:32543 E:32559 ||| JJ
2  ||| S:32559 E:32561 ||| CD
,  ||| S:32561 E:32563 ||| ,
1  ||| S:32563 E:32565 ||| CD
mM  ||| S:32565 E:32568 ||| JJ
MgCl  ||| S:32568 E:32584 ||| JJ
2  ||| S:32584 E:32586 ||| CD
,  ||| S:32586 E:32588 ||| ,
TBS ||| S:32588 E:32591 ||| NNP
,  ||| S:32591 E:32593 ||| ,
PMSF ||| S:32593 E:32597 ||| NNP
)  ||| S:32597 E:32599 ||| -RRB-
at  ||| S:32599 E:32602 ||| IN
4°C ||| S:32602 E:32605 ||| CD
.  ||| S:32605 E:32607 ||| .
The  ||| S:32607 E:32611 ||| DT
lysate  ||| S:32611 E:32618 ||| NN
was  ||| S:32618 E:32632 ||| VBD
spun  ||| S:32632 E:32637 ||| VBN
at  ||| S:32637 E:32640 ||| IN
14,000  ||| S:32640 E:32647 ||| CD
×  ||| S:32647 E:32649 ||| CD
g  ||| S:32649 E:32651 ||| NN
for  ||| S:32651 E:32655 ||| IN
15  ||| S:32655 E:32658 ||| CD
min  ||| S:32658 E:32662 ||| NN
at  ||| S:32662 E:32665 ||| IN
4°C ||| S:32665 E:32668 ||| NNP
,  ||| S:32668 E:32670 ||| ,
and  ||| S:32670 E:32674 ||| CC
the  ||| S:32674 E:32678 ||| DT
supernatant  ||| S:32678 E:32700 ||| NN
was  ||| S:32700 E:32704 ||| VBD
used  ||| S:32704 E:32709 ||| VBN
for  ||| S:32709 E:32713 ||| IN
affinity  ||| S:32713 E:32722 ||| JJ
chromatography ||| S:32722 E:32736 ||| NN
.  ||| S:32736 E:32738 ||| .
Lysate  ||| S:32738 E:32745 ||| NNP
was  ||| S:32745 E:32749 ||| VBD
applied  ||| S:32749 E:32767 ||| VBN
to  ||| S:32767 E:32770 ||| TO
the  ||| S:32770 E:32774 ||| DT
affinity  ||| S:32774 E:32783 ||| JJ
columns  ||| S:32783 E:32791 ||| NNS
( ||| S:32791 E:32792 ||| -LRB-
0.2  ||| S:32792 E:32796 ||| CD
ml  ||| S:32796 E:32799 ||| CD
lysate  ||| S:32799 E:32806 ||| NNS
was  ||| S:32806 E:32810 ||| VBD
applied  ||| S:32810 E:32818 ||| VBN
to  ||| S:32818 E:32821 ||| TO
0.1  ||| S:32821 E:32835 ||| CD
ml  ||| S:32835 E:32838 ||| NNS
affinity  ||| S:32838 E:32847 ||| VBP
matrix  ||| S:32847 E:32854 ||| JJ
bed  ||| S:32854 E:32858 ||| NN
volume ||| S:32858 E:32864 ||| NN
) ||| S:32864 E:32865 ||| -RRB-
,  ||| S:32865 E:32867 ||| ,
flow  ||| S:32867 E:32872 ||| NN
through  ||| S:32872 E:32880 ||| IN
fractions  ||| S:32880 E:32900 ||| NNS
were  ||| S:32900 E:32905 ||| VBD
collected  ||| S:32905 E:32915 ||| VBN
and  ||| S:32915 E:32919 ||| CC
passed  ||| S:32919 E:32926 ||| VBN
over  ||| S:32926 E:32931 ||| IN
the  ||| S:32931 E:32935 ||| DT
columns  ||| S:32935 E:32943 ||| NNS
twice  ||| S:32943 E:32949 ||| RB
more ||| S:32949 E:32953 ||| RBR
.  ||| S:32953 E:32965 ||| .
Columns  ||| S:32965 E:32973 ||| NNS
were  ||| S:32973 E:32978 ||| VBD
washed  ||| S:32978 E:32985 ||| VBN
with  ||| S:32985 E:32990 ||| IN
10  ||| S:32990 E:32993 ||| CD
column  ||| S:32993 E:33000 ||| NN
volumes  ||| S:33000 E:33008 ||| NNS
of  ||| S:33008 E:33011 ||| IN
Wash  ||| S:33011 E:33016 ||| NNP
Buffer  ||| S:33016 E:33033 ||| NNP
( ||| S:33033 E:33034 ||| -LRB-
40  ||| S:33034 E:33037 ||| CD
mM  ||| S:33037 E:33040 ||| JJ
octylglucoside ||| S:33040 E:33054 ||| NN
,  ||| S:33054 E:33056 ||| ,
1  ||| S:33056 E:33058 ||| CD
mM  ||| S:33058 E:33061 ||| JJ
CaCl  ||| S:33061 E:33077 ||| JJ
2  ||| S:33077 E:33079 ||| CD
,  ||| S:33079 E:33081 ||| ,
1  ||| S:33081 E:33083 ||| CD
mM  ||| S:33083 E:33086 ||| JJ
MgCl  ||| S:33086 E:33102 ||| JJ
2  ||| S:33102 E:33104 ||| CD
,  ||| S:33104 E:33106 ||| ,
TBS ||| S:33106 E:33109 ||| NNP
) ||| S:33109 E:33110 ||| -RRB-
,  ||| S:33110 E:33112 ||| ,
before  ||| S:33112 E:33119 ||| IN
elution  ||| S:33119 E:33127 ||| NN
of  ||| S:33127 E:33130 ||| IN
bound  ||| S:33130 E:33146 ||| JJ
protein  ||| S:33146 E:33154 ||| NN
with  ||| S:33154 E:33159 ||| IN
10  ||| S:33159 E:33162 ||| CD
mM  ||| S:33162 E:33165 ||| JJ
EDTA  ||| S:33165 E:33170 ||| NN
in  ||| S:33170 E:33173 ||| IN
Wash  ||| S:33173 E:33178 ||| NNP
Buffer ||| S:33178 E:33184 ||| NNP
.  ||| S:33184 E:33186 ||| .
Samples  ||| S:33186 E:33194 ||| NNS
from  ||| S:33194 E:33199 ||| IN
the  ||| S:33199 E:33213 ||| DT
final  ||| S:33213 E:33219 ||| JJ
wash  ||| S:33219 E:33224 ||| NN
and  ||| S:33224 E:33228 ||| CC
eluted  ||| S:33228 E:33235 ||| JJ
samples  ||| S:33235 E:33243 ||| NNS
were  ||| S:33243 E:33248 ||| VBD
separated  ||| S:33248 E:33258 ||| VBN
on  ||| S:33258 E:33261 ||| IN
4-20 ||| S:33261 E:33265 ||| CD
%  ||| S:33265 E:33277 ||| NN
gradient  ||| S:33277 E:33286 ||| FW
Novex  ||| S:33286 E:33292 ||| FW
gels ||| S:33292 E:33296 ||| FW
,  ||| S:33296 E:33298 ||| ,
the  ||| S:33298 E:33302 ||| DT
gels  ||| S:33302 E:33307 ||| NN
were  ||| S:33307 E:33312 ||| VBD
dried  ||| S:33312 E:33318 ||| VBN
and  ||| S:33318 E:33322 ||| CC
exposed  ||| S:33322 E:33330 ||| VBN
to  ||| S:33330 E:33343 ||| TO
phosphorimager  ||| S:33343 E:33358 ||| VB
cassette  ||| S:33358 E:33367 ||| NN
and  ||| S:33367 E:33371 ||| CC
the  ||| S:33371 E:33375 ||| DT
radioactive  ||| S:33375 E:33387 ||| JJ
signal  ||| S:33387 E:33394 ||| NN
was  ||| S:33394 E:33408 ||| VBD
measured  ||| S:33408 E:33417 ||| VBN
with  ||| S:33417 E:33422 ||| IN
a  ||| S:33422 E:33424 ||| DT
Storm  ||| S:33424 E:33430 ||| NN
phosphorimager  ||| S:33430 E:33445 ||| NN
instrument ||| S:33445 E:33455 ||| NN
.  ||| S:33455 E:33485 ||| .
MAPK  ||| S:33485 E:33490 ||| NNP
assay  ||| S:33490 E:33496 ||| NN
and  ||| S:33496 E:33500 ||| CC
immunoblotting  ||| S:33500 E:33525 ||| JJ
Wells  ||| S:33525 E:33531 ||| NNP
of  ||| S:33531 E:33534 ||| IN
a  ||| S:33534 E:33536 ||| DT
6-well  ||| S:33536 E:33543 ||| JJ
plate  ||| S:33543 E:33549 ||| NN
were  ||| S:33549 E:33554 ||| VBD
coated  ||| S:33554 E:33561 ||| VBN
with  ||| S:33561 E:33566 ||| IN
either  ||| S:33566 E:33573 ||| DT
20  ||| S:33573 E:33586 ||| CD
μg ||| S:33586 E:33588 ||| CD
/ ||| S:33588 E:33589 ||| CD
ml  ||| S:33589 E:33592 ||| JJ
fibronectin ||| S:33592 E:33603 ||| NN
,  ||| S:33603 E:33605 ||| ,
25  ||| S:33605 E:33608 ||| CD
μM  ||| S:33608 E:33611 ||| JJ
III1-C  ||| S:33611 E:33618 ||| NN
or  ||| S:33618 E:33621 ||| CC
25  ||| S:33621 E:33624 ||| CD
μM  ||| S:33624 E:33627 ||| JJ
III  ||| S:33627 E:33631 ||| NNP
11-C  ||| S:33631 E:33636 ||| NNP
for  ||| S:33636 E:33640 ||| IN
1  ||| S:33640 E:33652 ||| CD
hr  ||| S:33652 E:33655 ||| NN
at  ||| S:33655 E:33658 ||| IN
RT ||| S:33658 E:33660 ||| NNP
.  ||| S:33660 E:33662 ||| .
Wells  ||| S:33662 E:33668 ||| NNP
were  ||| S:33668 E:33673 ||| VBD
washed  ||| S:33673 E:33680 ||| VBN
3  ||| S:33680 E:33682 ||| CD
times  ||| S:33682 E:33688 ||| NNS
with  ||| S:33688 E:33693 ||| IN
PBS  ||| S:33693 E:33697 ||| NNP
before  ||| S:33697 E:33714 ||| IN
adding  ||| S:33714 E:33721 ||| VBG
cells ||| S:33721 E:33726 ||| NNS
.  ||| S:33726 E:33728 ||| .
Growing  ||| S:33728 E:33736 ||| VBG
RASMCs  ||| S:33736 E:33743 ||| NN
were  ||| S:33743 E:33748 ||| VBD
harvested  ||| S:33748 E:33758 ||| VBN
by  ||| S:33758 E:33771 ||| IN
trypsinization  ||| S:33771 E:33786 ||| NN
and  ||| S:33786 E:33790 ||| CC
collected  ||| S:33790 E:33800 ||| VBN
into  ||| S:33800 E:33805 ||| IN
DMEM  ||| S:33805 E:33810 ||| NNP
+  ||| S:33810 E:33812 ||| CD
0.5 ||| S:33812 E:33815 ||| CD
%  ||| S:33815 E:33817 ||| NN
BSA  ||| S:33817 E:33821 ||| FW
+  ||| S:33821 E:33833 ||| FW
soybean  ||| S:33833 E:33841 ||| FW
trypsin  ||| S:33841 E:33849 ||| FW
inhibitor ||| S:33849 E:33858 ||| FW
.  ||| S:33858 E:33860 ||| .
Cells  ||| S:33860 E:33866 ||| NNS
were  ||| S:33866 E:33871 ||| VBD
washed  ||| S:33871 E:33878 ||| VBN
3  ||| S:33878 E:33880 ||| CD
times  ||| S:33880 E:33886 ||| NNS
with  ||| S:33886 E:33901 ||| IN
DMEM  ||| S:33901 E:33906 ||| NNP
+  ||| S:33906 E:33908 ||| CD
0.5 ||| S:33908 E:33911 ||| CD
%  ||| S:33911 E:33913 ||| NN
BSA ||| S:33913 E:33916 ||| NNP
,  ||| S:33916 E:33918 ||| ,
then  ||| S:33918 E:33923 ||| RB
resuspended  ||| S:33923 E:33935 ||| VBN
at  ||| S:33935 E:33938 ||| IN
3  ||| S:33938 E:33940 ||| CD
×  ||| S:33940 E:33942 ||| CD
10  ||| S:33942 E:33945 ||| CD
5cells ||| S:33945 E:33951 ||| CD
/ ||| S:33951 E:33952 ||| CD
ml  ||| S:33952 E:33955 ||| NN
in  ||| S:33955 E:33968 ||| IN
DMEM  ||| S:33968 E:33973 ||| NNP
+  ||| S:33973 E:33975 ||| CD
0.5 ||| S:33975 E:33978 ||| CD
%  ||| S:33978 E:33980 ||| NN
BSA  ||| S:33980 E:33984 ||| NN
with  ||| S:33984 E:33989 ||| IN
or  ||| S:33989 E:33992 ||| CC
without  ||| S:33992 E:34000 ||| IN
integrin  ||| S:34000 E:34009 ||| NNS
blocking  ||| S:34009 E:34018 ||| VBG
agents  ||| S:34018 E:34035 ||| NNS
or  ||| S:34035 E:34038 ||| CC
other  ||| S:34038 E:34044 ||| JJ
additions ||| S:34044 E:34053 ||| NNS
,  ||| S:34053 E:34055 ||| ,
as  ||| S:34055 E:34058 ||| RB
described  ||| S:34058 E:34068 ||| VBN
in  ||| S:34068 E:34071 ||| IN
the  ||| S:34071 E:34075 ||| DT
figure  ||| S:34075 E:34082 ||| NN
legends ||| S:34082 E:34089 ||| NN
.  ||| S:34089 E:34101 ||| .
Cells  ||| S:34101 E:34107 ||| NNS
were  ||| S:34107 E:34112 ||| VBD
either  ||| S:34112 E:34119 ||| RB
left  ||| S:34119 E:34124 ||| VBN
in  ||| S:34124 E:34127 ||| IN
suspension  ||| S:34127 E:34138 ||| NN
( ||| S:34138 E:34139 ||| -LRB-
for  ||| S:34139 E:34143 ||| IN
suspended  ||| S:34143 E:34153 ||| VBN
and  ||| S:34153 E:34167 ||| CC
PDGF  ||| S:34167 E:34172 ||| NNP
stimulated  ||| S:34172 E:34183 ||| NN
samples ||| S:34183 E:34190 ||| NNS
)  ||| S:34190 E:34192 ||| -RRB-
or  ||| S:34192 E:34195 ||| CC
were  ||| S:34195 E:34200 ||| VBD
seeded  ||| S:34200 E:34207 ||| VBN
onto  ||| S:34207 E:34212 ||| IN
the  ||| S:34212 E:34216 ||| DT
coated  ||| S:34216 E:34233 ||| JJ
wells  ||| S:34233 E:34239 ||| NNS
( ||| S:34239 E:34240 ||| -LRB-
1  ||| S:34240 E:34242 ||| CD
ml  ||| S:34242 E:34245 ||| NN
per  ||| S:34245 E:34249 ||| IN
well ||| S:34249 E:34253 ||| RB
)  ||| S:34253 E:34255 ||| -RRB-
and  ||| S:34255 E:34259 ||| CC
allowed  ||| S:34259 E:34267 ||| VBN
to  ||| S:34267 E:34270 ||| TO
adhere  ||| S:34270 E:34277 ||| VB
for  ||| S:34277 E:34281 ||| IN
30  ||| S:34281 E:34284 ||| CD
min  ||| S:34284 E:34288 ||| NN
at  ||| S:34288 E:34301 ||| IN
37°C ||| S:34301 E:34305 ||| NNP
,  ||| S:34305 E:34307 ||| ,
or  ||| S:34307 E:34310 ||| CC
for  ||| S:34310 E:34314 ||| IN
the  ||| S:34314 E:34318 ||| DT
times  ||| S:34318 E:34324 ||| NNS
indicated  ||| S:34324 E:34334 ||| VBD
in  ||| S:34334 E:34337 ||| IN
the  ||| S:34337 E:34341 ||| DT
figure  ||| S:34341 E:34348 ||| NN
legend  ||| S:34348 E:34365 ||| NN
( ||| S:34365 E:34366 ||| -LRB-
Fig.  ||| S:34366 E:34371 ||| CD
5 ||| S:34371 E:34372 ||| CD
) ||| S:34372 E:34373 ||| -RRB-
.  ||| S:34373 E:34375 ||| .
The  ||| S:34375 E:34379 ||| DT
cells  ||| S:34379 E:34385 ||| NNS
stimulated  ||| S:34385 E:34396 ||| VBN
with  ||| S:34396 E:34401 ||| IN
PDGF  ||| S:34401 E:34406 ||| NNP
( ||| S:34406 E:34407 ||| -LRB-
2  ||| S:34407 E:34409 ||| LS
ng ||| S:34409 E:34411 ||| FW
/ ||| S:34411 E:34412 ||| FW
ml  ||| S:34412 E:34425 ||| FW
PDGF-BB ||| S:34425 E:34432 ||| FW
)  ||| S:34432 E:34434 ||| -RRB-
received  ||| S:34434 E:34443 ||| VBD
the  ||| S:34443 E:34447 ||| DT
growth  ||| S:34447 E:34454 ||| NN
factor  ||| S:34454 E:34461 ||| NN
10  ||| S:34461 E:34464 ||| CD
min  ||| S:34464 E:34468 ||| NN
before  ||| S:34468 E:34485 ||| IN
collecting  ||| S:34485 E:34496 ||| VBG
the  ||| S:34496 E:34500 ||| DT
cells  ||| S:34500 E:34506 ||| NNS
for  ||| S:34506 E:34510 ||| IN
lysis ||| S:34510 E:34515 ||| NN
,  ||| S:34515 E:34517 ||| ,
while  ||| S:34517 E:34523 ||| IN
the  ||| S:34523 E:34527 ||| DT
other  ||| S:34527 E:34533 ||| JJ
samples  ||| S:34533 E:34551 ||| NNS
received  ||| S:34551 E:34560 ||| VBD
no  ||| S:34560 E:34563 ||| DT
growth  ||| S:34563 E:34570 ||| NN
factor  ||| S:34570 E:34577 ||| NN
or  ||| S:34577 E:34580 ||| CC
serum ||| S:34580 E:34585 ||| NN
.  ||| S:34585 E:34587 ||| .
After  ||| S:34587 E:34593 ||| IN
the  ||| S:34593 E:34597 ||| DT
adhesion  ||| S:34597 E:34616 ||| JJ
period  ||| S:34616 E:34623 ||| NN
plates  ||| S:34623 E:34630 ||| NNS
were  ||| S:34630 E:34635 ||| VBD
placed  ||| S:34635 E:34642 ||| VBN
on  ||| S:34642 E:34645 ||| IN
ice ||| S:34645 E:34648 ||| NN
,  ||| S:34648 E:34650 ||| ,
unattached  ||| S:34650 E:34661 ||| JJ
cells  ||| S:34661 E:34667 ||| NNS
were  ||| S:34667 E:34682 ||| VBD
collected  ||| S:34682 E:34692 ||| VBN
and  ||| S:34692 E:34696 ||| CC
spun  ||| S:34696 E:34701 ||| VBD
down ||| S:34701 E:34705 ||| RB
,  ||| S:34705 E:34707 ||| ,
while  ||| S:34707 E:34713 ||| IN
cell  ||| S:34713 E:34718 ||| NN
monolayers  ||| S:34718 E:34729 ||| NNS
were  ||| S:34729 E:34744 ||| VBD
washed  ||| S:34744 E:34751 ||| VBN
once  ||| S:34751 E:34756 ||| RB
with  ||| S:34756 E:34761 ||| IN
ice  ||| S:34761 E:34765 ||| NN
cold  ||| S:34765 E:34770 ||| JJ
PBS  ||| S:34770 E:34774 ||| NNP
then  ||| S:34774 E:34779 ||| RB
lysed  ||| S:34779 E:34785 ||| VBN
with  ||| S:34785 E:34790 ||| IN
SDS-PAGE  ||| S:34790 E:34809 ||| JJ
sample  ||| S:34809 E:34816 ||| NN
buffer  ||| S:34816 E:34823 ||| NN
( ||| S:34823 E:34824 ||| -LRB-
100  ||| S:34824 E:34828 ||| CD
μl ||| S:34828 E:34830 ||| NNS
/ ||| S:34830 E:34831 ||| VBP
well ||| S:34831 E:34835 ||| RB
) ||| S:34835 E:34836 ||| -RRB-
.  ||| S:34836 E:34838 ||| .
Centrifuged  ||| S:34838 E:34850 ||| JJ
pellets  ||| S:34850 E:34858 ||| NN
of  ||| S:34858 E:34871 ||| IN
unattached  ||| S:34871 E:34882 ||| JJ
cells  ||| S:34882 E:34888 ||| NNS
were  ||| S:34888 E:34893 ||| VBD
combined  ||| S:34893 E:34902 ||| VBN
with  ||| S:34902 E:34907 ||| IN
the  ||| S:34907 E:34911 ||| DT
appropriate  ||| S:34911 E:34933 ||| JJ
monolayer  ||| S:34933 E:34943 ||| JJ
lysate  ||| S:34943 E:34950 ||| JJ
sample  ||| S:34950 E:34957 ||| NN
and  ||| S:34957 E:34961 ||| CC
the  ||| S:34961 E:34965 ||| DT
samples  ||| S:34965 E:34973 ||| NNS
were  ||| S:34973 E:34978 ||| VBD
heated  ||| S:34978 E:34985 ||| VBN
to  ||| S:34985 E:34998 ||| TO
100°C  ||| S:34998 E:35004 ||| CD
for  ||| S:35004 E:35008 ||| IN
5  ||| S:35008 E:35010 ||| CD
min ||| S:35010 E:35013 ||| NNS
.  ||| S:35013 E:35015 ||| .
Samples  ||| S:35015 E:35023 ||| NNS
were  ||| S:35023 E:35028 ||| VBD
separated  ||| S:35028 E:35038 ||| VBN
on  ||| S:35038 E:35041 ||| IN
4-20 ||| S:35041 E:35045 ||| CD
%  ||| S:35045 E:35047 ||| NN
gradient  ||| S:35047 E:35066 ||| FW
Novex  ||| S:35066 E:35072 ||| FW
gels ||| S:35072 E:35076 ||| FW
,  ||| S:35076 E:35078 ||| ,
transferred  ||| S:35078 E:35090 ||| VBN
to  ||| S:35090 E:35093 ||| TO
Immobilon  ||| S:35093 E:35103 ||| NNP
P  ||| S:35103 E:35105 ||| NN
membranes ||| S:35105 E:35114 ||| NN
,  ||| S:35114 E:35116 ||| ,
blocked  ||| S:35116 E:35134 ||| VBN
with  ||| S:35134 E:35139 ||| IN
5 ||| S:35139 E:35140 ||| CD
%  ||| S:35140 E:35142 ||| NN
nonfat  ||| S:35142 E:35149 ||| VBZ
dry  ||| S:35149 E:35153 ||| JJ
milk  ||| S:35153 E:35158 ||| NN
in  ||| S:35158 E:35161 ||| IN
TBS-Tween ||| S:35161 E:35170 ||| NNP
,  ||| S:35170 E:35172 ||| ,
then  ||| S:35172 E:35177 ||| RB
probed  ||| S:35177 E:35184 ||| VBN
with  ||| S:35184 E:35199 ||| IN
anti-phospho-p44 ||| S:35199 E:35215 ||| CD
/ ||| S:35215 E:35216 ||| CD
42  ||| S:35216 E:35219 ||| CD
MAPK  ||| S:35219 E:35224 ||| JJ
antibody  ||| S:35224 E:35233 ||| NN
according  ||| S:35233 E:35243 ||| VBG
to  ||| S:35243 E:35246 ||| TO
the  ||| S:35246 E:35260 ||| DT
manufacturer ||| S:35260 E:35272 ||| NN
's  ||| S:35272 E:35275 ||| POS
recommendations ||| S:35275 E:35290 ||| NNS
.  ||| S:35290 E:35292 ||| .
Blots  ||| S:35292 E:35298 ||| NNP
were  ||| S:35298 E:35303 ||| VBD
then  ||| S:35303 E:35308 ||| RB
stripped  ||| S:35308 E:35327 ||| VBN
in  ||| S:35327 E:35330 ||| IN
Stripping  ||| S:35330 E:35340 ||| NNP
Buffer  ||| S:35340 E:35347 ||| NNP
( ||| S:35347 E:35348 ||| -LRB-
2 ||| S:35348 E:35349 ||| CD
%  ||| S:35349 E:35351 ||| NN
SDS ||| S:35351 E:35354 ||| NNP
,  ||| S:35354 E:35356 ||| ,
100  ||| S:35356 E:35360 ||| CD
mM  ||| S:35360 E:35363 ||| JJ
β-mercaptoethanol ||| S:35363 E:35380 ||| NN
,  ||| S:35380 E:35392 ||| ,
62.5  ||| S:35392 E:35397 ||| CD
mM  ||| S:35397 E:35400 ||| JJ
Tris ||| S:35400 E:35404 ||| NNP
,  ||| S:35404 E:35406 ||| ,
pH  ||| S:35406 E:35409 ||| JJ
6.7 ||| S:35409 E:35412 ||| CD
)  ||| S:35412 E:35414 ||| -RRB-
at  ||| S:35414 E:35417 ||| IN
50°C  ||| S:35417 E:35422 ||| CD
for  ||| S:35422 E:35426 ||| IN
30  ||| S:35426 E:35429 ||| CD
min ||| S:35429 E:35432 ||| NN
,  ||| S:35432 E:35434 ||| ,
washed  ||| S:35434 E:35441 ||| VBD
4  ||| S:35441 E:35443 ||| CD
times  ||| S:35443 E:35459 ||| NNS
with  ||| S:35459 E:35464 ||| IN
TBS-Tween ||| S:35464 E:35473 ||| NNP
,  ||| S:35473 E:35475 ||| ,
blocked  ||| S:35475 E:35483 ||| VBN
with  ||| S:35483 E:35488 ||| IN
5 ||| S:35488 E:35489 ||| CD
%  ||| S:35489 E:35491 ||| NN
nonfat  ||| S:35491 E:35498 ||| VBZ
dry  ||| S:35498 E:35502 ||| JJ
milk  ||| S:35502 E:35507 ||| NN
in  ||| S:35507 E:35520 ||| IN
TBS-Tween ||| S:35520 E:35529 ||| NNP
,  ||| S:35529 E:35531 ||| ,
then  ||| S:35531 E:35536 ||| RB
probed  ||| S:35536 E:35543 ||| VBN
with  ||| S:35543 E:35548 ||| IN
anti-p44 ||| S:35548 E:35556 ||| CD
/ ||| S:35556 E:35557 ||| CD
42  ||| S:35557 E:35560 ||| CD
ERK  ||| S:35560 E:35564 ||| JJ
antibody  ||| S:35564 E:35583 ||| NN
according  ||| S:35583 E:35593 ||| VBG
to  ||| S:35593 E:35596 ||| TO
the  ||| S:35596 E:35600 ||| DT
manufacturer ||| S:35600 E:35612 ||| NN
's  ||| S:35612 E:35615 ||| POS
recommendations ||| S:35615 E:35630 ||| NNS
.  ||| S:35630 E:35632 ||| .
All  ||| S:35632 E:35646 ||| DT
blots  ||| S:35646 E:35652 ||| NN
were  ||| S:35652 E:35657 ||| VBD
developed  ||| S:35657 E:35667 ||| VBN
with  ||| S:35667 E:35672 ||| IN
the  ||| S:35672 E:35676 ||| DT
ECL  ||| S:35676 E:35680 ||| NNP
plus  ||| S:35680 E:35685 ||| CC
reagent  ||| S:35685 E:35693 ||| NNS
and  ||| S:35693 E:35707 ||| CC
exposed  ||| S:35707 E:35715 ||| VBN
to  ||| S:35715 E:35718 ||| TO
Hyperfilm ||| S:35718 E:35727 ||| NNP
.  ||| S:35727 E:35729 ||| .
For  ||| S:35729 E:35733 ||| IN
both  ||| S:35733 E:35738 ||| DT
antibodies  ||| S:35738 E:35749 ||| NNS
the  ||| S:35749 E:35753 ||| DT
typical  ||| S:35753 E:35771 ||| JJ
exposure  ||| S:35771 E:35780 ||| NN
times  ||| S:35780 E:35786 ||| NNS
were  ||| S:35786 E:35791 ||| VBD
under  ||| S:35791 E:35797 ||| IN
5  ||| S:35797 E:35799 ||| CD
min ||| S:35799 E:35802 ||| NNS
.  ||| S:35802 E:35832 ||| .
Heparitinase  ||| S:35832 E:35845 ||| JJ
treatment  ||| S:35845 E:35855 ||| NN
of  ||| S:35855 E:35858 ||| IN
cells  ||| S:35858 E:35864 ||| NNS
and  ||| S:35864 E:35868 ||| CC
lysates  ||| S:35868 E:35886 ||| CD
6  ||| S:35886 E:35888 ||| CD
well  ||| S:35888 E:35893 ||| RB
plates  ||| S:35893 E:35900 ||| RB
were  ||| S:35900 E:35905 ||| VBD
coated  ||| S:35905 E:35912 ||| VBN
with  ||| S:35912 E:35917 ||| IN
either  ||| S:35917 E:35924 ||| DT
fibronectin ||| S:35924 E:35935 ||| NN
,  ||| S:35935 E:35947 ||| ,
III1-C  ||| S:35947 E:35954 ||| NNP
or  ||| S:35954 E:35957 ||| CC
III  ||| S:35957 E:35961 ||| NNP
11-C  ||| S:35961 E:35966 ||| NNP
as  ||| S:35966 E:35969 ||| RB
described  ||| S:35969 E:35979 ||| VBN
above ||| S:35979 E:35984 ||| IN
.  ||| S:35984 E:35986 ||| .
Growing  ||| S:35986 E:35994 ||| VBG
RASMCs  ||| S:35994 E:36011 ||| NN
were  ||| S:36011 E:36016 ||| VBD
harvested  ||| S:36016 E:36026 ||| VBN
by  ||| S:36026 E:36029 ||| IN
trypsinization  ||| S:36029 E:36044 ||| NN
and  ||| S:36044 E:36048 ||| CC
washed  ||| S:36048 E:36055 ||| VBN
in  ||| S:36055 E:36058 ||| IN
DMEM  ||| S:36058 E:36063 ||| NNP
+  ||| S:36063 E:36065 ||| NNP
BSA  ||| S:36065 E:36079 ||| NNP
as  ||| S:36079 E:36082 ||| RB
described  ||| S:36082 E:36092 ||| VBN
above ||| S:36092 E:36097 ||| IN
.  ||| S:36097 E:36099 ||| .
For  ||| S:36099 E:36103 ||| IN
GAGase  ||| S:36103 E:36110 ||| JJ
treatment  ||| S:36110 E:36120 ||| NN
of  ||| S:36120 E:36123 ||| IN
intact  ||| S:36123 E:36130 ||| JJ
cells ||| S:36130 E:36135 ||| NNS
,  ||| S:36135 E:36147 ||| ,
the  ||| S:36147 E:36151 ||| DT
cells  ||| S:36151 E:36157 ||| NNS
remained  ||| S:36157 E:36166 ||| VBD
in  ||| S:36166 E:36169 ||| IN
suspension  ||| S:36169 E:36180 ||| NN
and  ||| S:36180 E:36184 ||| CC
received  ||| S:36184 E:36193 ||| VBD
either  ||| S:36193 E:36200 ||| RB
no  ||| S:36200 E:36213 ||| DT
enzyme  ||| S:36213 E:36220 ||| NN
or  ||| S:36220 E:36223 ||| CC
0.1  ||| S:36223 E:36227 ||| CD
u ||| S:36227 E:36228 ||| CD
/ ||| S:36228 E:36229 ||| CD
ml  ||| S:36229 E:36232 ||| CD
heparitinase  ||| S:36232 E:36245 ||| NNS
or  ||| S:36245 E:36248 ||| CC
0.1  ||| S:36248 E:36252 ||| CD
u ||| S:36252 E:36253 ||| FW
/ ||| S:36253 E:36254 ||| FW
ml  ||| S:36254 E:36267 ||| FW
chondroitinase  ||| S:36267 E:36282 ||| FW
ABC  ||| S:36282 E:36286 ||| NNP
for  ||| S:36286 E:36290 ||| IN
1  ||| S:36290 E:36292 ||| CD
hr  ||| S:36292 E:36295 ||| NN
at  ||| S:36295 E:36298 ||| IN
37°C  ||| S:36298 E:36303 ||| CD
with  ||| S:36303 E:36308 ||| IN
constant  ||| S:36308 E:36317 ||| JJ
gentle  ||| S:36317 E:36334 ||| JJ
rotation ||| S:36334 E:36342 ||| NN
.  ||| S:36342 E:36344 ||| .
Cells  ||| S:36344 E:36350 ||| NNS
were  ||| S:36350 E:36355 ||| VBD
then  ||| S:36355 E:36360 ||| RB
plated  ||| S:36360 E:36367 ||| VBN
onto  ||| S:36367 E:36372 ||| IN
precoated  ||| S:36372 E:36382 ||| JJ
dishes  ||| S:36382 E:36399 ||| NNS
and  ||| S:36399 E:36403 ||| CC
processed  ||| S:36403 E:36413 ||| VBN
for  ||| S:36413 E:36417 ||| IN
immunoblotting  ||| S:36417 E:36432 ||| NN
with  ||| S:36432 E:36437 ||| IN
anti-phospho-p44 ||| S:36437 E:36453 ||| CD
/ ||| S:36453 E:36454 ||| CD
42  ||| S:36454 E:36467 ||| CD
MAPK  ||| S:36467 E:36472 ||| JJ
antibody  ||| S:36472 E:36481 ||| NN
as  ||| S:36481 E:36484 ||| IN
described  ||| S:36484 E:36494 ||| VBN
above ||| S:36494 E:36499 ||| IN
.  ||| S:36499 E:36501 ||| .
Alternatively ||| S:36501 E:36514 ||| RB
,  ||| S:36514 E:36516 ||| ,
after  ||| S:36516 E:36532 ||| IN
heparitinase  ||| S:36532 E:36545 ||| JJ
digestion  ||| S:36545 E:36555 ||| JJ
cells  ||| S:36555 E:36561 ||| NNS
were  ||| S:36561 E:36566 ||| VBD
lysed  ||| S:36566 E:36572 ||| VBN
directly  ||| S:36572 E:36581 ||| RB
in  ||| S:36581 E:36584 ||| IN
SDS  ||| S:36584 E:36598 ||| NNP
sample  ||| S:36598 E:36605 ||| NN
buffer  ||| S:36605 E:36612 ||| NN
and  ||| S:36612 E:36616 ||| CC
analyzed  ||| S:36616 E:36625 ||| VBD
by  ||| S:36625 E:36628 ||| IN
immunoblotting  ||| S:36628 E:36643 ||| NN
with  ||| S:36643 E:36648 ||| IN
the  ||| S:36648 E:36662 ||| DT
3G10  ||| S:36662 E:36667 ||| NNP
mAb  ||| S:36667 E:36671 ||| NNP
( ||| S:36671 E:36672 ||| -LRB-
essentially  ||| S:36672 E:36684 ||| RB
as  ||| S:36684 E:36687 ||| RB
described  ||| S:36687 E:36697 ||| VBN
above  ||| S:36697 E:36703 ||| IN
for  ||| S:36703 E:36717 ||| IN
anti-phospho-p44 ||| S:36717 E:36733 ||| CD
/ ||| S:36733 E:36734 ||| CD
42  ||| S:36734 E:36737 ||| CD
MAPK  ||| S:36737 E:36742 ||| CD
immunoblotting ||| S:36742 E:36756 ||| CD
) ||| S:36756 E:36757 ||| -RRB-
.  ||| S:36757 E:36769 ||| .
For  ||| S:36769 E:36773 ||| IN
GAGase  ||| S:36773 E:36780 ||| JJ
treatment  ||| S:36780 E:36790 ||| NN
of  ||| S:36790 E:36793 ||| IN
cell  ||| S:36793 E:36798 ||| NN
lysates ||| S:36798 E:36805 ||| NN
,  ||| S:36805 E:36807 ||| ,
cells  ||| S:36807 E:36813 ||| NNS
were  ||| S:36813 E:36818 ||| VBD
lysed  ||| S:36818 E:36834 ||| VBN
on  ||| S:36834 E:36837 ||| IN
ice  ||| S:36837 E:36841 ||| NN
in  ||| S:36841 E:36844 ||| IN
NP40  ||| S:36844 E:36849 ||| NNP
Lysis  ||| S:36849 E:36855 ||| NNP
buffer  ||| S:36855 E:36862 ||| NN
( ||| S:36862 E:36863 ||| -LRB-
1 ||| S:36863 E:36864 ||| CD
%  ||| S:36864 E:36866 ||| NN
Nonidet  ||| S:36866 E:36874 ||| NNP
P  ||| S:36874 E:36876 ||| NNP
40 ||| S:36876 E:36878 ||| CD
,  ||| S:36878 E:36880 ||| ,
150  ||| S:36880 E:36884 ||| CD
mM  ||| S:36884 E:36897 ||| JJ
NaCl ||| S:36897 E:36901 ||| NN
,  ||| S:36901 E:36903 ||| ,
50  ||| S:36903 E:36906 ||| CD
mM  ||| S:36906 E:36909 ||| JJ
Tris ||| S:36909 E:36913 ||| NNP
,  ||| S:36913 E:36915 ||| ,
pH  ||| S:36915 E:36918 ||| NNP
8.0 ||| S:36918 E:36921 ||| NNP
)  ||| S:36921 E:36923 ||| -RRB-
plus  ||| S:36923 E:36928 ||| CC
protease  ||| S:36928 E:36937 ||| JJ
inhibitors  ||| S:36937 E:36958 ||| NNS
( ||| S:36958 E:36959 ||| -LRB-
Complete™  ||| S:36959 E:36969 ||| FW
protease  ||| S:36969 E:36978 ||| FW
inhibitor  ||| S:36978 E:36988 ||| FW
cocktail ||| S:36988 E:36996 ||| FW
)  ||| S:36996 E:36998 ||| -RRB-
at  ||| S:36998 E:37001 ||| IN
2  ||| S:37001 E:37003 ||| CD
×  ||| S:37003 E:37005 ||| CD
10  ||| S:37005 E:37018 ||| CD
6cells ||| S:37018 E:37024 ||| CD
/ ||| S:37024 E:37025 ||| CD
ml ||| S:37025 E:37027 ||| NNS
.  ||| S:37027 E:37029 ||| .
Insoluble  ||| S:37029 E:37039 ||| JJ
material  ||| S:37039 E:37048 ||| NN
was  ||| S:37048 E:37052 ||| VBD
removed  ||| S:37052 E:37060 ||| VBN
by  ||| S:37060 E:37073 ||| IN
centrifugation  ||| S:37073 E:37088 ||| NN
at  ||| S:37088 E:37091 ||| IN
14,000  ||| S:37091 E:37098 ||| CD
×  ||| S:37098 E:37100 ||| CD
g  ||| S:37100 E:37102 ||| NN
for  ||| S:37102 E:37106 ||| IN
15  ||| S:37106 E:37109 ||| CD
min  ||| S:37109 E:37113 ||| NN
at  ||| S:37113 E:37116 ||| IN
4°C ||| S:37116 E:37119 ||| CD
.  ||| S:37119 E:37121 ||| .
Lysate  ||| S:37121 E:37138 ||| NNP
was  ||| S:37138 E:37142 ||| VBD
prepared  ||| S:37142 E:37151 ||| VBN
for  ||| S:37151 E:37155 ||| IN
heparitinase  ||| S:37155 E:37168 ||| JJ
treatment  ||| S:37168 E:37178 ||| NN
by  ||| S:37178 E:37181 ||| IN
adding  ||| S:37181 E:37188 ||| VBG
CaCl  ||| S:37188 E:37204 ||| JJ
2  ||| S:37204 E:37206 ||| CD
to  ||| S:37206 E:37209 ||| TO
10  ||| S:37209 E:37212 ||| CD
μM  ||| S:37212 E:37215 ||| JJ
final  ||| S:37215 E:37221 ||| JJ
concentration ||| S:37221 E:37234 ||| NN
.  ||| S:37234 E:37246 ||| .
Heparitinase  ||| S:37246 E:37259 ||| NNP
was  ||| S:37259 E:37263 ||| VBD
added  ||| S:37263 E:37269 ||| VBN
to  ||| S:37269 E:37272 ||| TO
0.1  ||| S:37272 E:37276 ||| CD
u ||| S:37276 E:37277 ||| CD
/ ||| S:37277 E:37278 ||| CD
ml  ||| S:37278 E:37281 ||| CD
final  ||| S:37281 E:37287 ||| JJ
concentration  ||| S:37287 E:37311 ||| NN
and  ||| S:37311 E:37315 ||| CC
the  ||| S:37315 E:37319 ||| DT
lysate  ||| S:37319 E:37326 ||| NN
was  ||| S:37326 E:37330 ||| VBD
incubated  ||| S:37330 E:37340 ||| VBN
at  ||| S:37340 E:37343 ||| IN
37°C  ||| S:37343 E:37348 ||| CD
for  ||| S:37348 E:37352 ||| IN
1  ||| S:37352 E:37354 ||| CD
hr ||| S:37354 E:37356 ||| NNS
.  ||| S:37356 E:37358 ||| .
The  ||| S:37358 E:37362 ||| DT
lysate  ||| S:37362 E:37379 ||| NN
was  ||| S:37379 E:37383 ||| VBD
then  ||| S:37383 E:37388 ||| RB
applied  ||| S:37388 E:37396 ||| VBN
to  ||| S:37396 E:37399 ||| TO
affinity  ||| S:37399 E:37408 ||| VB
chromatography  ||| S:37408 E:37423 ||| JJ
columns  ||| S:37423 E:37431 ||| NNS
as  ||| S:37431 E:37444 ||| RB
described  ||| S:37444 E:37454 ||| VBD
below.  ||| S:37454 E:37489 ||| CD
35SO  ||| S:37489 E:37494 ||| CD
4labeling  ||| S:37494 E:37504 ||| CD
and  ||| S:37504 E:37508 ||| CC
affinity  ||| S:37508 E:37517 ||| JJ
chromatography  ||| S:37517 E:37542 ||| NNS
Growing  ||| S:37542 E:37550 ||| VBG
RASMCs  ||| S:37550 E:37557 ||| JJ
labeled  ||| S:37557 E:37565 ||| NN
for  ||| S:37565 E:37569 ||| IN
20  ||| S:37569 E:37572 ||| CD
hr  ||| S:37572 E:37575 ||| NN
at  ||| S:37575 E:37578 ||| IN
37°C  ||| S:37578 E:37583 ||| CD
with  ||| S:37583 E:37588 ||| IN
200  ||| S:37588 E:37602 ||| CD
μCi ||| S:37602 E:37605 ||| JJ
/ ||| S:37605 E:37606 ||| CD
ml  ||| S:37606 E:37609 ||| CD
35S04  ||| S:37609 E:37615 ||| CD
in  ||| S:37615 E:37618 ||| IN
DMEM  ||| S:37618 E:37623 ||| NNP
+  ||| S:37623 E:37625 ||| CD
10 ||| S:37625 E:37627 ||| CD
%  ||| S:37627 E:37629 ||| NN
dialyzed  ||| S:37629 E:37638 ||| VBD
FCS  ||| S:37638 E:37642 ||| NNP
+  ||| S:37642 E:37644 ||| NNP
Pen-Strep ||| S:37644 E:37653 ||| NNP
.  ||| S:37653 E:37665 ||| .
Cells  ||| S:37665 E:37671 ||| NNS
were  ||| S:37671 E:37676 ||| VBD
placed  ||| S:37676 E:37683 ||| VBN
on  ||| S:37683 E:37686 ||| IN
ice ||| S:37686 E:37689 ||| NN
,  ||| S:37689 E:37691 ||| ,
washed  ||| S:37691 E:37698 ||| VBD
once  ||| S:37698 E:37703 ||| RB
with  ||| S:37703 E:37708 ||| IN
PBS ||| S:37708 E:37711 ||| NNP
,  ||| S:37711 E:37713 ||| ,
then  ||| S:37713 E:37728 ||| RB
lysed  ||| S:37728 E:37734 ||| VBN
in  ||| S:37734 E:37737 ||| IN
NP40  ||| S:37737 E:37742 ||| NNP
Lysis  ||| S:37742 E:37748 ||| NNP
buffer  ||| S:37748 E:37755 ||| NN
as  ||| S:37755 E:37758 ||| IN
described  ||| S:37758 E:37768 ||| VBN
above ||| S:37768 E:37773 ||| IN
.  ||| S:37773 E:37775 ||| .
III1-C  ||| S:37775 E:37782 ||| NNP
and  ||| S:37782 E:37796 ||| CC
III  ||| S:37796 E:37800 ||| NNP
11-C  ||| S:37800 E:37805 ||| NNP
columns  ||| S:37805 E:37813 ||| NNS
were  ||| S:37813 E:37818 ||| VBD
produced  ||| S:37818 E:37827 ||| VBN
as  ||| S:37827 E:37830 ||| RB
described  ||| S:37830 E:37840 ||| VBN
above ||| S:37840 E:37845 ||| IN
.  ||| S:37845 E:37847 ||| .
Cell  ||| S:37847 E:37862 ||| NN
lysates  ||| S:37862 E:37870 ||| NNS
were  ||| S:37870 E:37875 ||| VBD
applied  ||| S:37875 E:37883 ||| VBN
to  ||| S:37883 E:37886 ||| TO
III1-C  ||| S:37886 E:37893 ||| CD
or  ||| S:37893 E:37896 ||| CC
III  ||| S:37896 E:37900 ||| NNP
11-C  ||| S:37900 E:37905 ||| NNP
columns  ||| S:37905 E:37923 ||| NNS
( ||| S:37923 E:37924 ||| -LRB-
typically  ||| S:37924 E:37934 ||| RB
500  ||| S:37934 E:37938 ||| CD
μl  ||| S:37938 E:37941 ||| CD
lysate  ||| S:37941 E:37948 ||| NNS
was  ||| S:37948 E:37952 ||| VBD
applied  ||| S:37952 E:37960 ||| VBN
to  ||| S:37960 E:37963 ||| TO
250  ||| S:37963 E:37967 ||| CD
μl  ||| S:37967 E:37970 ||| NNS
affinity  ||| S:37970 E:37989 ||| VBP
matrix  ||| S:37989 E:37996 ||| JJ
bed  ||| S:37996 E:38000 ||| NN
volume ||| S:38000 E:38006 ||| NN
) ||| S:38006 E:38007 ||| -RRB-
,  ||| S:38007 E:38009 ||| ,
flow  ||| S:38009 E:38014 ||| NN
through  ||| S:38014 E:38022 ||| IN
fractions  ||| S:38022 E:38032 ||| NNS
were  ||| S:38032 E:38037 ||| VBD
collected  ||| S:38037 E:38057 ||| VBN
and  ||| S:38057 E:38061 ||| CC
passed  ||| S:38061 E:38068 ||| VBN
over  ||| S:38068 E:38073 ||| IN
the  ||| S:38073 E:38077 ||| DT
columns  ||| S:38077 E:38085 ||| NNS
twice  ||| S:38085 E:38091 ||| RB
more ||| S:38091 E:38095 ||| RBR
.  ||| S:38095 E:38097 ||| .
The  ||| S:38097 E:38101 ||| DT
final  ||| S:38101 E:38107 ||| JJ
flow  ||| S:38107 E:38122 ||| NN
through  ||| S:38122 E:38130 ||| IN
fractions  ||| S:38130 E:38140 ||| NNS
were  ||| S:38140 E:38145 ||| VBD
then  ||| S:38145 E:38150 ||| RB
collected ||| S:38150 E:38159 ||| VBN
.  ||| S:38159 E:38161 ||| .
Columns  ||| S:38161 E:38169 ||| NNS
were  ||| S:38169 E:38184 ||| VBD
washed  ||| S:38184 E:38191 ||| VBN
with  ||| S:38191 E:38196 ||| IN
10  ||| S:38196 E:38199 ||| CD
column  ||| S:38199 E:38206 ||| NN
volumes  ||| S:38206 E:38214 ||| NNS
of  ||| S:38214 E:38217 ||| IN
NP40  ||| S:38217 E:38222 ||| NNP
Lysis  ||| S:38222 E:38228 ||| NNP
buffer ||| S:38228 E:38234 ||| NN
,  ||| S:38234 E:38236 ||| ,
then  ||| S:38236 E:38251 ||| RB
bound  ||| S:38251 E:38257 ||| VBN
material  ||| S:38257 E:38266 ||| NN
was  ||| S:38266 E:38270 ||| VBD
removed  ||| S:38270 E:38278 ||| VBN
by  ||| S:38278 E:38281 ||| IN
boiling  ||| S:38281 E:38289 ||| VBG
the  ||| S:38289 E:38293 ||| DT
Sepharose  ||| S:38293 E:38303 ||| JJ
beads  ||| S:38303 E:38319 ||| NN
in  ||| S:38319 E:38322 ||| IN
2  ||| S:38322 E:38324 ||| CD
column  ||| S:38324 E:38331 ||| NN
volumes  ||| S:38331 E:38339 ||| NNS
of  ||| S:38339 E:38342 ||| IN
SDS  ||| S:38342 E:38346 ||| NNP
sample  ||| S:38346 E:38353 ||| NN
buffer ||| S:38353 E:38359 ||| NN
.  ||| S:38359 E:38361 ||| .
Alternatively ||| S:38361 E:38374 ||| RB
,  ||| S:38374 E:38386 ||| ,
the  ||| S:38386 E:38390 ||| DT
bound  ||| S:38390 E:38396 ||| JJ
material  ||| S:38396 E:38405 ||| NN
was  ||| S:38405 E:38409 ||| VBD
first  ||| S:38409 E:38415 ||| JJ
eluted  ||| S:38415 E:38422 ||| NN
with  ||| S:38422 E:38427 ||| IN
2  ||| S:38427 E:38429 ||| CD
column  ||| S:38429 E:38436 ||| NN
volumes  ||| S:38436 E:38454 ||| NNS
of  ||| S:38454 E:38457 ||| IN
8  ||| S:38457 E:38459 ||| CD
M  ||| S:38459 E:38461 ||| NNP
urea  ||| S:38461 E:38466 ||| FW
buffer  ||| S:38466 E:38473 ||| FW
( ||| S:38473 E:38474 ||| -LRB-
8  ||| S:38474 E:38476 ||| CD
M  ||| S:38476 E:38478 ||| NNP
urea ||| S:38478 E:38482 ||| NN
,  ||| S:38482 E:38484 ||| ,
0.1  ||| S:38484 E:38488 ||| CD
M  ||| S:38488 E:38490 ||| NNP
NaH  ||| S:38490 E:38505 ||| NNP
2  ||| S:38505 E:38507 ||| CD
PO  ||| S:38507 E:38521 ||| CD
4  ||| S:38521 E:38523 ||| CD
,  ||| S:38523 E:38525 ||| ,
10  ||| S:38525 E:38528 ||| CD
mM  ||| S:38528 E:38531 ||| JJ
Tris ||| S:38531 E:38535 ||| NNP
,  ||| S:38535 E:38537 ||| ,
pH  ||| S:38537 E:38540 ||| NNP
8.0 ||| S:38540 E:38543 ||| NNP
) ||| S:38543 E:38544 ||| -RRB-
,  ||| S:38544 E:38546 ||| ,
followed  ||| S:38546 E:38555 ||| VBN
by  ||| S:38555 E:38568 ||| IN
washing  ||| S:38568 E:38576 ||| VBG
with  ||| S:38576 E:38581 ||| IN
10  ||| S:38581 E:38584 ||| CD
column  ||| S:38584 E:38591 ||| NN
volumes  ||| S:38591 E:38599 ||| NNS
of  ||| S:38599 E:38602 ||| IN
NP40  ||| S:38602 E:38607 ||| NNP
Lysis  ||| S:38607 E:38613 ||| NNP
buffer ||| S:38613 E:38619 ||| NN
,  ||| S:38619 E:38621 ||| ,
and  ||| S:38621 E:38635 ||| CC
then  ||| S:38635 E:38640 ||| RB
removing  ||| S:38640 E:38649 ||| VBG
any  ||| S:38649 E:38653 ||| DT
remaining  ||| S:38653 E:38663 ||| VBG
bound  ||| S:38663 E:38669 ||| VBN
material  ||| S:38669 E:38678 ||| NN
by  ||| S:38678 E:38681 ||| IN
boiling  ||| S:38681 E:38689 ||| VBG
the  ||| S:38689 E:38703 ||| DT
Sepharose  ||| S:38703 E:38713 ||| JJ
beads  ||| S:38713 E:38719 ||| NN
in  ||| S:38719 E:38722 ||| IN
SDS  ||| S:38722 E:38726 ||| NNP
sample  ||| S:38726 E:38733 ||| NN
buffer ||| S:38733 E:38739 ||| NN
.  ||| S:38739 E:38741 ||| .
Samples  ||| S:38741 E:38749 ||| NNS
were  ||| S:38749 E:38764 ||| VBD
separated  ||| S:38764 E:38774 ||| VBN
on  ||| S:38774 E:38777 ||| IN
4-20 ||| S:38777 E:38781 ||| CD
%  ||| S:38781 E:38783 ||| NN
Novex  ||| S:38783 E:38789 ||| NNP
SDS-PAGE  ||| S:38789 E:38798 ||| JJ
gels ||| S:38798 E:38802 ||| NN
,  ||| S:38802 E:38804 ||| ,
the  ||| S:38804 E:38808 ||| DT
gels  ||| S:38808 E:38813 ||| NN
were  ||| S:38813 E:38828 ||| VBD
fixed  ||| S:38828 E:38834 ||| VBN
and  ||| S:38834 E:38838 ||| CC
dried  ||| S:38838 E:38844 ||| NNS
and  ||| S:38844 E:38848 ||| CC
the  ||| S:38848 E:38852 ||| DT
radioactive  ||| S:38852 E:38864 ||| JJ
material  ||| S:38864 E:38873 ||| NN
was  ||| S:38873 E:38877 ||| VBD
detected  ||| S:38877 E:38896 ||| VBN
by  ||| S:38896 E:38899 ||| IN
using  ||| S:38899 E:38905 ||| VBG
a  ||| S:38905 E:38907 ||| DT
phosphorimager ||| S:38907 E:38921 ||| NN
.  ||| S:38921 E:38947 ||| .
